MoonMoon的个人主页 - 老虎社区

MoonMoon

MoonMoon

暂无个人介绍

IP属地：未知

28关注

24粉丝

0主题

0勋章

2021-12-22

Hi

Gold holds tight range as higher yields counter Omicron fears

2021-12-19

Like

5 Growth Stocks to Buy Now for 2022

2021-12-18

$CapLand China T(AU8U.SI)$Missed the bottom:(

2021-12-17

Like

Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022

2021-12-16

Hi

Roku Stock Tumbled. Some See a Buying Opportunity.

2021-12-15

Hi

Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation

2021-12-12

Hi

Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035

2021-12-10

Hi

Carsome, Grab collaborate on 'Own Your Ride Campaign'

2021-12-08

Hi

Confluent Announces Proposed $1.0 Billion Offering of Convertible Senior Notes

2021-12-07

Like

Palantir Technologies (PLTR) Is One Of The Best Technology Stocks According To Stanley Druckenmiller

2021-12-06

Like

Alibaba's HK stock tumbles to record low on e-commerce rejig plan

2021-12-05

Cool

Ford aims to be world's #2 electric vehicle maker within two years - COO

2021-12-03

Like

5 Stocks To Watch For December 3, 2021

2021-12-02

Is the dividend sustainable?

2 Ridiculously Cheap Dividend Stocks To Buy for 2022

2021-12-01

Like

Regeneron's COVID-19 antibody drug may be less effective against Omicron

2021-11-30

Like

抱歉，原内容已删除

2021-11-29

Like

November jobs report: What to know this week

2021-11-28

Like

Google, Dell Lead Five Diverse Stocks Near Buy Points

2021-11-26

Like pls

Zoom shares jumped nearly 10% in premarket trading

2021-11-25

Lol why she WB sell

If Only Berkshire Hathaway Had Listened To Us, And Why It's Time To Exit Apple

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":"3581831647982295","uuid":"3581831647982295","gmtCreate":1618739147766,"gmtModify":1625294153718,"name":"MoonMoon","pinyin":"moonmoon","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":24,"headSize":28,"tweetSize":172,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.09.02","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.08.13","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"35ec162348d5460f88c959321e554969-1","templateUuid":"35ec162348d5460f88c959321e554969","name":"精英交易员","description":"证券或期货账户累计交易次数达到30次","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.03.23","exceedPercentage":"60.47%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":2,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":691327574,"gmtCreate":1640140039586,"gmtModify":1640140039874,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/691327574","repostId":"2193164050","repostType":4,"repost":{"id":"2193164050","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640138715,"share":"https://www.laohu8.com/m/news/2193164050?lang=&edition=full","pubTime":"2021-12-22 10:05","market":"us","language":"en","title":"Gold holds tight range as higher yields counter Omicron fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2193164050","media":"Reuters","summary":"Dec 22 (Reuters) - Gold traded within a tight range on Wednesday as higher U.S. Treasury yields and ","content":"<p>Dec 22 (Reuters) - Gold traded within a tight range on Wednesday as higher U.S. Treasury yields and improved risk appetite countered concerns about the rapidly spreading Omicron coronavirus variant.</p>\n<p><b>FUNDAMENTALS</b></p>\n<p>Spot gold was little changed at $1,789.12 per ounce by 0126 GMT. U.S. gold futures&nbsp;also remained unchanged, at $1,789.50.</p>\n<p>U.S. Treasury yields were higher on Tuesday as traders focused on optimistic economic conditions and discounted inflation fears at a 20-year bond auction. Higher yields increase the opportunity cost of holding bullion, which pays no interest.</p>\n<p>Global shares rose, with European and U.S. stocks rebounding on renewed risk appetite, despite the surging number of Omicron cases around the world.</p>\n<p>Countries across Europe considered new curbs on movement on Tuesday while U.S. President Joe Biden appealed to all Americans to get vaccinated to fight the Omicron variant sweeping the world days before the second Christmas of the pandemic.</p>\n<p>The U.S. Food and Drug Administration is set to authorise COVID-19 treatment pills from both Pfizer Inc&nbsp;and Merck&nbsp;as early as Wednesday, Bloomberg News reported, citing people familiar with the matter.</p>\n<p>The dollar index&nbsp;edged lower, starting a third successive session under pressure as investors favoured riskier currencies and asset classes.</p>\n<p>Spot silver&nbsp;was down 0.1% at $22.47 an ounce, platinum&nbsp;shed 0.3% to $931.99 and palladium&nbsp;was up 0.2% at $1,795.17.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Gold holds tight range as higher yields counter Omicron fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGold holds tight range as higher yields counter Omicron fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-22 10:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 22 (Reuters) - Gold traded within a tight range on Wednesday as higher U.S. Treasury yields and improved risk appetite countered concerns about the rapidly spreading Omicron coronavirus variant.</p>\n<p><b>FUNDAMENTALS</b></p>\n<p>Spot gold was little changed at $1,789.12 per ounce by 0126 GMT. U.S. gold futures&nbsp;also remained unchanged, at $1,789.50.</p>\n<p>U.S. Treasury yields were higher on Tuesday as traders focused on optimistic economic conditions and discounted inflation fears at a 20-year bond auction. Higher yields increase the opportunity cost of holding bullion, which pays no interest.</p>\n<p>Global shares rose, with European and U.S. stocks rebounding on renewed risk appetite, despite the surging number of Omicron cases around the world.</p>\n<p>Countries across Europe considered new curbs on movement on Tuesday while U.S. President Joe Biden appealed to all Americans to get vaccinated to fight the Omicron variant sweeping the world days before the second Christmas of the pandemic.</p>\n<p>The U.S. Food and Drug Administration is set to authorise COVID-19 treatment pills from both Pfizer Inc&nbsp;and Merck&nbsp;as early as Wednesday, Bloomberg News reported, citing people familiar with the matter.</p>\n<p>The dollar index&nbsp;edged lower, starting a third successive session under pressure as investors favoured riskier currencies and asset classes.</p>\n<p>Spot silver&nbsp;was down 0.1% at $22.47 an ounce, platinum&nbsp;shed 0.3% to $931.99 and palladium&nbsp;was up 0.2% at $1,795.17.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"159934":"黄金ETF","518880":"黄金ETF","GLD":"SPDR黄金ETF","NUGT":"二倍做多黄金矿业指数ETF-Direxion","DUST":"二倍做空黄金矿业指数ETF-Direxion","GDX":"黄金矿业ETF-VanEck","IAU":"黄金信托ETF(iShares)"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193164050","content_text":"Dec 22 (Reuters) - Gold traded within a tight range on Wednesday as higher U.S. Treasury yields and improved risk appetite countered concerns about the rapidly spreading Omicron coronavirus variant.\nFUNDAMENTALS\nSpot gold was little changed at $1,789.12 per ounce by 0126 GMT. U.S. gold futures also remained unchanged, at $1,789.50.\nU.S. Treasury yields were higher on Tuesday as traders focused on optimistic economic conditions and discounted inflation fears at a 20-year bond auction. Higher yields increase the opportunity cost of holding bullion, which pays no interest.\nGlobal shares rose, with European and U.S. stocks rebounding on renewed risk appetite, despite the surging number of Omicron cases around the world.\nCountries across Europe considered new curbs on movement on Tuesday while U.S. President Joe Biden appealed to all Americans to get vaccinated to fight the Omicron variant sweeping the world days before the second Christmas of the pandemic.\nThe U.S. Food and Drug Administration is set to authorise COVID-19 treatment pills from both Pfizer Inc and Merck as early as Wednesday, Bloomberg News reported, citing people familiar with the matter.\nThe dollar index edged lower, starting a third successive session under pressure as investors favoured riskier currencies and asset classes.\nSpot silver was down 0.1% at $22.47 an ounce, platinum shed 0.3% to $931.99 and palladium was up 0.2% at $1,795.17.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1115,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699711193,"gmtCreate":1639893315730,"gmtModify":1639893315997,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/699711193","repostId":"2192903795","repostType":4,"repost":{"id":"2192903795","pubTimestamp":1639880431,"share":"https://www.laohu8.com/m/news/2192903795?lang=&edition=full","pubTime":"2021-12-19 10:20","market":"us","language":"en","title":"5 Growth Stocks to Buy Now for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192903795","media":"Motley Fool","summary":"Can these five stock picks boost your 2022 gains?","content":"<p>Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.</p>\n<p><a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a> is the first stock on the list. It's easy to see why some investors would shy away from Nvidia at these levels. The stock price has delivered over 67,000% returns since going public in 1999. A $10,000 investment would be worth approximately $6.7 million today. But the company is firing on all cylinders, and when you look under the hood, you will find that its future looks very bright, which can arguably justify the premium share price. Nvidia has its hands in nearly every secular tailwind imaginable:</p>\n<ul>\n <li>Data centers</li>\n <li>Cloud computing</li>\n <li>Cybersecurity&nbsp;</li>\n <li>Space exploration</li>\n <li>Video gaming</li>\n <li>Online gambling</li>\n <li>Augmented reality (AR)</li>\n <li>Virtual reality (VR)</li>\n <li>Mixed reality (MR)</li>\n <li>Autonomous driving</li>\n <li>Electric vehicles</li>\n <li>Genomics</li>\n <li>Esports</li>\n <li>5G</li>\n <li>E-commerce</li>\n <li>Cryptocurrency</li>\n <li>Artificial intelligence (AI)</li>\n <li>Metaverse</li>\n <li>Big data</li>\n</ul>\n<p><a href=\"https://laohu8.com/S/TSLA\"><b>Tesla</b> </a> has made a historic run over the past couple of years, but with Elon Musk at the helm, the future still looks very bright. The company continues to grow rapidly while improving net profit margins and cash flows. The EV super cycle is just getting started, and Tesla is poised to be top dog. Not only is Tesla a top autonomous and electric vehicle manufacturer, it is, in my opinion, also the best artificial intelligence company in the world.&nbsp;</p>\n<p><b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> offers what it calls a \"data warehouse-as-a-service\" (DaaS), a cloud-based data storage and analytics solution. Think \"big data.\" Interestingly, Snowflake is not a SaaS company since its revenue is over 90% consumption based. Snowflake reduces cost and improves agility. Its data platform is unique in that it is not built on an existing big data platform. In addition to big data and analytics, I believe Snowflake is positioned well to create a unique digital advertising moat, which I discuss in detail here.&nbsp;I have been a fan of this stock since pre-IPO, and I have high conviction long term.</p>\n<p><a href=\"https://laohu8.com/S/U\"><b>Unity Software</b>&nbsp;</a>&nbsp;is best known for gaming. It provides tools and software to assist developers in game creation and marketing. In 2019, over 50% of the top 1,000 mobile games were created using Unity. Unity has players in 195 countries, so it's literally a global company. Unity powers billon-dollar mobile games like <i>Pokémon Go</i> and <i>Angry Birds</i>.&nbsp;</p>\n<p>But augmented reality (AR) and virtual reality (VR) are why I personally own the stock. Think metaverse! However, Unity is actually quite diverse in terms of its offerings and industry segments. Here are some other areas Unity works in outside of gaming:</p>\n<ul>\n <li>Automotive, transportation, and manufacturing</li>\n <li>Film, animation, and cinematics</li>\n <li>Architecture, engineering, and construction</li>\n <li>Government and aerospace</li>\n <li>Gambling</li>\n</ul>\n<p><b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b> (NYSE:PATH) is a global software company focused on robotic process automation, also called RPA. The company's software enables organizations to automate data entry and repetitive tasks. RPA technology makes it simple for businesses to build, deploy, and manage bots. These software robots emulate human actions and provide many benefits. Examples include:</p>\n<ul>\n <li>Increased production times</li>\n <li>Reduction of costs</li>\n <li>Increased employee creativity and innovation</li>\n <li>Improved efficiency</li>\n <li>Increased employee happiness and retention</li>\n <li>Improved process quality</li>\n <li>Higher employee productivity</li>\n <li>Improved customer service</li>\n</ul>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Growth Stocks to Buy Now for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Growth Stocks to Buy Now for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.\nNvidia  is the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"U":"Unity Software Inc.","BK4555":"新能源车","SNOW":"Snowflake","BK4533":"AQR资本管理(全球第二大对冲基金)","NVDA":"英伟达","BK4535":"淡马锡持仓","BK4543":"AI","BK4559":"巴菲特持仓","TSLA":"特斯拉","BK4527":"明星科技股","BK4550":"红杉资本持仓","BK4116":"互联网服务与基础架构","BK4141":"半导体产品","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4097":"系统软件","BK4505":"高瓴资本持仓","VR":"GLOBAL X METAVERSE ETF","BK4549":"软银资本持仓","PATH":"UiPath","BK4099":"汽车制造商","BK4548":"巴美列捷福持仓","BK4529":"IDC概念","BK4213":"石油与天然气的勘探与生产","BK4528":"SaaS概念","BK4023":"应用软件","BK4539":"次新股","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4567":"ESG概念","BK4534":"瑞士信贷持仓"},"source_url":"https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192903795","content_text":"Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.\nNvidia  is the first stock on the list. It's easy to see why some investors would shy away from Nvidia at these levels. The stock price has delivered over 67,000% returns since going public in 1999. A $10,000 investment would be worth approximately $6.7 million today. But the company is firing on all cylinders, and when you look under the hood, you will find that its future looks very bright, which can arguably justify the premium share price. Nvidia has its hands in nearly every secular tailwind imaginable:\n\nData centers\nCloud computing\nCybersecurity \nSpace exploration\nVideo gaming\nOnline gambling\nAugmented reality (AR)\nVirtual reality (VR)\nMixed reality (MR)\nAutonomous driving\nElectric vehicles\nGenomics\nEsports\n5G\nE-commerce\nCryptocurrency\nArtificial intelligence (AI)\nMetaverse\nBig data\n\nTesla  has made a historic run over the past couple of years, but with Elon Musk at the helm, the future still looks very bright. The company continues to grow rapidly while improving net profit margins and cash flows. The EV super cycle is just getting started, and Tesla is poised to be top dog. Not only is Tesla a top autonomous and electric vehicle manufacturer, it is, in my opinion, also the best artificial intelligence company in the world. \nSnowflake offers what it calls a \"data warehouse-as-a-service\" (DaaS), a cloud-based data storage and analytics solution. Think \"big data.\" Interestingly, Snowflake is not a SaaS company since its revenue is over 90% consumption based. Snowflake reduces cost and improves agility. Its data platform is unique in that it is not built on an existing big data platform. In addition to big data and analytics, I believe Snowflake is positioned well to create a unique digital advertising moat, which I discuss in detail here. I have been a fan of this stock since pre-IPO, and I have high conviction long term.\nUnity Software  is best known for gaming. It provides tools and software to assist developers in game creation and marketing. In 2019, over 50% of the top 1,000 mobile games were created using Unity. Unity has players in 195 countries, so it's literally a global company. Unity powers billon-dollar mobile games like Pokémon Go and Angry Birds. \nBut augmented reality (AR) and virtual reality (VR) are why I personally own the stock. Think metaverse! However, Unity is actually quite diverse in terms of its offerings and industry segments. Here are some other areas Unity works in outside of gaming:\n\nAutomotive, transportation, and manufacturing\nFilm, animation, and cinematics\nArchitecture, engineering, and construction\nGovernment and aerospace\nGambling\n\nUiPath (NYSE:PATH) is a global software company focused on robotic process automation, also called RPA. The company's software enables organizations to automate data entry and repetitive tasks. RPA technology makes it simple for businesses to build, deploy, and manage bots. These software robots emulate human actions and provide many benefits. Examples include:\n\nIncreased production times\nReduction of costs\nIncreased employee creativity and innovation\nImproved efficiency\nIncreased employee happiness and retention\nImproved process quality\nHigher employee productivity\nImproved customer service","news_type":1},"isVote":1,"tweetType":1,"viewCount":1151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699203468,"gmtCreate":1639800324899,"gmtModify":1639800325224,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/AU8U.SI\">$CapLand China T(AU8U.SI)$</a>Missed the bottom:(","listText":"<a href=\"https://laohu8.com/S/AU8U.SI\">$CapLand China T(AU8U.SI)$</a>Missed the bottom:(","text":"$CapLand China T(AU8U.SI)$Missed the bottom:(","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699203468","isVote":1,"tweetType":1,"viewCount":1140,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690751483,"gmtCreate":1639712146541,"gmtModify":1639712542601,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/690751483","repostId":"1162808117","repostType":4,"repost":{"id":"1162808117","pubTimestamp":1639709791,"share":"https://www.laohu8.com/m/news/1162808117?lang=&edition=full","pubTime":"2021-12-17 10:56","market":"us","language":"en","title":"Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1162808117","media":"InvestorPlace","summary":"It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstoc","content":"<p>It's time to decide which of these meme stocks are good investments</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/328b1ec2a89b0b45da9884d8db54b98f\" tg-width=\"1024\" tg-height=\"576\" width=\"100%\" height=\"auto\"><span>Source: Michael Vi / Shutterstock.com</span></p>\n<p>We’re past the point of denial about meme stocks. What looked unsustainable nine months ago is proving to have staying power. Retail investors continue to identify their favorite stocks and drive up the price.</p>\n<p>The bullish case for meme stocks says that retail investors, with more research available to them than ever before, are willing to take a risk on companies that may be the next&nbsp;<b>Amazon</b>(NASDAQ:<b><u>AMZN</u></b>). The bearish case is that they may be propping up companies that deserve to trade for much, much lower.</p>\n<p>Who’s to say which side is right? I tend to believe that some of the moral outrage being expressed by retail investors against hedge funds is a rationale to avoid admitting that they’re investment strategy is similar to gambling. But there are many things in life that are a gamble and it’s not my money.</p>\n<p>That argument will continue to play out in 2022. So it may be interesting to look at 10 meme stocks that have been part of the this movement in 2021. And it’s also time to take a look at how these stocks may fare in 2022.</p>\n<ul>\n <li><b>GameStop</b>(NYSE:<b><u>GME</u></b>)</li>\n <li><b>AMC Entertainment</b>(NYSE:<b><u>AMC</u></b>)</li>\n <li><b>BlackBerry</b>(NYSE:<b><u>BB</u></b>)</li>\n <li><b>Clover Health</b>(NASDAQ:<b><u>CLOV</u></b>)</li>\n <li><b>Zomedica</b>(NYSE:<b><u>ZOM</u></b>)</li>\n <li><b>Sundial Growers</b>(NASDAQ:<b><u>SNDL</u></b>)</li>\n <li><b>Bed Bath &amp; Beyond</b>(NASDAQ:<b><u>BBBY</u></b>)</li>\n <li><b>Tesla</b>(NASDAQ:<b><u>TSLA</u></b>)</li>\n <li><b>ContextLogic</b>(NASDAQ:<b><u>WISH</u></b>)</li>\n <li><b>XPresSpa</b>(NASDAQ:<b><u>XSPA</u></b>)</li>\n</ul>\n<p><b>GameStop (GME)</b></p>\n<p>GameStop is the company that made the terms “meme stocks” and “short squeeze” household names. The initial surge in GME stock was caused by retail investors who identified a high level of short interest in the stock. This led to the short squeeze to end all short squeezes. GameStop stock moved from $17.25 to a closing price of $347.51 in late January.</p>\n<p>However, a&nbsp;recent report&nbsp;from the&nbsp;<b>Securities &amp; Exchange Commission</b>(SEC) confirms that the rise in the GME stock price was largely due to retail investors continuing to bid the stock higher, not as much short sellers covering their position.</p>\n<p>Needless to say, the stock price wasn’t sustainable, but GME stock is still up over 600% in 2021. It’s unrealistic to expect that the company will deliver that kind of performance in 2022. The company’s ability to pivot from a brick-and-mortar to a digital model has yet to be determined. But at this point, loyal GameStop investors believe in the stock, and that may be enough to push the stock higher.</p>\n<p><b>AMC Entertainment (AMC)</b></p>\n<p>When it comes to meme stocks, AMC Entertainment is the Robin to GameStop’s Batman. However, the AMC apes may say the opposite is true. It really doesn’t matter. What matters is that the committed AMC army has seen the stock post a 1,000% gain in 2021.</p>\n<p>The company is known for its chain of movie theatres. That was a troubled business model prior to the pandemic. However, as is the case with GameStop, the stock is not moving forward because investors are putting stock in the company’s current fundamentals; they have their eyes fixed on the future.</p>\n<p>Between AMC’s move into the non-fungible token (NFT) space and its willingness to accept some forms of cryptocurrency, the retail crowd believes there’s an emerging growth story for AMC stock.</p>\n<p>I don’t share that belief. Revenue for 2021 is expected to be about a billion dollars shy of where it was in 2019. Yet at this point in 2019, AMC stock was trading at around $8. As for 2022, the loyalty of retail investors could prop up the stock for some time to come. However, like GameStop, conservative investors should stay far away.</p>\n<p><b>BlackBerry (BB)</b></p>\n<p>BlackBerry may be best known to some people as the manufacturer of the mobile phone of the same name. And while some people may long to have their BlackBerry, the larger story of the company had to do with the safety and security that was built into the product. That’s because BlackBerry is, at its core, a software company.</p>\n<p>And that’s why, if you’re looking to buy the stock in 2022, you’ll want to look at their cybersecurity offerings that currently accounts for approximately two-thirds of BlackBerry’s revenue.</p>\n<p>There is some sentiment that BlackBerry is an acquisition target. However, the reason to buy BB stock is for its strategic partnerships with&nbsp;<b>Microsoft</b>(NASDAQ:<b><u>MSFT</u></b>) and Amazon. The latter is the most intriguing because it will allow BlackBerry’s Intelligent Vehicle Data Platform (IVY) to provide a&nbsp;consistent and secure common app&nbsp;that can be used for autonomous driving.</p>\n<p>Although the autonomous vehicle (AV) future may be years away, if you believe in that future, a small, speculative position in BB stock may pay off in the long run.</p>\n<p><b>Clover Health (CLOV)</b></p>\n<p>Like many companies on this list, the risk/reward calculus for Clover Health in 2022 comes down to its ability to generate revenue with its Clover Assistant. The Clover Assistant uses AI and predictive analysis to give doctors actionable patient care information that will drive better health outcomes.</p>\n<p>The bullish case says that by focusing on Medicare Advantage patients, Clover Health has a huge addressable market. The flipside to that argument is that many doctors the company is targeting don’t have that many Medicare Advantage patients.</p>\n<p>And, because of the regulatory environment that surrounds Medicate Advantage, it may not be as profitable as expected. One way that the company may look to address this is by opening up the Clover Assistant to fee-for-service Medicare patients.</p>\n<p>With that said, CLOV stock does have a $9 price target from the analyst community, which suggests that risk-tolerant investors may be rewarded for their investment.</p>\n<p><b>Zomedica (ZOM)</b></p>\n<p>I’ve followed Zomedica for most of 2021 and thought it was miscast as a meme stock. But the stock chart says it all. ZOM stock was literally a penny stock in December 2020. But in the first two months of 2021, it soared to over $2 a share. It’s since fallen back and is now back in penny stock territory.</p>\n<p>The story of Zomedica will come down to the acceptance of its Truforma product. This allows veterinarians to run diagnostic tests in their offices that they currently would have to send to an outside lab at additional time and expense. The company has launched a Customer Appreciation Program that will seed the product in veterinarian offices at no cost. The catalyst is that the offices make an agreement to buy the assays that are required to run the diagnostic tests directly from Zomedica.</p>\n<p>The company also recently acquired PulseVet, which gives the company another revenue-generation opportunity for the company that should start contributing to the company’s revenue in the next few quarters.</p>\n<p><b>Sundial Growers (SNDL)</b></p>\n<p>The cannabis sector continues to draw speculative interest, although profitability still seems to be years away. And Sundial Growers remains one of the most volatile stocks in the sector.</p>\n<p>If you’re going to invest in SNDL stock in 2022, you have to be convinced that their business model will work. But before you answer that question, you have to buy into what that business model is. It appears that the most profitable path is if the company can benefit from its affiliate filing an application to be a Business Development Company (BDC).</p>\n<p>This would seem like a better option than trying to forge a path ahead as a cannabis retailer. That continues to be a difficult path for any cannabis company, particularly as legalization in the United States is likely going to take longer than expected.</p>\n<p><b>Bed Bath &amp; Beyond (BBBY)</b></p>\n<p>Bed Bath &amp; Beyond is a curious case among the meme stocks. I can’t say the company is doing anything definitively wrong. But it’s also not doing anything that justifies a stock price that at one point was over $35 a share in 2021.</p>\n<p>That’s why it’s part of this meme stock list, because retail investors have figured out a formula and they’re making it work. Still, you have to be careful with your expectations. The company’s revenue and earnings are still down from pre-pandemic levels and yet the stock price is above pre-pandemic levels.</p>\n<p>The company recently announced a partnership with&nbsp;<b>Kroger</b>(NYSE:<b><u>KR</u></b>) that got some investors excited. However, it doesn’t appear to be a move that will be noticeable to the bottom line for several quarters, if ever.</p>\n<p>Bed Bath &amp; Beyond is making some moves to close underperforming stores and introduce private-label brands. But it’s unclear how much playing defense will be able to help, which makes BBBY stock a risky option in 2022.</p>\n<p><b>Tesla (TSLA)</b></p>\n<p>Before meme stocks were a thing, there was Tesla. And one thing you can say about owning TSLA is that there’s never a dull moment. After the stock climbed to over $1,200 a share this year, it’s down to around $930, and that still has rewarded investors to the tune of a 32% gain for the year.</p>\n<p>I’ve long felt that TSLA stock is valued the way it is because investors view it as a technology play more than an electric vehicle (EV) play. However, it would seem that the company’s immediate fortunes will depend on its EV business, which should be a catalyst in 2022.</p>\n<p>Faisal Humayun recently wrote, Tesla plans to launch a&nbsp;$25,000 fully autonomous electric vehicle. That would be a clear game changer in terms of market share. And with $16.1 billion of cash on hand, the company has the balance sheet to invest in future expansion and innovation.</p>\n<p><b>ContextLogic (WISH)</b></p>\n<p>The only words I can offer to those looking to invest in ContextLogic is let the buyer beware. I can’t say the company isn’t trying to improve its financial situation. But the long-term outlook for WISH stock is troubled. And it’s unclear what the sales outlook is.&nbsp; Plus, the company’s founder and chief executive officer (CEO) announced he will be stepping aside as soon as a replacement is found.</p>\n<p>On the other hand, if you’re a believer in the speculative nature of the meme stock movement, then there are few stocks that bear it out more than WISH stock. The stock continues to be propped up by retail investors. And the analyst community gives the company a share price of over $11. That’s a gain of over 250% from its current price.</p>\n<p>But short interest remains high. And if you’re looking to open a position on WISH stock, you may want to wait until the outlook becomes clear.</p>\n<p><b>XPresSpa (XSPA)</b></p>\n<p>I have to admit, if someone had told me there was a business case for XpresSpa Group in 2022, I would have been skeptical. And while I won’t be buying XSPA stock anytime soon, I’ll let you decide for yourself.</p>\n<p>For those who are unfamiliar, the company has two business units. Its namesake unit, XpresSpa, offers premium spa services and “exclusive travel products and accessories through partnership with some of the leading cosmetics brands in the world.”</p>\n<p>However, with the collapse of travel during the Covid-19 pandemic, the company made a strategic pivot to turn their existing facilities into Covid-19 testing facilities. The idea was to have a location for airline crews and passengers to get fast, convenient testing at the airport.</p>\n<p>And as the pandemic remains in the public consciousness, rapid testing will remain a viable option, particularly as a significant segment of the population remains unvaccinated. However, it’s fair to question how much revenue the company can generate from this model. The company was continuing to lose money so it’s certainly not enough to be profitable.</p>\n<p>And with the company losing money prior to the pandemic in its prior business model, this is still a speculative bet.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top 10 Meme Stocks of 2021 and How They’ll Fare in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop 10 Meme Stocks of 2021 and How They’ll Fare in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-17 10:56 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstock.com\nWe’re past the point of denial about meme stocks. What looked unsustainable nine months ago is...</p>\n\n<a href=\"https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","ZOM":"Zomedica Pharmaceuticals Corp.","CLOV":"Clover Health Corp","BB":"黑莓","GME":"游戏驿站","AMC":"AMC院线","SNDL":"SNDL Inc.","BBBY":"3B家居"},"source_url":"https://investorplace.com/2021/12/top-10-meme-stocks-and-how-they-fare-in-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1162808117","content_text":"It's time to decide which of these meme stocks are good investments\nSource: Michael Vi / Shutterstock.com\nWe’re past the point of denial about meme stocks. What looked unsustainable nine months ago is proving to have staying power. Retail investors continue to identify their favorite stocks and drive up the price.\nThe bullish case for meme stocks says that retail investors, with more research available to them than ever before, are willing to take a risk on companies that may be the next Amazon(NASDAQ:AMZN). The bearish case is that they may be propping up companies that deserve to trade for much, much lower.\nWho’s to say which side is right? I tend to believe that some of the moral outrage being expressed by retail investors against hedge funds is a rationale to avoid admitting that they’re investment strategy is similar to gambling. But there are many things in life that are a gamble and it’s not my money.\nThat argument will continue to play out in 2022. So it may be interesting to look at 10 meme stocks that have been part of the this movement in 2021. And it’s also time to take a look at how these stocks may fare in 2022.\n\nGameStop(NYSE:GME)\nAMC Entertainment(NYSE:AMC)\nBlackBerry(NYSE:BB)\nClover Health(NASDAQ:CLOV)\nZomedica(NYSE:ZOM)\nSundial Growers(NASDAQ:SNDL)\nBed Bath & Beyond(NASDAQ:BBBY)\nTesla(NASDAQ:TSLA)\nContextLogic(NASDAQ:WISH)\nXPresSpa(NASDAQ:XSPA)\n\nGameStop (GME)\nGameStop is the company that made the terms “meme stocks” and “short squeeze” household names. The initial surge in GME stock was caused by retail investors who identified a high level of short interest in the stock. This led to the short squeeze to end all short squeezes. GameStop stock moved from $17.25 to a closing price of $347.51 in late January.\nHowever, a recent report from the Securities & Exchange Commission(SEC) confirms that the rise in the GME stock price was largely due to retail investors continuing to bid the stock higher, not as much short sellers covering their position.\nNeedless to say, the stock price wasn’t sustainable, but GME stock is still up over 600% in 2021. It’s unrealistic to expect that the company will deliver that kind of performance in 2022. The company’s ability to pivot from a brick-and-mortar to a digital model has yet to be determined. But at this point, loyal GameStop investors believe in the stock, and that may be enough to push the stock higher.\nAMC Entertainment (AMC)\nWhen it comes to meme stocks, AMC Entertainment is the Robin to GameStop’s Batman. However, the AMC apes may say the opposite is true. It really doesn’t matter. What matters is that the committed AMC army has seen the stock post a 1,000% gain in 2021.\nThe company is known for its chain of movie theatres. That was a troubled business model prior to the pandemic. However, as is the case with GameStop, the stock is not moving forward because investors are putting stock in the company’s current fundamentals; they have their eyes fixed on the future.\nBetween AMC’s move into the non-fungible token (NFT) space and its willingness to accept some forms of cryptocurrency, the retail crowd believes there’s an emerging growth story for AMC stock.\nI don’t share that belief. Revenue for 2021 is expected to be about a billion dollars shy of where it was in 2019. Yet at this point in 2019, AMC stock was trading at around $8. As for 2022, the loyalty of retail investors could prop up the stock for some time to come. However, like GameStop, conservative investors should stay far away.\nBlackBerry (BB)\nBlackBerry may be best known to some people as the manufacturer of the mobile phone of the same name. And while some people may long to have their BlackBerry, the larger story of the company had to do with the safety and security that was built into the product. That’s because BlackBerry is, at its core, a software company.\nAnd that’s why, if you’re looking to buy the stock in 2022, you’ll want to look at their cybersecurity offerings that currently accounts for approximately two-thirds of BlackBerry’s revenue.\nThere is some sentiment that BlackBerry is an acquisition target. However, the reason to buy BB stock is for its strategic partnerships with Microsoft(NASDAQ:MSFT) and Amazon. The latter is the most intriguing because it will allow BlackBerry’s Intelligent Vehicle Data Platform (IVY) to provide a consistent and secure common app that can be used for autonomous driving.\nAlthough the autonomous vehicle (AV) future may be years away, if you believe in that future, a small, speculative position in BB stock may pay off in the long run.\nClover Health (CLOV)\nLike many companies on this list, the risk/reward calculus for Clover Health in 2022 comes down to its ability to generate revenue with its Clover Assistant. The Clover Assistant uses AI and predictive analysis to give doctors actionable patient care information that will drive better health outcomes.\nThe bullish case says that by focusing on Medicare Advantage patients, Clover Health has a huge addressable market. The flipside to that argument is that many doctors the company is targeting don’t have that many Medicare Advantage patients.\nAnd, because of the regulatory environment that surrounds Medicate Advantage, it may not be as profitable as expected. One way that the company may look to address this is by opening up the Clover Assistant to fee-for-service Medicare patients.\nWith that said, CLOV stock does have a $9 price target from the analyst community, which suggests that risk-tolerant investors may be rewarded for their investment.\nZomedica (ZOM)\nI’ve followed Zomedica for most of 2021 and thought it was miscast as a meme stock. But the stock chart says it all. ZOM stock was literally a penny stock in December 2020. But in the first two months of 2021, it soared to over $2 a share. It’s since fallen back and is now back in penny stock territory.\nThe story of Zomedica will come down to the acceptance of its Truforma product. This allows veterinarians to run diagnostic tests in their offices that they currently would have to send to an outside lab at additional time and expense. The company has launched a Customer Appreciation Program that will seed the product in veterinarian offices at no cost. The catalyst is that the offices make an agreement to buy the assays that are required to run the diagnostic tests directly from Zomedica.\nThe company also recently acquired PulseVet, which gives the company another revenue-generation opportunity for the company that should start contributing to the company’s revenue in the next few quarters.\nSundial Growers (SNDL)\nThe cannabis sector continues to draw speculative interest, although profitability still seems to be years away. And Sundial Growers remains one of the most volatile stocks in the sector.\nIf you’re going to invest in SNDL stock in 2022, you have to be convinced that their business model will work. But before you answer that question, you have to buy into what that business model is. It appears that the most profitable path is if the company can benefit from its affiliate filing an application to be a Business Development Company (BDC).\nThis would seem like a better option than trying to forge a path ahead as a cannabis retailer. That continues to be a difficult path for any cannabis company, particularly as legalization in the United States is likely going to take longer than expected.\nBed Bath & Beyond (BBBY)\nBed Bath & Beyond is a curious case among the meme stocks. I can’t say the company is doing anything definitively wrong. But it’s also not doing anything that justifies a stock price that at one point was over $35 a share in 2021.\nThat’s why it’s part of this meme stock list, because retail investors have figured out a formula and they’re making it work. Still, you have to be careful with your expectations. The company’s revenue and earnings are still down from pre-pandemic levels and yet the stock price is above pre-pandemic levels.\nThe company recently announced a partnership with Kroger(NYSE:KR) that got some investors excited. However, it doesn’t appear to be a move that will be noticeable to the bottom line for several quarters, if ever.\nBed Bath & Beyond is making some moves to close underperforming stores and introduce private-label brands. But it’s unclear how much playing defense will be able to help, which makes BBBY stock a risky option in 2022.\nTesla (TSLA)\nBefore meme stocks were a thing, there was Tesla. And one thing you can say about owning TSLA is that there’s never a dull moment. After the stock climbed to over $1,200 a share this year, it’s down to around $930, and that still has rewarded investors to the tune of a 32% gain for the year.\nI’ve long felt that TSLA stock is valued the way it is because investors view it as a technology play more than an electric vehicle (EV) play. However, it would seem that the company’s immediate fortunes will depend on its EV business, which should be a catalyst in 2022.\nFaisal Humayun recently wrote, Tesla plans to launch a $25,000 fully autonomous electric vehicle. That would be a clear game changer in terms of market share. And with $16.1 billion of cash on hand, the company has the balance sheet to invest in future expansion and innovation.\nContextLogic (WISH)\nThe only words I can offer to those looking to invest in ContextLogic is let the buyer beware. I can’t say the company isn’t trying to improve its financial situation. But the long-term outlook for WISH stock is troubled. And it’s unclear what the sales outlook is.  Plus, the company’s founder and chief executive officer (CEO) announced he will be stepping aside as soon as a replacement is found.\nOn the other hand, if you’re a believer in the speculative nature of the meme stock movement, then there are few stocks that bear it out more than WISH stock. The stock continues to be propped up by retail investors. And the analyst community gives the company a share price of over $11. That’s a gain of over 250% from its current price.\nBut short interest remains high. And if you’re looking to open a position on WISH stock, you may want to wait until the outlook becomes clear.\nXPresSpa (XSPA)\nI have to admit, if someone had told me there was a business case for XpresSpa Group in 2022, I would have been skeptical. And while I won’t be buying XSPA stock anytime soon, I’ll let you decide for yourself.\nFor those who are unfamiliar, the company has two business units. Its namesake unit, XpresSpa, offers premium spa services and “exclusive travel products and accessories through partnership with some of the leading cosmetics brands in the world.”\nHowever, with the collapse of travel during the Covid-19 pandemic, the company made a strategic pivot to turn their existing facilities into Covid-19 testing facilities. The idea was to have a location for airline crews and passengers to get fast, convenient testing at the airport.\nAnd as the pandemic remains in the public consciousness, rapid testing will remain a viable option, particularly as a significant segment of the population remains unvaccinated. However, it’s fair to question how much revenue the company can generate from this model. The company was continuing to lose money so it’s certainly not enough to be profitable.\nAnd with the company losing money prior to the pandemic in its prior business model, this is still a speculative bet.","news_type":1},"isVote":1,"tweetType":1,"viewCount":994,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690055840,"gmtCreate":1639616181625,"gmtModify":1639616181902,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/690055840","repostId":"1169241179","repostType":4,"repost":{"id":"1169241179","pubTimestamp":1639611934,"share":"https://www.laohu8.com/m/news/1169241179?lang=&edition=full","pubTime":"2021-12-16 07:45","market":"us","language":"en","title":"Roku Stock Tumbled. Some See a Buying Opportunity.","url":"https://stock-news.laohu8.com/highlight/detail?id=1169241179","media":"Barrons","summary":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its","content":"<p>Roku&nbsp;stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with&nbsp;Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.</p>\n<p>Roku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy&nbsp;Nasdaq Composite index&nbsp;up more than 2%, and the&nbsp;S&amp;P 500 index&nbsp;up 1.6%.</p>\n<p>Investors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.</p>\n<p>“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.</p>\n<p>Roku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in&nbsp;Roku’s ability to continue to import products,” Roku said.</p>\n<p>Oppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.</p>\n<p>Aside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.</p>\n<p>Also on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.</p>\n<p>“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”</p>\n<p>Other analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.</p>\n<p>J.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.</p>\n<p>“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.</p>\n<p>He expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Roku Stock Tumbled. Some See a Buying Opportunity.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRoku Stock Tumbled. Some See a Buying Opportunity.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-16 07:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts ...</p>\n\n<a href=\"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ROKU":"Roku Inc"},"source_url":"https://www.barrons.com/articles/roku-stock-tumbled-51639611376?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169241179","content_text":"Roku stock on Wednesday sank to its lowest close in more than a year in the face of an update in its patent feud with Universal Electronics,and an analyst price-target cut. Some bullish analysts downplayed the patent announcement, calling the drop a buying opportunity in the maker of streaming devices.\nRoku (ticker: ROKU) stock fell 7.9% to close at $203.94 on Wednesday, its lowest close since $203.49 on Nov. 3, 2020. The stock is down 58% from July 26, when shares closed at a record $479.50. The Wednesday drop came as remarks from the Fed sent the tech-heavy Nasdaq Composite index up more than 2%, and the S&P 500 index up 1.6%.\nInvestors were caught off guard Wednesday by an announcement by Universal Electronics (UEIC), referring to the public release of the International Trade Commission’s decision in a patent-infringement case, related to technology in certain Roku remote controls. The case was decided in November.\n“We brought this action to protect our highly innovative intellectual property from unauthorized use by Roku, and we are gratified that the ITC recognized Roku’s infringement and ordered it halted,” Universal Electronics said in the news release.\nRoku said in a statement that there were no new developments in the case. “Based on the ITC’s ruling, we do not anticipate any disruption in Roku’s ability to continue to import products,” Roku said.\nOppenheimer analyst Jason Helfstein noted that the news release may have weighed on Roku stock. He called the dip a buying opportunity, pointing to his bullish outlook for connected-television advertising spending. Helfstein rates Roku stock at Outperform with a $400 price target.\nAside from selling streaming devices, the company makes the lion’s share of its sales from certain advertisements and subscriptions made on its platform. Shares have fallen in recent months amid lower expectations for growth as the pandemic’s reopening unfolds.\nAlso on Wednesday, Morgan Stanley analyst Benjamin Swinburne, who has an Underweight rating on Roku stock, slashed his price target to $190 from $295. He does acknowledge that the stock’s risk-reward setup is less skewed toward risk following recent declines in the share price.\n“We believe the market is underestimating the competition on Platform active accounts in the U.S., as well as the time it takes for international expansion to scale,” Swinburne wrote. “Active account growth has benefited strongly in the U.S. from share gains at TCL, and sustained growth will require additional share gains or major new smart TV partners.”\nOther analysts were more upbeat. Benchmark analyst Daniel Kurnos called the stock’s reaction overstated in a Wednesday note. He has a $525 target with a Buy rating on the stock.\nJ.P.Morgan analyst Doug Anmuth called Roku the leading streaming platform in the U.S. by hours streamed, though he did cut his target to $315 from $435.\n“Our bull thesis is largely driven by what we believe to be Roku’s significant advertising opportunity, with streaming accounting for about 42% of TV viewing time for 18-49 year olds in the U.S., but only an estimated about 15% of TV ad budgets,” he wrote.\nHe expects outsize growth in Roku’s advertisements business to drive revenue growth north of 25% year over year through 2024, with profitability improving as the platform segment stabilizes and grows as a percentage of revenue. Anmuth rates Roku stock at Outperform.","news_type":1},"isVote":1,"tweetType":1,"viewCount":926,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607594589,"gmtCreate":1639558297633,"gmtModify":1639558302754,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/607594589","repostId":"1107549050","repostType":4,"repost":{"id":"1107549050","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639552499,"share":"https://www.laohu8.com/m/news/1107549050?lang=&edition=full","pubTime":"2021-12-15 15:14","market":"us","language":"en","title":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation","url":"https://stock-news.laohu8.com/highlight/detail?id=1107549050","media":"Tiger Newspress","summary":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and c","content":"<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 15:14</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation</b></p>\n<ul>\n <li>Positive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile</li>\n <li>Phase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022</li>\n <li>Companies intend to file booster data with regulatory authorities following the Phase 3 results</li>\n</ul>\n<p>Sanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson &amp; Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.</p>\n<p>The ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.</p>\n<p>Regulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.</p>\n<p><i>“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”</i>said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.<i>“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”</i></p>\n<p>Roger Connor, President of GSK Vaccines, added<i>: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"</i></p>\n<p>In parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson &amp; Johnson vaccines.</p>\n<p><b>About the booster trial (VAT0002)</b></p>\n<p>The VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.</p>\n<p>Participants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson &amp; Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.</p>\n<p>The trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.</p>\n<p><b>About the Phase 3 efficacy trial (VAT0008)</b></p>\n<p>The primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants &gt;18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.</p>\n<p>These efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.</p>\n<p><b>About the Sanofi and GSK collaboration</b></p>\n<p>In the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.</p>\n<p><b>About GSK</b></p>\n<p>GSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.</p>\n<p><b>About Sanofi</b></p>\n<p>Sanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.</p>\n<p>With more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNY":"赛诺菲安万特","GSK":"葛兰素史克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107549050","content_text":"Sanofi and GSK announce positive preliminary booster data for their COVID-19 vaccine candidate and continuation of Phase 3 trial per independent Monitoring Board recommendation\n\nPositive booster data show that neutralizing antibodies increased across all primary vaccines received (mRNA or adenovirus) in a 9- to 43-fold range and for all age groups tested, with a good safety and tolerability profile\nPhase 3 trial continues to accrue number of events needed for analysis as populations around the world are increasingly exposed to COVID-19 variants; results expected in Q1, 2022\nCompanies intend to file booster data with regulatory authorities following the Phase 3 results\n\nSanofi and GSK announced today that a single booster dose of their recombinant adjuvanted COVID-19 vaccine candidate delivered consistently strong immune responses. Preliminary results from the VAT0002 clinical trial investigating the safety and immunogenicity of the booster showed neutralizing antibodies increased 9- to 43-fold regardless of the primary vaccine received (AstraZeneca, Johnson & Johnson, Moderna, Pfizer/BioNTech) and for all age groups tested. The booster was well tolerated, with a safety profile similar to currently approved COVID-19 vaccines. This is the most comprehensive booster trial to date to explore boosting across different vaccine technologies used for primary vaccination.\nThe ongoing global Phase 3 trial, VAT0008, includes regular reviews by an independent Data Safety Monitoring Board (DSMB). During its last review, the DSMB identified no safety concerns and recommended the trial to continue into early 2022 to accrue more data.\nRegulatory authorities require Phase 3 efficacy to be demonstrated in “naive” populations, i.e. participants who have never been infected by the COVID-19 virus (seronegative). The Phase 3 trial recruited most participants in Q3 2021, coinciding with a significant increase in the number of people infected by the COVID-19 virus globally due to the Delta variant. To provide the necessary data to regulatory authorities for the booster vaccine submission, the trial will continue to accrue the number of events needed for analysis, with results expected in Q1, 2022.\n“These preliminary data show we have a strong booster candidate, whatever primary vaccine you have received.”said Thomas Triomphe, Executive Vice President, Sanofi Pasteur.“This is consistent with our efforts to provide relevantresponses to evolving public health needs. While pursuing a phase 3 trial is a challenge in a quickly shifting pandemic environment, we look forward to seeing the results to support submissions of our booster vaccine as quickly as possible.”\nRoger Connor, President of GSK Vaccines, added: “As the pandemic threat continues with the current dominant Delta variant and Omicron rapidly gaining ground, booster vaccines will continue to be needed to help protect people over time. The initial booster data are promising, and we await the phase III results to determine the next steps on making protein-based adjuvanted COVID-19 vaccines available.\"\nIn parallel, Sanofi continues its contribution to global public health needs with the manufacturing of up to half a billion doses from BioNTech/Pfizer, Moderna, and Johnson & Johnson vaccines.\nAbout the booster trial (VAT0002)\nThe VAT0002 extension trial is the most comprehensive heterologous booster trial conducted to date. In the first cohort of this trial, the four most-widely approved COVID-19 primary vaccines using mRNA and adenovirus vector technologies were boosted with the Sanofi/GSK protein-based adjuvanted vaccine candidate after full primary vaccination to assess its safety profile and immunogenicity.\nParticipants in the first cohort (n=521) had previously been vaccinated with the approved dosing schedule of an authorized COVID-19 mRNA vaccine (Moderna, Pfizer/BioNTech,) or adenovirus vector vaccine (AstraZeneca, Johnson & Johnson,). This preliminary analysis includes data from trial participants who received one 5µg booster dose of the adjuvanted recombinant protein vaccine targeting the D614 parent virus, between four and ten months after a complete primary vaccination schedule.\nThe trial is ongoing across sites in multiple countries, including the U.S., France, and the UK. To address the emergence of COVID-19 variants of concern, additional trial cohorts are assessing the boosting potential of monovalent and bivalent vaccine formulations also containing the Beta (B.1.351) variant. More data from this trial are expected during the first half of 2022. The Omicron variant was not circulating during the trial. Using sera from booster trial participants, testing is underway to establish the ability of the vaccine candidate to cross-neutralize against Omicron.\nAbout the Phase 3 efficacy trial (VAT0008)\nThe primary endpoint of this ongoing Phase 3, randomized, double-blind, placebo-controlled trial is the prevention of symptomatic COVID-19 in SARS-CoV-2 naïve adults, with secondary endpoints of preventing severe COVID-19 disease and infection. Stage one of the trial is assessing the efficacy of a vaccine formulation containing the spike protein against the original D614 (parent) virus in more than 10,000 participants >18 years of age, randomized to receive two doses of 10µg vaccine or placebo at day 1 and day 22 across sites in the US, Asia, Africa and Latin America. A second stage in the trial is evaluating a second bivalent formulation, adding the spike protein of the B.1.351 (Beta) variant.\nThese efforts are supported by federal funds from the Biomedical Advanced Research and Development Authority, part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services in collaboration with the U.S. Department of Defense Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense under Contract # W15QKN-16-9-1002.\nAbout the Sanofi and GSK collaboration\nIn the collaboration between the two companies, Sanofi provides its recombinant antigen and GSK contributes its pandemic adjuvant, both established vaccine platforms that have proven successful against influenza.\nAbout GSK\nGSK is a science-led global healthcare company with a special purpose: to help people do more, feel better, live longer. GSK is the leading manufacturer of vaccines globally.\nAbout Sanofi\nSanofi is dedicated to supporting people through their health challenges. It is a global biopharmaceutical company focused on human health. It prevent illness with vaccines, provide innovative treatments to fight pain and ease suffering. It stand by the few who suffer from rare diseases and the millions with long-term chronic conditions.\nWith more than 100,000 people in 100 countries, Sanofi is transforming scientific innovation into healthcare solutions around the globe.","news_type":1},"isVote":1,"tweetType":1,"viewCount":700,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604990057,"gmtCreate":1639297081749,"gmtModify":1639297081985,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604990057","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4023":"应用软件","BK4549":"软银资本持仓","BK4135":"资产管理与托管银行","BAM":"布鲁克菲尔德资产管理","AI":"C3.ai, Inc.","BK4551":"寇图资本持仓","BK4528":"SaaS概念","LMND":"Lemonade, Inc.","BK4548":"巴美列捷福持仓","BK4107":"财产与意外伤害保险","BK4543":"AI","BK4535":"淡马锡持仓","LTCH":"Latch, Inc.","BK4215":"住宅房地产投资信托","AVB":"阿湾物产","ESG":"FlexShares STOXX US ESG Select Index Fund"},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":756,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605339080,"gmtCreate":1639110506500,"gmtModify":1639110507536,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/605339080","repostId":"1101781374","repostType":4,"repost":{"id":"1101781374","pubTimestamp":1639108039,"share":"https://www.laohu8.com/m/news/1101781374?lang=&edition=full","pubTime":"2021-12-10 11:47","market":"us","language":"en","title":"Carsome, Grab collaborate on 'Own Your Ride Campaign'","url":"https://stock-news.laohu8.com/highlight/detail?id=1101781374","media":"new straits times","summary":"Carsome has tied up with Grab to launch the nationwide \"Own Your Ride\" campaign, which seeks to bene","content":"<p>Carsome has tied up with Grab to launch the nationwide \"Own Your Ride\" campaign, which seeks to benefit over 100,000 Grab driver-partners and delivery-partners across the country.</p>\n<p>The campaign allows Grab driver-partners and delivery-partners to enjoy purchase discounts of up to RM600, trade-in discounts of RM1,000, and one-year after-sales service when purchasing Carsome Certified cars – on top of the Carsome Promise package.</p>\n<p>The offer can be viewed through the Grab's Driver reward programme, GrabBenefits, within the driver app. From there, all Grab driver-partners have to do is save the offer, browse for cars on Carsome's website, test drive their car of choice, and present the voucher code to Carsome Consultants when making payment to redeem the discount.</p>\n<p>\"As part of our GrabBenefits programme, we listen to our driver and delivery partners, and seek opportunities to work with like-minded corporate partners to offer benefits that matter to them, such as defraying their operating costs as they continue to serve our consumers.</p>\n<p>\"This partnership with Carsome will provide our partners with a more attractive option when they source for a new vehicle and one that will help them upkeep the vehicle affordably,\" said Grab Malaysia's country operations director Rashid Shukor.</p>\n<p>Carsome co-founder and group chief executive officer Eric Cheng c</p>\n<p>\"We are very excited to join hands with Grab in providing access to Grab driver-partners who are looking for new ways to buy or sell a car. Our Carsome Promise offers them convenience and quality assurance, be it for owning their first car or when upgrading their cars,\" he said.</p>\n<p>Each after-sales service includes the Leichtlauf Performance, 10W40 (4L), OEM Filter, and a 15-Point Check including air filter check, cleaning, and labour charges.</p>\n<p>The Carsome Promise package, on the other hand, ensures that every car passes a thorough 175-point inspection and comes with a one-year warranty, five-day money-back guarantee and a fixed price with no hidden fees.</p>\n<p>The \"Own Your Ride Campaign\" runs from now till April 30, 2022.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Carsome, Grab collaborate on 'Own Your Ride Campaign'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCarsome, Grab collaborate on 'Own Your Ride Campaign'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 11:47 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nst.com.my/cbt/2021/12/752931/carsome-grab-collaborate-own-your-ride-campaign><strong>new straits times</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Carsome has tied up with Grab to launch the nationwide \"Own Your Ride\" campaign, which seeks to benefit over 100,000 Grab driver-partners and delivery-partners across the country.\nThe campaign allows ...</p>\n\n<a href=\"https://www.nst.com.my/cbt/2021/12/752931/carsome-grab-collaborate-own-your-ride-campaign\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://www.nst.com.my/cbt/2021/12/752931/carsome-grab-collaborate-own-your-ride-campaign","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101781374","content_text":"Carsome has tied up with Grab to launch the nationwide \"Own Your Ride\" campaign, which seeks to benefit over 100,000 Grab driver-partners and delivery-partners across the country.\nThe campaign allows Grab driver-partners and delivery-partners to enjoy purchase discounts of up to RM600, trade-in discounts of RM1,000, and one-year after-sales service when purchasing Carsome Certified cars – on top of the Carsome Promise package.\nThe offer can be viewed through the Grab's Driver reward programme, GrabBenefits, within the driver app. From there, all Grab driver-partners have to do is save the offer, browse for cars on Carsome's website, test drive their car of choice, and present the voucher code to Carsome Consultants when making payment to redeem the discount.\n\"As part of our GrabBenefits programme, we listen to our driver and delivery partners, and seek opportunities to work with like-minded corporate partners to offer benefits that matter to them, such as defraying their operating costs as they continue to serve our consumers.\n\"This partnership with Carsome will provide our partners with a more attractive option when they source for a new vehicle and one that will help them upkeep the vehicle affordably,\" said Grab Malaysia's country operations director Rashid Shukor.\nCarsome co-founder and group chief executive officer Eric Cheng c\n\"We are very excited to join hands with Grab in providing access to Grab driver-partners who are looking for new ways to buy or sell a car. Our Carsome Promise offers them convenience and quality assurance, be it for owning their first car or when upgrading their cars,\" he said.\nEach after-sales service includes the Leichtlauf Performance, 10W40 (4L), OEM Filter, and a 15-Point Check including air filter check, cleaning, and labour charges.\nThe Carsome Promise package, on the other hand, ensures that every car passes a thorough 175-point inspection and comes with a one-year warranty, five-day money-back guarantee and a fixed price with no hidden fees.\nThe \"Own Your Ride Campaign\" runs from now till April 30, 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":1022,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602385926,"gmtCreate":1638972766516,"gmtModify":1638972766771,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/602385926","repostId":"1175631540","repostType":4,"repost":{"id":"1175631540","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638971326,"share":"https://www.laohu8.com/m/news/1175631540?lang=&edition=full","pubTime":"2021-12-08 21:48","market":"us","language":"en","title":"Confluent Announces Proposed $1.0 Billion Offering of Convertible Senior Notes","url":"https://stock-news.laohu8.com/highlight/detail?id=1175631540","media":"Tiger Newspress","summary":"Confluent stock dropped 7.7% in premarket trading after announcing proposed $1.0 billion offering of","content":"<p>Confluent&nbsp;stock&nbsp;dropped&nbsp;7.7%&nbsp;in premarket trading&nbsp;after&nbsp;announcing proposed $1.0 billion offering of convertible senior notes.</p>\n<p><img src=\"https://static.tigerbbs.com/d476c7b993aae8544efebc2be2798615\" tg-width=\"850\" tg-height=\"620\" width=\"100%\" height=\"auto\"></p>\n<p><b>Confluent, Inc.(NASDAQ: CFLT)</b>,the platform for data in motion, today announced its intent to offer, subject to market conditions and other factors,$1.0 billionaggregate principal amount of Convertible Senior Notes due 2027 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Confluent also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional$100.0 millionaggregate principal amount of Notes.</p>\n<p>The Notes will be general unsecured obligations of Confluent and will accrue interest payable semiannually in arrears. The notes will be convertible into cash, shares of Confluent’s Class A common stock or a combination of cash and shares of Confluent’s Class A common stock, at Confluent’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Offering.</p>\n<p>Confluent expects to use a portion of the net proceeds from the Offering to pay the cost of the capped call transactions described below. Confluent expects to use the remaining net proceeds for working capital and other general corporate purposes. Confluent may also use a portion of the net proceeds for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. If the initial purchasers exercise their option to purchase additional Notes, Confluent expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the Option Counterparties (as defined below) and the remaining net proceeds for working capital and other general corporate purposes and for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. However, Confluent does not have any agreements or commitments to enter into any material acquisitions or investments at this time.</p>\n<p>In connection with the pricing of the Notes, Confluent expects to enter into capped call transactions with one or more of the initial purchasers or affiliates thereof and/or other financial institutions (the “Option Counterparties”). The capped call transactions will cover, subject to customary adjustments, the number of shares of Confluent’s Class A common stock initially underlying the Notes. The capped call transactions are expected generally to reduce the potential dilution to Confluent’s Class A common stock upon any conversion of Notes and/or offset any cash payments Confluent is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.</p>\n<p>In connection with establishing their initial hedges of the capped call transactions, Confluent expects the Option Counterparties or their respective affiliates will enter into various derivative transactions with respect to Confluent’s Class A common stock and/or purchase shares of Confluent’s Class A common stock concurrently with or shortly after the pricing of the Notes, including with, or from, as the case may be, certain investors in the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Confluent’s Class A common stock or the trading price of the Notes at that time.</p>\n<p>In addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Confluent’s Class A common stock and/or purchasing or selling Confluent’s Class A common stock or other securities of Confluent in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during the 40 trading day period beginning on the 41st scheduled trading day prior to maturity of the Notes, or, to the extent Confluent exercises the relevant election under the capped call transactions, following any repurchase, redemption or conversion of the Notes). This activity could also cause or avoid an increase or a decrease in the market price of Confluent’s Class A common stock or the Notes which could affect a noteholder’s ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, this could affect the number of shares, if any, and value of the consideration that a noteholder will receive upon conversion of its Notes.</p>\n<p>The Notes and any shares of Confluent’s Class A common stock potentially issuable upon conversion of the Notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold inthe United Statesabsent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.</p>\n<p>This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Confluent Announces Proposed $1.0 Billion Offering of Convertible Senior Notes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nConfluent Announces Proposed $1.0 Billion Offering of Convertible Senior Notes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-08 21:48</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Confluent&nbsp;stock&nbsp;dropped&nbsp;7.7%&nbsp;in premarket trading&nbsp;after&nbsp;announcing proposed $1.0 billion offering of convertible senior notes.</p>\n<p><img src=\"https://static.tigerbbs.com/d476c7b993aae8544efebc2be2798615\" tg-width=\"850\" tg-height=\"620\" width=\"100%\" height=\"auto\"></p>\n<p><b>Confluent, Inc.(NASDAQ: CFLT)</b>,the platform for data in motion, today announced its intent to offer, subject to market conditions and other factors,$1.0 billionaggregate principal amount of Convertible Senior Notes due 2027 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Confluent also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional$100.0 millionaggregate principal amount of Notes.</p>\n<p>The Notes will be general unsecured obligations of Confluent and will accrue interest payable semiannually in arrears. The notes will be convertible into cash, shares of Confluent’s Class A common stock or a combination of cash and shares of Confluent’s Class A common stock, at Confluent’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Offering.</p>\n<p>Confluent expects to use a portion of the net proceeds from the Offering to pay the cost of the capped call transactions described below. Confluent expects to use the remaining net proceeds for working capital and other general corporate purposes. Confluent may also use a portion of the net proceeds for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. If the initial purchasers exercise their option to purchase additional Notes, Confluent expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the Option Counterparties (as defined below) and the remaining net proceeds for working capital and other general corporate purposes and for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. However, Confluent does not have any agreements or commitments to enter into any material acquisitions or investments at this time.</p>\n<p>In connection with the pricing of the Notes, Confluent expects to enter into capped call transactions with one or more of the initial purchasers or affiliates thereof and/or other financial institutions (the “Option Counterparties”). The capped call transactions will cover, subject to customary adjustments, the number of shares of Confluent’s Class A common stock initially underlying the Notes. The capped call transactions are expected generally to reduce the potential dilution to Confluent’s Class A common stock upon any conversion of Notes and/or offset any cash payments Confluent is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.</p>\n<p>In connection with establishing their initial hedges of the capped call transactions, Confluent expects the Option Counterparties or their respective affiliates will enter into various derivative transactions with respect to Confluent’s Class A common stock and/or purchase shares of Confluent’s Class A common stock concurrently with or shortly after the pricing of the Notes, including with, or from, as the case may be, certain investors in the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Confluent’s Class A common stock or the trading price of the Notes at that time.</p>\n<p>In addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Confluent’s Class A common stock and/or purchasing or selling Confluent’s Class A common stock or other securities of Confluent in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during the 40 trading day period beginning on the 41st scheduled trading day prior to maturity of the Notes, or, to the extent Confluent exercises the relevant election under the capped call transactions, following any repurchase, redemption or conversion of the Notes). This activity could also cause or avoid an increase or a decrease in the market price of Confluent’s Class A common stock or the Notes which could affect a noteholder’s ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, this could affect the number of shares, if any, and value of the consideration that a noteholder will receive upon conversion of its Notes.</p>\n<p>The Notes and any shares of Confluent’s Class A common stock potentially issuable upon conversion of the Notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold inthe United Statesabsent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.</p>\n<p>This press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CFLT":"Confluent, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175631540","content_text":"Confluent stock dropped 7.7% in premarket trading after announcing proposed $1.0 billion offering of convertible senior notes.\n\nConfluent, Inc.(NASDAQ: CFLT),the platform for data in motion, today announced its intent to offer, subject to market conditions and other factors,$1.0 billionaggregate principal amount of Convertible Senior Notes due 2027 (the “Notes”) in a private placement (the “Offering”) to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Confluent also intends to grant the initial purchasers of the Notes an option to purchase, within a 13-day period beginning on, and including, the date on which the Notes are first issued, up to an additional$100.0 millionaggregate principal amount of Notes.\nThe Notes will be general unsecured obligations of Confluent and will accrue interest payable semiannually in arrears. The notes will be convertible into cash, shares of Confluent’s Class A common stock or a combination of cash and shares of Confluent’s Class A common stock, at Confluent’s election. The interest rate, initial conversion rate and other terms of the Notes will be determined at the time of pricing of the Offering.\nConfluent expects to use a portion of the net proceeds from the Offering to pay the cost of the capped call transactions described below. Confluent expects to use the remaining net proceeds for working capital and other general corporate purposes. Confluent may also use a portion of the net proceeds for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. If the initial purchasers exercise their option to purchase additional Notes, Confluent expects to use a portion of the net proceeds from the sale of the additional Notes to enter into additional capped call transactions with the Option Counterparties (as defined below) and the remaining net proceeds for working capital and other general corporate purposes and for acquisitions of, or strategic investments in, complementary businesses, products, services, or technologies. However, Confluent does not have any agreements or commitments to enter into any material acquisitions or investments at this time.\nIn connection with the pricing of the Notes, Confluent expects to enter into capped call transactions with one or more of the initial purchasers or affiliates thereof and/or other financial institutions (the “Option Counterparties”). The capped call transactions will cover, subject to customary adjustments, the number of shares of Confluent’s Class A common stock initially underlying the Notes. The capped call transactions are expected generally to reduce the potential dilution to Confluent’s Class A common stock upon any conversion of Notes and/or offset any cash payments Confluent is required to make in excess of the principal amount of converted Notes, as the case may be, with such reduction and/or offset subject to a cap.\nIn connection with establishing their initial hedges of the capped call transactions, Confluent expects the Option Counterparties or their respective affiliates will enter into various derivative transactions with respect to Confluent’s Class A common stock and/or purchase shares of Confluent’s Class A common stock concurrently with or shortly after the pricing of the Notes, including with, or from, as the case may be, certain investors in the Notes. This activity could increase (or reduce the size of any decrease in) the market price of Confluent’s Class A common stock or the trading price of the Notes at that time.\nIn addition, the Option Counterparties or their respective affiliates may modify their hedge positions by entering into or unwinding various derivatives with respect to Confluent’s Class A common stock and/or purchasing or selling Confluent’s Class A common stock or other securities of Confluent in secondary market transactions following the pricing of the Notes and prior to the maturity of the Notes (and are likely to do so during the 40 trading day period beginning on the 41st scheduled trading day prior to maturity of the Notes, or, to the extent Confluent exercises the relevant election under the capped call transactions, following any repurchase, redemption or conversion of the Notes). This activity could also cause or avoid an increase or a decrease in the market price of Confluent’s Class A common stock or the Notes which could affect a noteholder’s ability to convert the Notes and, to the extent the activity occurs during any observation period related to a conversion of Notes, this could affect the number of shares, if any, and value of the consideration that a noteholder will receive upon conversion of its Notes.\nThe Notes and any shares of Confluent’s Class A common stock potentially issuable upon conversion of the Notes have not been and will not be registered under the Securities Act, any state securities laws or the securities laws of any other jurisdiction, and unless so registered, may not be offered or sold inthe United Statesabsent registration or an applicable exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and other applicable securities laws.\nThis press release is neither an offer to sell nor a solicitation of an offer to buy any of these securities nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to the registration or qualification thereof under the securities laws of any such state or jurisdiction.","news_type":1},"isVote":1,"tweetType":1,"viewCount":757,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":606812071,"gmtCreate":1638854333931,"gmtModify":1638854334158,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/606812071","repostId":"1188299558","repostType":4,"repost":{"id":"1188299558","pubTimestamp":1638847168,"share":"https://www.laohu8.com/m/news/1188299558?lang=&edition=full","pubTime":"2021-12-07 11:19","market":"us","language":"en","title":"Palantir Technologies (PLTR) Is One Of The Best Technology Stocks According To Stanley Druckenmiller","url":"https://stock-news.laohu8.com/highlight/detail?id=1188299558","media":"ownsnap","summary":"November was not very profitable for Palantir Technologies (PLTR). During this month, the shares fel","content":"<p>November was not very profitable for Palantir Technologies (PLTR). During this month, the shares fell from $26.56 to $18.98, losing a total of 28%. And in the pre-market trading session, the company plunged by 2.21%, and the current price is $18.59. Despite this, Palantir was included in the list of the former president of Duquesne Capital Stanley Druckenmiller. He compiled this list of the top 10 technology stocks. Stanley Druckenmiller is a billionaire, investor, and philanthropist. Now he has a lot of investments in his family office in New York. And his portfolio is valued at $3 billion for Q3. In addition to such large companies as MSFT, GOOG, AMZN, FB, Palantir was also included in the list.</p>\n<p>On December 2, it became known that Palantir Technologies and Space Systems Command’s Cross-Mission Ground &amp; Communications Enterprise signed a contract worth $ 43 million. The company will continue to support national security goals by providing its platform. According to the data for the 3rd quarter, the profit per share was only $0.04. And the income for Q3 was $392.15 million, which is $ 5.86 million more than analysts’ estimates. The billionaire himself owns 1.63 million shares of PLTR which he purchased for 39.2 million dollars.</p>","source":"lsy1627012030966","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir Technologies (PLTR) Is One Of The Best Technology Stocks According To Stanley Druckenmiller</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir Technologies (PLTR) Is One Of The Best Technology Stocks According To Stanley Druckenmiller\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-07 11:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://ownsnap.com/palantir-technologies-pltr-is-one-of-the-best-technology-stocks-according-to-stanley-druckenmiller/><strong>ownsnap</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>November was not very profitable for Palantir Technologies (PLTR). During this month, the shares fell from $26.56 to $18.98, losing a total of 28%. And in the pre-market trading session, the company ...</p>\n\n<a href=\"https://ownsnap.com/palantir-technologies-pltr-is-one-of-the-best-technology-stocks-according-to-stanley-druckenmiller/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://ownsnap.com/palantir-technologies-pltr-is-one-of-the-best-technology-stocks-according-to-stanley-druckenmiller/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188299558","content_text":"November was not very profitable for Palantir Technologies (PLTR). During this month, the shares fell from $26.56 to $18.98, losing a total of 28%. And in the pre-market trading session, the company plunged by 2.21%, and the current price is $18.59. Despite this, Palantir was included in the list of the former president of Duquesne Capital Stanley Druckenmiller. He compiled this list of the top 10 technology stocks. Stanley Druckenmiller is a billionaire, investor, and philanthropist. Now he has a lot of investments in his family office in New York. And his portfolio is valued at $3 billion for Q3. In addition to such large companies as MSFT, GOOG, AMZN, FB, Palantir was also included in the list.\nOn December 2, it became known that Palantir Technologies and Space Systems Command’s Cross-Mission Ground & Communications Enterprise signed a contract worth $ 43 million. The company will continue to support national security goals by providing its platform. According to the data for the 3rd quarter, the profit per share was only $0.04. And the income for Q3 was $392.15 million, which is $ 5.86 million more than analysts’ estimates. The billionaire himself owns 1.63 million shares of PLTR which he purchased for 39.2 million dollars.","news_type":1},"isVote":1,"tweetType":1,"viewCount":987,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608522243,"gmtCreate":1638762387415,"gmtModify":1638762387593,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608522243","repostId":"2189570543","repostType":4,"repost":{"id":"2189570543","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638762024,"share":"https://www.laohu8.com/m/news/2189570543?lang=&edition=full","pubTime":"2021-12-06 11:40","market":"hk","language":"en","title":"Alibaba's HK stock tumbles to record low on e-commerce rejig plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2189570543","media":"Reuters","summary":"** Hong Kong shares of Alibaba Group fall as much as 8.3% to HK$109.50, lowest since listing in the ","content":"<p>** Hong Kong shares of Alibaba Group fall as much as 8.3% to HK$109.50, lowest since listing in the city in November 2019, and on course for fifth consecutive session of decline</p>\n<p>** Stock set for worst day since Nov. 19; biggest percentage decliner on the benchmark index and Hang Seng Commerce &amp; Industry Index , third biggest on Hang Seng Tech Index</p>\n<p>** Alibaba said on Monday it was reorganising its international and domestic e-commerce businesses and would appoint a new chief financial officer</p>\n<p>** Says it would form two new units to house its main e-commerce businesses - international digital commerce and China digital commerce, so as to become more agile and accelerate growth</p>\n<p>** \"The transition announced today is happening earlier than we expected. After a series of headline news over the past year, the next few years will be critical for Alibaba Group to prove its ability to recover from the macro slowdown and emerge even stronger operationally\" - Citi</p>\n<p>** Hang Seng Commerce &amp; Industry Index, Hang Seng Tech Index&nbsp;and the benchmark index&nbsp;fall between 1% and 2%</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Alibaba's HK stock tumbles to record low on e-commerce rejig plan</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAlibaba's HK stock tumbles to record low on e-commerce rejig plan\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-06 11:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>** Hong Kong shares of Alibaba Group fall as much as 8.3% to HK$109.50, lowest since listing in the city in November 2019, and on course for fifth consecutive session of decline</p>\n<p>** Stock set for worst day since Nov. 19; biggest percentage decliner on the benchmark index and Hang Seng Commerce &amp; Industry Index , third biggest on Hang Seng Tech Index</p>\n<p>** Alibaba said on Monday it was reorganising its international and domestic e-commerce businesses and would appoint a new chief financial officer</p>\n<p>** Says it would form two new units to house its main e-commerce businesses - international digital commerce and China digital commerce, so as to become more agile and accelerate growth</p>\n<p>** \"The transition announced today is happening earlier than we expected. After a series of headline news over the past year, the next few years will be critical for Alibaba Group to prove its ability to recover from the macro slowdown and emerge even stronger operationally\" - Citi</p>\n<p>** Hang Seng Commerce &amp; Industry Index, Hang Seng Tech Index&nbsp;and the benchmark index&nbsp;fall between 1% and 2%</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4504":"桥水持仓","BK4548":"巴美列捷福持仓","BK1142":"互联网与直销零售","BK1591":"就地过年概念","BK4565":"NFT概念","BK4554":"元宇宙及AR概念","BK1502":"双十一","BK1608":"元宇宙概念","BK1517":"云办公","BK1575":"同股不同权","BK1584":"蚂蚁金服概念","09988":"阿里巴巴-W","BK4531":"中概回港概念","BK1586":"云计算","BK4534":"瑞士信贷持仓","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4558":"双十一","QNETCN":"纳斯达克中美互联网老虎指数","BK1588":"回港中概股","BK4524":"宅经济概念","BK4535":"淡马锡持仓","BABA":"阿里巴巴","BK4527":"明星科技股","BK4538":"云计算","BK4526":"热门中概股","BK4503":"景林资产持仓","BK4122":"互联网与直销零售","BK1521":"挪威政府全球养老基金持仓","BK4505":"高瓴资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2189570543","content_text":"** Hong Kong shares of Alibaba Group fall as much as 8.3% to HK$109.50, lowest since listing in the city in November 2019, and on course for fifth consecutive session of decline\n** Stock set for worst day since Nov. 19; biggest percentage decliner on the benchmark index and Hang Seng Commerce & Industry Index , third biggest on Hang Seng Tech Index\n** Alibaba said on Monday it was reorganising its international and domestic e-commerce businesses and would appoint a new chief financial officer\n** Says it would form two new units to house its main e-commerce businesses - international digital commerce and China digital commerce, so as to become more agile and accelerate growth\n** \"The transition announced today is happening earlier than we expected. After a series of headline news over the past year, the next few years will be critical for Alibaba Group to prove its ability to recover from the macro slowdown and emerge even stronger operationally\" - Citi\n** Hang Seng Commerce & Industry Index, Hang Seng Tech Index and the benchmark index fall between 1% and 2%","news_type":1},"isVote":1,"tweetType":1,"viewCount":334,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608898233,"gmtCreate":1638675108488,"gmtModify":1638675108637,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Cool&nbsp;","listText":"Cool&nbsp;","text":"Cool","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/608898233","repostId":"2188291505","repostType":4,"repost":{"id":"2188291505","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1638544217,"share":"https://www.laohu8.com/m/news/2188291505?lang=&edition=full","pubTime":"2021-12-03 23:10","market":"us","language":"en","title":"Ford aims to be world's #2 electric vehicle maker within two years - COO","url":"https://stock-news.laohu8.com/highlight/detail?id=2188291505","media":"Reuters","summary":"Dec 3  - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.Speaking at an investor conference, Drake said Ford is working with five","content":"<p>Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.</p>\n<p>Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.</p>\n<p>Speaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD&nbsp;and Panasonic .</p>\n<p>Ford expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford aims to be world's #2 electric vehicle maker within two years - COO</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord aims to be world's #2 electric vehicle maker within two years - COO\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-03 23:10</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.</p>\n<p>Driving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.</p>\n<p>Speaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD&nbsp;and Panasonic .</p>\n<p>Ford expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4555":"新能源车","BK4099":"汽车制造商","F":"福特汽车"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188291505","content_text":"Dec 3 (Reuters) - Ford Motor Co expects to be the world's second largest electric vehicle manufacturer within two years, with annual production capacity of nearly 600,000, a top company executive said Friday.\nDriving the automaker's optimism is increasing demand for its next new EV, the Ford F-150 Lightning pickup, with retail reservations now approaching 200,000, according to Lisa Drake, chief operating officer of Ford North America.\nSpeaking at an investor conference, Drake said Ford is working with five global battery suppliers to manufacture and help develop battery cells for its future EVs. Those suppliers include SK On, LG Energy Solution, CATL, BYD and Panasonic .\nFord expects to reduce EV battery cell cost to $80 per kilowatt-hour at the pack level \"well before the end of the decade,\" Drake said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":494,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601655338,"gmtCreate":1638525749687,"gmtModify":1638525864748,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601655338","repostId":"2188540330","repostType":4,"repost":{"id":"2188540330","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1638524158,"share":"https://www.laohu8.com/m/news/2188540330?lang=&edition=full","pubTime":"2021-12-03 17:35","market":"us","language":"en","title":"5 Stocks To Watch For December 3, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2188540330","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Big Lots, Inc.  (NYSE: BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For December 3, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For December 3, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-12-03 17:35</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects&nbsp;<b>Big Lots, Inc.</b>&nbsp;(NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading&nbsp;Thursday.</li>\n <li><b>DiDi Global Inc.</b>&nbsp;(NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading&nbsp;Friday.</li>\n <li>Analysts are expecting&nbsp;<b>Hibbett, Inc.</b>&nbsp;(NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading&nbsp;Thursday.</li>\n</ul>\n<ul>\n <li><b>Tesla Inc</b> (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.</li>\n <li><b>Ulta Beauty, Inc.</b> (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HIBB":"希贝特体育","DIDI":"滴滴(已退市)","BK4200":"专卖店","BK4022":"陆运","BIG":"必乐透","BK4535":"淡马锡持仓","TSLA":"特斯拉","BK4114":"综合货品商店","BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","ULTA":"Ulta美容","CEO":"中海油","BK4539":"次新股","BK4526":"热门中概股"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188540330","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects Big Lots, Inc. (NYSE:BIG) to report a quarterly loss at $0.16 per share on revenue of $1.32 billion before the opening bell. Big Lots shares fell 5% to $41.45 in after-hours trading Thursday.\nDiDi Global Inc. (NYSE:DIDI) said that its board of directors had authorized the company to initiate procedures to delist the company’s shares from the New York Stock Exchange. The company, however, announced plans to pursue a listing of its class A ordinary shares on the Main Board of the Hong Kong Stock Exchange. DiDi Global shares jumped 9.5% to $8.54 in premarket trading Friday.\nAnalysts are expecting Hibbett, Inc. (NASDAQ:HIBB) to have earned $1.57 per share on revenue of $360.63 million for the latest quarter. The company will release earnings before the markets open. Hibbett shares rose 0.3% to $72.35 in after-hours trading Thursday.\n\n\nTesla Inc (NASDAQ:TSLA) Elon Musk sold another 934,091 shares worth around $1.01 billion in order to fulfill his tax obligations, as per filings made with the U.S. Securities And Exchange Commission Thursday. Musk also exercised options to purchase 2.1 million shares of the automaker at $6.24, as per one of the filings. In late November, the company’s CEO had sold $1 billion worth of Tesla shares. Tesla shares rose 0.3% to $1,088 in premarket tradingFriday.\nUlta Beauty, Inc. (NASDAQ:ULTA) reported better-than-expected results for its third quarter and raised its FY21 forecast. Ulta Beauty shares climbed 5.2% to $403.50 in the after-hours trading Thursday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":279,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":603507041,"gmtCreate":1638421447621,"gmtModify":1638421563758,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Is the dividend sustainable?","listText":"Is the dividend sustainable?","text":"Is the dividend sustainable?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/603507041","repostId":"1182613816","repostType":4,"repost":{"id":"1182613816","pubTimestamp":1638415076,"share":"https://www.laohu8.com/m/news/1182613816?lang=&edition=full","pubTime":"2021-12-02 11:17","market":"us","language":"en","title":"2 Ridiculously Cheap Dividend Stocks To Buy for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=1182613816","media":"Motley Fool","summary":"The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could ","content":"<p>The&nbsp;<b>S&amp;P 500</b>had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.</p>\n<p>For investors looking to get away from this volatility and find more safety, holding dividend stocks in your portfolio can be an excellent decision. They can ensure that you're collecting a recurring stream of income you can use to help offset losses in your portfolio. And at best, they can boost your returns. Two dividend stocks that pay an above-average yield and are incredibly cheap right now are&nbsp;<b>AbbVie</b>(NYSE:ABBV)and&nbsp;<b>ViacomCBS</b>(NASDAQ:VIAC).</p>\n<p>1. AbbVie</p>\n<p>AbbVie makes for an ideal buy-and-forget investment. The&nbsp;healthcare stock&nbsp;yields an impressive 4.8% right now -- well above the&nbsp;<b>S&amp;P 500</b>average of just 1.4%. And the dividend is well supported; in the past 12 months, the company has generated free cash flow of $21.7 billion, more than double the $9 billion in dividends it paid out during that time.</p>\n<p>When the company released its latest quarterly earnings results on Oct. 29, it reported sales of $14.3 billion, 11% higher than the year-ago period. The company also raised its guidance for a third time in 2021, anticipating that its adjusted diluted earnings per share will come in between $12.63 and $12.67 for the full year. That's well above the $5.64 in dividends that the company is paying out annually per share. TheDividend Aristocratalso raised its dividend by 8.5% in a hike that will come into effect next year.</p>\n<p>While investors may be worried about the company's expiring patent on rhe&nbsp;umatoid arthritis drug Humira, AbbVie's management anticipates that newer drugs like Skyrizi and Rinvoq will generate long-term growth and make up for the inevitable decline in Humira's sales. Both drugs still have a long way to go. In just the latest quarter, they achieved combined sales of $1.2 billion in sales while Humira brought in more than $5.4 billion.</p>\n<p>CEO Richard Gonzalez said, \"What we're basically trying to accomplish with the company is build a set of assets that could ultimately significantly replace Humira in the marketplace and be superior to Humira.\"</p>\n<p>Even if there's a dip in profitability, AbbVie has plenty of room to support its dividend. And with other pharma stocks like&nbsp;<b>Pfizer</b>,<b>Merck</b>, and&nbsp;<b>Amgen</b>&nbsp;trading at forward&nbsp;price-to-earnings(P/E) multiples of more than 12, AbbVie's multiple of nine makes the stock look like a bargain buy.</p>\n<p>2. ViacomCBS</p>\n<p>Media and entertainment company ViacomCBS pays a dividend that currently yields right around 3% per year. While it's not as high as AbbVie's payout, the stock could more than make up for that with some possibly stronger gains. Viacom currently trades at a forward P/E of less than nine, which is dirt cheap as streaming stocks&nbsp;<b>WaltDisney</b>&nbsp;and&nbsp;<b>Netflix</b>&nbsp;trade at multiples of 35 and 62, respectively.</p>\n<p>One of the reasons investors aren't as bullish on ViacomCBS is that it still isn't a big rival to those streaming giants. At 47 million global streaming subscribers across its services (including Paramount+), ViacomCBS is nowhere near Netflix's tally of 214 million and has a long way to go in catching up to Disney at over 118 million.</p>\n<p>Plus, ViacomCBS's streaming service isn't even the biggest part of its business. In the latest quarter, its advertising, affiliate, and licensing segments together contributed the vast majority of the company's revenue -- about $5.5 billion in all. However, this latest quarter marked the first time that its global streaming revenue surpassed $1 billion. And with revenue growth of 72% over the year-ago period, streaming is by far the company's fastest-growing segment.</p>\n<p>Although it may not be as popular as its bigger-name rivals, ViacomCBS is posting some strong results of late and it could be an&nbsp;attractive contrarian betto take. Plus, its dividend makes it an even better buy.</p>\n<p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Ridiculously Cheap Dividend Stocks To Buy for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Ridiculously Cheap Dividend Stocks To Buy for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-02 11:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.\nFor investors ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ABBV":"艾伯维公司"},"source_url":"https://www.fool.com/investing/2021/12/01/2-ridiculously-cheap-dividend-stocks-to-buy-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1182613816","content_text":"The S&P 500had its worst day of the year on Friday, falling 900 points on the news that there could be a new obstacle in the economy's recovery: omicron, the latest COVID-19 variant.\nFor investors looking to get away from this volatility and find more safety, holding dividend stocks in your portfolio can be an excellent decision. They can ensure that you're collecting a recurring stream of income you can use to help offset losses in your portfolio. And at best, they can boost your returns. Two dividend stocks that pay an above-average yield and are incredibly cheap right now are AbbVie(NYSE:ABBV)and ViacomCBS(NASDAQ:VIAC).\n1. AbbVie\nAbbVie makes for an ideal buy-and-forget investment. The healthcare stock yields an impressive 4.8% right now -- well above the S&P 500average of just 1.4%. And the dividend is well supported; in the past 12 months, the company has generated free cash flow of $21.7 billion, more than double the $9 billion in dividends it paid out during that time.\nWhen the company released its latest quarterly earnings results on Oct. 29, it reported sales of $14.3 billion, 11% higher than the year-ago period. The company also raised its guidance for a third time in 2021, anticipating that its adjusted diluted earnings per share will come in between $12.63 and $12.67 for the full year. That's well above the $5.64 in dividends that the company is paying out annually per share. TheDividend Aristocratalso raised its dividend by 8.5% in a hike that will come into effect next year.\nWhile investors may be worried about the company's expiring patent on rhe umatoid arthritis drug Humira, AbbVie's management anticipates that newer drugs like Skyrizi and Rinvoq will generate long-term growth and make up for the inevitable decline in Humira's sales. Both drugs still have a long way to go. In just the latest quarter, they achieved combined sales of $1.2 billion in sales while Humira brought in more than $5.4 billion.\nCEO Richard Gonzalez said, \"What we're basically trying to accomplish with the company is build a set of assets that could ultimately significantly replace Humira in the marketplace and be superior to Humira.\"\nEven if there's a dip in profitability, AbbVie has plenty of room to support its dividend. And with other pharma stocks like Pfizer,Merck, and Amgen trading at forward price-to-earnings(P/E) multiples of more than 12, AbbVie's multiple of nine makes the stock look like a bargain buy.\n2. ViacomCBS\nMedia and entertainment company ViacomCBS pays a dividend that currently yields right around 3% per year. While it's not as high as AbbVie's payout, the stock could more than make up for that with some possibly stronger gains. Viacom currently trades at a forward P/E of less than nine, which is dirt cheap as streaming stocks WaltDisney and Netflix trade at multiples of 35 and 62, respectively.\nOne of the reasons investors aren't as bullish on ViacomCBS is that it still isn't a big rival to those streaming giants. At 47 million global streaming subscribers across its services (including Paramount+), ViacomCBS is nowhere near Netflix's tally of 214 million and has a long way to go in catching up to Disney at over 118 million.\nPlus, ViacomCBS's streaming service isn't even the biggest part of its business. In the latest quarter, its advertising, affiliate, and licensing segments together contributed the vast majority of the company's revenue -- about $5.5 billion in all. However, this latest quarter marked the first time that its global streaming revenue surpassed $1 billion. And with revenue growth of 72% over the year-ago period, streaming is by far the company's fastest-growing segment.\nAlthough it may not be as popular as its bigger-name rivals, ViacomCBS is posting some strong results of late and it could be an attractive contrarian betto take. Plus, its dividend makes it an even better buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":398,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609777843,"gmtCreate":1638333415513,"gmtModify":1638333415668,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609777843","repostId":"1101502249","repostType":4,"repost":{"id":"1101502249","pubTimestamp":1638330314,"share":"https://www.laohu8.com/m/news/1101502249?lang=&edition=full","pubTime":"2021-12-01 11:45","market":"us","language":"en","title":"Regeneron's COVID-19 antibody drug may be less effective against Omicron","url":"https://stock-news.laohu8.com/highlight/detail?id=1101502249","media":"Reuters","summary":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective ag","content":"<p>Nov 30 (Reuters) - <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.</p>\n<p>Global markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.</p>\n<p>Based on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.</p>\n<p>The company said&nbsp;it was doing further study to quantify the potential impact using the variant's genetic sequence.</p>\n<p>One of the antibodies&nbsp;used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.</p>\n<p>\"<a href=\"https://laohu8.com/S/JE\">Just</a> like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"</p>\n<p><a href=\"https://laohu8.com/S/LLY\">Eli Lilly and</a> Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.</p>\n<p>Regeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.</p>\n<p>Rival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.</p>\n<p>The company is \"working to confirm this in the lab as a matter of urgency\", it added.</p>\n<p>Gilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron</p>\n<p>The U.S. Food &amp; Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Regeneron's COVID-19 antibody drug may be less effective against Omicron</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRegeneron's COVID-19 antibody drug may be less effective against Omicron\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-01 11:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after ...</p>\n\n<a href=\"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc.","LLY":"礼来","GILD":"吉利德科学","REGN":"再生元制药公司"},"source_url":"https://www.reuters.com/business/healthcare-pharmaceuticals/regeneron-says-covid-19-drug-could-be-less-effective-against-omicron-variant-2021-11-30/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1101502249","content_text":"Nov 30 (Reuters) - Regeneron Pharmaceuticals Inc's COVID-19 antibody drug could be less effective against Omicron, it said on Tuesday, adding to fears about the efficacy of existing treatments after Moderna's top boss raised similar concerns about the company's vaccine.\nGlobal markets tumbled after comments from Moderna's(MRNA.O)chief executive officer rekindled worries that the variant may weigh on a nascent global economic recovery.\nBased on its study of Omicron's individual mutations, \"there may be reduced neutralization activity of both vaccine-induced and monoclonal antibody conveyed immunity\", Regeneron(REGN.O)said, adding that the analysis included its COVID-19 antibody cocktail, REGEN-COV.\nThe company said it was doing further study to quantify the potential impact using the variant's genetic sequence.\nOne of the antibodies used in the treatment will likely take a hit, the other less so, CEO Len Schleifer said in a CNBC interview.\n\"Just like vaccines will have to adapt, we're probably going to have to constantly adapt our monoclonals.\"\nEli Lilly and Co(LLY.N), which makes a similar monoclonal antibody treatment, is also working to understand neutralization activity of its therapies on Omicron, the company told Reuters in an e-mailed statement.\nRegeneron shares fell about 3% in morning trading, while those of Lillyshed 2.5%.\nRival Vir Biotechnology Inc(VIR.O)said based on the Omicron sequence its antibody therapy, sotrovimab, will likely maintain potency against the variant.\nThe company is \"working to confirm this in the lab as a matter of urgency\", it added.\nGilead Inc(GILD.O)said it believed its intravenous therapy, Remdesivir, currently the only antiviral approved for treating COVID-19, will continue to be effective against currently identified variants, including Omicron\nThe U.S. Food & Drug Administration said on Tuesday it was evaluating the effectiveness of authorized COVID-19 vaccines against Omicron and was expecting to have more information in the next few weeks.","news_type":1},"isVote":1,"tweetType":1,"viewCount":587,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":609826680,"gmtCreate":1638266774449,"gmtModify":1638266779338,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/609826680","repostId":"1109000741","repostType":4,"isVote":1,"tweetType":1,"viewCount":476,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600201151,"gmtCreate":1638152464271,"gmtModify":1638152464398,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600201151","repostId":"1124072014","repostType":4,"repost":{"id":"1124072014","pubTimestamp":1638140765,"share":"https://www.laohu8.com/m/news/1124072014?lang=&edition=full","pubTime":"2021-11-29 07:06","market":"us","language":"en","title":"November jobs report: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1124072014","media":"yahoo","summary":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor","content":"<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.</p>\n<p>The Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.</p>\n<p>\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.</p>\n<p>\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply could<i>worsen</i>over the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"</p>\n<p>On a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.</p>\n<p>Growing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.</p>\n<p>Other recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.</p>\n<p>Even given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.</p>\n<p>Returning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.</p>\n<p>\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"</p>\n<p>Economic calendar</p>\n<ul>\n <li><p><b>Monday:</b>Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)</p></li>\n <li><p><b>Tuesday:</b>FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)</p></li>\n <li><p><b>Wednesday:</b>MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book</p></li>\n <li><p><b>Thursday:</b>Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)</p></li>\n <li><p><b>Friday:</b>Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)</p></li>\n</ul>\n<p>Earnings calendar</p>\n<ul>\n <li><p><b>Monday:</b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday:</b>Salesforce.com (CRM) after market close</p></li>\n <li><p><b>Wednesday:</b>PVH Corp. (PVH) after market close</p></li>\n <li><p><b>Thursday:</b>Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close</p></li>\n <li><p><b>Friday:</b><i>No notable reports scheduled for release</i></p></li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>November jobs report: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovember jobs report: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 07:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html><strong>yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时"},"source_url":"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124072014","content_text":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.\n\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.\n\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply couldworsenover the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"\nOn a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.\nGrowing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.\nOther recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.\nEven given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.\nReturning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.\n\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"\nEconomic calendar\n\nMonday:Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)\nTuesday:FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)\nWednesday:MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book\nThursday:Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)\nFriday:Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)\n\nEarnings calendar\n\nMonday:No notable reports scheduled for release\nTuesday:Salesforce.com (CRM) after market close\nWednesday:PVH Corp. (PVH) after market close\nThursday:Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close\nFriday:No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":600135238,"gmtCreate":1638084729410,"gmtModify":1638084729562,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like&nbsp;","listText":"Like&nbsp;","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/600135238","repostId":"2186328547","repostType":4,"repost":{"id":"2186328547","pubTimestamp":1638069455,"share":"https://www.laohu8.com/m/news/2186328547?lang=&edition=full","pubTime":"2021-11-28 11:17","market":"us","language":"en","title":"Google, Dell Lead Five Diverse Stocks Near Buy Points","url":"https://stock-news.laohu8.com/highlight/detail?id=2186328547","media":"ADELIA CELLINI LINECKER","summary":"Google leads five stocks to watch this week around buy points. It's on IBD Leaderboard, Long-Term Leaders and the IBD 50.","content":"<p>Google parent <b>Alphabet</b>, computer maker <b>Dell Technologies</b>, steelmaker <b>Nucor</b>, Chip-equipment maker <b>Lam Research</b>&nbsp;and rental-home investor <b>Invitation Homes</b> are five stocks to watch this week near buy points.</p>\n<p>The recent plunges in many hot software stocks amid renewed sector rotation underscores the importance of having diversified leaders in your portfolio. But with the market selling off sharply Friday, this time led by energy and financial stocks, investors should be cautious about new buys.</p>\n<p>Google, Nucor stock and Invitation Homes have pulled back modestly below buy points. Dell stock has bounced from its 50-day line, and Lam Research is closing in on a buy point.</p>\n<p>Google stock and Nucor are on IBD Leaderboard. GOOGL stock also is on IBD Long-Term Leaders and the IBD 50. Dell is on SwingTrader.</p>\n<h2><b>Google Stock</b></h2>\n<p>Shares fell 4.5% to 2,845.64 in last week's stock market trading. Google stock closed just below its 50-day line and 10-week moving average. Shares have retreated modestly below a flat-base buy point of 2,925.17, according to MarketSmith. An alternate entry would be 3,019.43 from a four-weeks-tight pattern.</p>\n<p>Investors could use a rebound off the 50-day/10-week line as a possible entry. That's a good place to buy Long-Term Leaders stocks such as GOOGL.</p>\n<p>Google's relative strength line is going sideways, but is still near all-time highs. Its RS Rating is 88 out of a possible 99, while its EPS Rating is 98.</p>\n<p>Google beat Wall Street estimates for the third quarter. It had EPS of $27.99 vs. views for $23.48. Sales came in at $65.12 billion vs. estimates of $63.34 billion.</p>\n<p>In a call with investors on Oct. 26, CEO Ruth Porat said Apple's privacy settings changes, which now ask iPhone users for explicit permission to track them, had a modest impact on YouTube revenue.</p>\n<p>Google's ad revenue climbed 43% to $53.13 billion. That's up from $37.1 billion in the year-ago period and slightly higher than the prior quarter. YouTube ads rose to $7.21 billion, up from $5.04 billion last year.</p>\n<h2><b>Dell Stock</b></h2>\n<p>Dell stock rose 2.1% to 56.18 last week. Shares now have a flat base with a 58.53 buy point. Dell stock bounced from its 50-day line on Thursday, flashing an early buy signal on strong earnings. But shares pulled back modestly Friday. Investors might now want to wait for Dell to get above Thursday's high of 58, or simply wait for a breakout.</p>\n<p>On Nov. 23, Dell reported third-quarter earnings of $2.37 a share, a year-over-year increase of 17%, on a 21% jump in sales to $28.39 billion, both above analyst views.&nbsp;</p>\n<p>It was Dell's best third quarter in its history, driven by growth in all business units, customer segments and geographies, as well as broad strength across commercial PCs, servers and storage, the company said in a written statement.</p>\n<p>Dell was Wednesday's IBD Stock Of The Day.</p>\n<p>Meanwhile, rival <b>HP</b> gapped out of a base Wednesday on its earnings.</p>\n<h2><b>Nucor Stock</b></h2>\n<p>Shares rose 1% last week to 113.98. Nucor stock broke out past a cup-with-handle buy point of 119.42 on Nov. 22, but gave up most of that day's 6% gain by Friday's close. Its relative strength line is ticking downward but still near multiyear highs. Its RS Rating is 93, while its EPS Rating is 96.</p>\n<p>Steelmakers like Nucor have a had a stellar year supplying homebuilders in a record year and gearing up for massive infrastructure spending. IBD's Steel-Producers industry group has soared nearly 86% year to date.</p>\n<p>Nucor has had four straight quarters of triple-digit earnings growth and four quarters in a row of accelerating sales growth.</p>\n<p>Rival <b><a href=\"https://laohu8.com/S/STLD\">Steel Dynamics</a></b> broke out past a cup-with-handle buy point of 69.01 intraday on Nov. 22, but has since fallen below that buy point.</p>\n<h2><b>Invitation Homes Stock</b></h2>\n<p>INVH stock broke out past a cup-with-handle buy point of 41.93 on Nov. 24, but retreated just below it on Friday. INVH stock edged up 0.6% to 41.15 for the week.</p>\n<p>Invitation Homes has an RS Rating of 93 and an EPS Rating of 96.</p>\n<p>The recent housing boom isn't just helping homebuilders. As raw materials prices spike up and supplies remain tight, folks are delaying home buying or renting homes while renovations&nbsp;and new homes take longer to complete. That's pushed up rents across the board.</p>\n<p>As a result, Invitation Homes, the largest owner of rental homes in the U.S., has seen soaring demand. The company, a real estate investment trust, or REIT, owns more than 80,000 homes, which it rents out.</p>\n<p>In October, Invitation Homes reported better-than-expected Q3 results. The company was able to raise rents by 11% amid the housing shortage.</p>\n<h2><b>Lam Research Stock</b></h2>\n<p>Shares pulled back late last week, perhaps starting work on a handle. Chip-equipment maker Lam Research has been steadily moving toward a 673.90 buy point from a consolidation going back to early June or April.&nbsp;</p>\n<p>Its relative strength line is rising again after several months of sideways movement. Lam's RS Rating is 80, while its EPS Rating is 94. The company has posted seven straight quarters of earnings and revenue growth, amid sky-high demand for its products across all industries.</p>","source":"lsy1610449120050","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Google, Dell Lead Five Diverse Stocks Near Buy Points</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoogle, Dell Lead Five Diverse Stocks Near Buy Points\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-28 11:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers><strong>ADELIA CELLINI LINECKER</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Google parent Alphabet, computer maker Dell Technologies, steelmaker Nucor, Chip-equipment maker Lam Research and rental-home investor Invitation Homes are five stocks to watch this week near buy ...</p>\n\n<a href=\"https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DELL":"戴尔","LRCX":"拉姆研究","GOOG":"谷歌","NUE":"纽柯钢铁","INVH":"Invitation Homes Inc."},"source_url":"https://www.investors.com/news/google-dell-lead-five-diverse-stocks-near-buy-points/?src=A00519A=aflTigerBrokers","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2186328547","content_text":"Google parent Alphabet, computer maker Dell Technologies, steelmaker Nucor, Chip-equipment maker Lam Research and rental-home investor Invitation Homes are five stocks to watch this week near buy points.\nThe recent plunges in many hot software stocks amid renewed sector rotation underscores the importance of having diversified leaders in your portfolio. But with the market selling off sharply Friday, this time led by energy and financial stocks, investors should be cautious about new buys.\nGoogle, Nucor stock and Invitation Homes have pulled back modestly below buy points. Dell stock has bounced from its 50-day line, and Lam Research is closing in on a buy point.\nGoogle stock and Nucor are on IBD Leaderboard. GOOGL stock also is on IBD Long-Term Leaders and the IBD 50. Dell is on SwingTrader.\nGoogle Stock\nShares fell 4.5% to 2,845.64 in last week's stock market trading. Google stock closed just below its 50-day line and 10-week moving average. Shares have retreated modestly below a flat-base buy point of 2,925.17, according to MarketSmith. An alternate entry would be 3,019.43 from a four-weeks-tight pattern.\nInvestors could use a rebound off the 50-day/10-week line as a possible entry. That's a good place to buy Long-Term Leaders stocks such as GOOGL.\nGoogle's relative strength line is going sideways, but is still near all-time highs. Its RS Rating is 88 out of a possible 99, while its EPS Rating is 98.\nGoogle beat Wall Street estimates for the third quarter. It had EPS of $27.99 vs. views for $23.48. Sales came in at $65.12 billion vs. estimates of $63.34 billion.\nIn a call with investors on Oct. 26, CEO Ruth Porat said Apple's privacy settings changes, which now ask iPhone users for explicit permission to track them, had a modest impact on YouTube revenue.\nGoogle's ad revenue climbed 43% to $53.13 billion. That's up from $37.1 billion in the year-ago period and slightly higher than the prior quarter. YouTube ads rose to $7.21 billion, up from $5.04 billion last year.\nDell Stock\nDell stock rose 2.1% to 56.18 last week. Shares now have a flat base with a 58.53 buy point. Dell stock bounced from its 50-day line on Thursday, flashing an early buy signal on strong earnings. But shares pulled back modestly Friday. Investors might now want to wait for Dell to get above Thursday's high of 58, or simply wait for a breakout.\nOn Nov. 23, Dell reported third-quarter earnings of $2.37 a share, a year-over-year increase of 17%, on a 21% jump in sales to $28.39 billion, both above analyst views. \nIt was Dell's best third quarter in its history, driven by growth in all business units, customer segments and geographies, as well as broad strength across commercial PCs, servers and storage, the company said in a written statement.\nDell was Wednesday's IBD Stock Of The Day.\nMeanwhile, rival HP gapped out of a base Wednesday on its earnings.\nNucor Stock\nShares rose 1% last week to 113.98. Nucor stock broke out past a cup-with-handle buy point of 119.42 on Nov. 22, but gave up most of that day's 6% gain by Friday's close. Its relative strength line is ticking downward but still near multiyear highs. Its RS Rating is 93, while its EPS Rating is 96.\nSteelmakers like Nucor have a had a stellar year supplying homebuilders in a record year and gearing up for massive infrastructure spending. IBD's Steel-Producers industry group has soared nearly 86% year to date.\nNucor has had four straight quarters of triple-digit earnings growth and four quarters in a row of accelerating sales growth.\nRival Steel Dynamics broke out past a cup-with-handle buy point of 69.01 intraday on Nov. 22, but has since fallen below that buy point.\nInvitation Homes Stock\nINVH stock broke out past a cup-with-handle buy point of 41.93 on Nov. 24, but retreated just below it on Friday. INVH stock edged up 0.6% to 41.15 for the week.\nInvitation Homes has an RS Rating of 93 and an EPS Rating of 96.\nThe recent housing boom isn't just helping homebuilders. As raw materials prices spike up and supplies remain tight, folks are delaying home buying or renting homes while renovations and new homes take longer to complete. That's pushed up rents across the board.\nAs a result, Invitation Homes, the largest owner of rental homes in the U.S., has seen soaring demand. The company, a real estate investment trust, or REIT, owns more than 80,000 homes, which it rents out.\nIn October, Invitation Homes reported better-than-expected Q3 results. The company was able to raise rents by 11% amid the housing shortage.\nLam Research Stock\nShares pulled back late last week, perhaps starting work on a handle. Chip-equipment maker Lam Research has been steadily moving toward a 673.90 buy point from a consolidation going back to early June or April. \nIts relative strength line is rising again after several months of sideways movement. Lam's RS Rating is 80, while its EPS Rating is 94. The company has posted seven straight quarters of earnings and revenue growth, amid sky-high demand for its products across all industries.","news_type":1},"isVote":1,"tweetType":1,"viewCount":482,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877604960,"gmtCreate":1637919980680,"gmtModify":1637919980838,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877604960","repostId":"1146431533","repostType":4,"repost":{"id":"1146431533","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637918422,"share":"https://www.laohu8.com/m/news/1146431533?lang=&edition=full","pubTime":"2021-11-26 17:20","market":"us","language":"en","title":"Zoom shares jumped nearly 10% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1146431533","media":"Tiger Newspress","summary":"Zoom shares jumped nearly 10% in premarket trading.Britain said on Friday that a newly identified co","content":"<p>Zoom&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;10%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/7014ab353e2b4dace840a04b4326f098\" tg-width=\"877\" tg-height=\"626\" referrerpolicy=\"no-referrer\">Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant <a href=\"https://laohu8.com/S/AONE.U\">one</a> yet found and so it needed to ascertain whether or not it made vaccines ineffective.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zoom shares jumped nearly 10% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZoom shares jumped nearly 10% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-26 17:20</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Zoom&nbsp;shares&nbsp;jumped&nbsp;nearly&nbsp;10%&nbsp;in&nbsp;premarket&nbsp;trading.<img src=\"https://static.tigerbbs.com/7014ab353e2b4dace840a04b4326f098\" tg-width=\"877\" tg-height=\"626\" referrerpolicy=\"no-referrer\">Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant <a href=\"https://laohu8.com/S/AONE.U\">one</a> yet found and so it needed to ascertain whether or not it made vaccines ineffective.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1146431533","content_text":"Zoom shares jumped nearly 10% in premarket trading.Britain said on Friday that a newly identified coronavirus variant spreading in South Africa was considered by scientists to be the most significant one yet found and so it needed to ascertain whether or not it made vaccines ineffective.","news_type":1},"isVote":1,"tweetType":1,"viewCount":380,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":877095390,"gmtCreate":1637836647265,"gmtModify":1637836647380,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Lol why she WB sell","listText":"Lol why she WB sell","text":"Lol why she WB sell","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/877095390","repostId":"1105943125","repostType":4,"repost":{"id":"1105943125","pubTimestamp":1637829564,"share":"https://www.laohu8.com/m/news/1105943125?lang=&edition=full","pubTime":"2021-11-25 16:39","market":"us","language":"en","title":"If Only Berkshire Hathaway Had Listened To Us, And Why It's Time To Exit Apple","url":"https://stock-news.laohu8.com/highlight/detail?id=1105943125","media":"seekingalpha","summary":"Summary\n\nOur original recommendation for Berkshire Hathaway to buy Apple was predicated partially on","content":"<p>Summary</p>\n<ul>\n <li>Our original recommendation for Berkshire Hathaway to buy Apple was predicated partially on our opinion that the company was undervalued.</li>\n <li>At this point, even with the tax expenses of selling, we feel the valuation has hit a point where Berkshire Hathaway should be selling.</li>\n <li>Berkshire Hathaway has a cash problem that's not to be trivialized, however, that doesn't justify holding onto overvalued assets.</li>\n <li>The company can use its cash to make significant additional investments in other businesses where it's growing.</li>\n</ul>\n<p>Just over three years ago, we wrote an article discussing how Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B)should utilize its massive cash pile to acquire Apple(NASDAQ:AAPL). As we'll see throughout this article, while that trade would have panned out well, it's time for Berkshire Hathaway to exit its massive Apple investment.</p>\n<p>The Acquisition</p>\n<p>Our original recommendation for the acquisition price with premium was a $1.23 trillion acquisition. Since then, Apple's market capitalization has more than doubled to $2.6 trillion. That's on the basis of substantial strength during COVID-19, where the company's FCF went from almost $65 billion to more than $90 billion.</p>\n<p>New product lines for the business are growing well and it can be expected to continue growing going forward. Our pessimistic acquisition time assumption was Apple's FCF would stay constant at $65 billion while debt was paid out, however, this new FCF would have helped greatly accelerate the debt pay down for the company.</p>\n<p>Berkshire Hathaway's market capitalization, with the expansion in value, would be 3x as large. The company would have $865 billion in debt and have earned almost $150 billion in FCF in the most recent year. The giant would be a valuable long-term investment.</p>\n<p>Apple Buffett Investment</p>\n<p>Apple's Buffett investment has been arguably the best investment he's ever made.</p>\n<p>Warren Buffett's Apple&nbsp;investment has cost him roughly $40 billion. As Apple hits all-time highs, the most recent valuation of Apple's stake is almost $150 billion, implying paper profits of more than $100 billion. The peak capital gains tax rate is roughly 20%, implying ~$22 billion in taxes for the profits that the portfolio has seen so far.</p>\n<p>That means that if he were to sell the investment, he'd turn $40 billion of cash into $125 billion of cash. That'd take Berkshire Hathaway's total cash position to roughly $260 billion.</p>\n<p>Apple Valuation</p>\n<p>Our thesis for selling Apple is based on the company's recent massive multiple expansion.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dc5459716333b52cbca613111fcee56e\" tg-width=\"1844\" tg-height=\"564\" width=\"100%\" height=\"auto\"><span>Apple P/E Ratio - MacroTrends</span></p>\n<p>A significant part of Apple's returns over the past five years have been the company's massive multiple expansion. The company's PE ratio has gone from just over 10 to almost 30. That 3x expansion means that the company's PE yield is just over 3%. It's worth noting it's been expanding EPS and aggressively buying back shares supporting EPS.</p>\n<p>However, the takeaway here is that multiple expansion can't be expected to continue forever and the law of large numbers exists. That means that Apple's upcoming five-year returns can be expected to not match with the past five-year returns. As Apple becomes bigger and bigger, it becomes more and more a vehicle for the S&amp;P 500 with individual company risk.</p>\n<p>Our Recommendation</p>\n<p>Our recommendation is that Berkshire Hathaway should sell Apple. For normal investors who hold Apple in their individual portfolios, we recommend the same. The reason is threefold.</p>\n<p>1. Apple's size means that continuing to provide market-beating returns is unlikely.</p>\n<p>2. The company's majority of share price performance has been multiple expansion, which can't be guaranteed to continue.</p>\n<p>3. Apple has enjoyed a peer-leading industry position, however, historically in tech, that's extremely difficult to maintain.</p>\n<p>Berkshire Hathaway will be left with a massive pile of cash and there are several ways we can see the company deploying it. For note, that $260 billion initial post tax cash will be almost half of its market capitalization. In our view, we can see several different ways that the company can utilize this cash to maximize shareholder rewards.</p>\n<p>1. Simply invest in the S&amp;P 500. It has a 0.7% higher dividend yield than Apple meaning rolling the $150 billion cash into that would add more than $1 billion in additional dividend for the company. Berkshire Hathaway has discussed how beating the S&amp;P 500 is difficult, and this is a simple solution to a complex problem.</p>\n<p>2. Buybacks. The remainder of Berkshire Hathaway's portfolio is incredibly strong and generates massive FCF. The company has been buying back stock&nbsp;to the tune of roughly $20 billion annualized. It can accelerate that, enabling the value in the rest of its portfolio to be much more magnified. Buying back a significant amount at market value is tough, but it could buy back a reasonable amount.</p>\n<p>3. Acquisitions. There are a few industries that Berkshire Hathaway has been willing to touch in the existing market. Energy,such as the recent almost $10 billion Dominion acquisition, has been one of them. There's plenty of larger companies in the energy markets, and Berkshire Hathaway could make a stab for a larger one towards a $100 billion valuation.</p>\n<p>Any of these paths, or some combination, in our opinion, could help Berkshire Hathaway drive more substantial shareholder rewards.</p>\n<p>Why Discuss</p>\n<p>A classic question for all Seeking Alpha articles, but why are we discussing Berkshire Hathaway portfolio recommendations with you? What's the actionable advice?</p>\n<p>The first is that we believe, for the same reasons, Apple investors should sell their current investments in Apple. The company is a great company, no doubt about it, however, that doesn't make it a great investment, especially at the current valuation. The law of large numbers limits upside, but as an individual company, there's still substantial downside.</p>\n<p>The second is that Berkshire Hathaway investors should pay close attention to how the company treats its Apple stake as well. The investment now makes up almost 25% of the company's portfolio. That means leaving it invested in Apple, which we expect will underperform, can present a drag on the rest of the company's portfolio and hurt its value as an investment.</p>\n<p>All of this, and what happens with the remainder of the company's cash position, is something we recommend investors pay close attention to.</p>\n<p>Thesis Risk</p>\n<p>The risk to our thesis is that Apple is focused on consistent growth and the company has performed well recently. That's especially true given new projects Apple is focused on,like recent news about the Apple Car. There's a chance, with a limit of the law of large numbers, Apple can for at least some period of time continue outperforming the market.</p>\n<p>It's also worth noting that Berkshire Hathaway will need to, because of the 20% tax rate, find a way to reinvest at slightly higher returns.</p>\n<p>Conclusion</p>\n<p>Berkshire Hathaway's massive Apple investment is now almost 25% of its valuation as a company. Even by historical norms with other companies, that's incredibly high in a single business. That single business has seen those returns primarily through multiple expansion (at the P/E of 10, the $40 billion investment would be $50 billion versus $150 billion).</p>\n<p>Our view is that Berkshire Hathaway should eat the tax expense and grab the cash. In our view, there are numerous things the company can do over the coming years to achieve higher returns than its Apple investment would. Whether the company does those things is important because underperformance of Apple could drag the rest of its portfolio.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>If Only Berkshire Hathaway Had Listened To Us, And Why It's Time To Exit Apple</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIf Only Berkshire Hathaway Had Listened To Us, And Why It's Time To Exit Apple\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-25 16:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4471860-if-only-buffett-had-listened-to-us-and-why-its-time-to-exit-apple><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nOur original recommendation for Berkshire Hathaway to buy Apple was predicated partially on our opinion that the company was undervalued.\nAt this point, even with the tax expenses of selling,...</p>\n\n<a href=\"https://seekingalpha.com/article/4471860-if-only-buffett-had-listened-to-us-and-why-its-time-to-exit-apple\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://seekingalpha.com/article/4471860-if-only-buffett-had-listened-to-us-and-why-its-time-to-exit-apple","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1105943125","content_text":"Summary\n\nOur original recommendation for Berkshire Hathaway to buy Apple was predicated partially on our opinion that the company was undervalued.\nAt this point, even with the tax expenses of selling, we feel the valuation has hit a point where Berkshire Hathaway should be selling.\nBerkshire Hathaway has a cash problem that's not to be trivialized, however, that doesn't justify holding onto overvalued assets.\nThe company can use its cash to make significant additional investments in other businesses where it's growing.\n\nJust over three years ago, we wrote an article discussing how Berkshire Hathaway (NYSE:BRK.A) (NYSE:BRK.B)should utilize its massive cash pile to acquire Apple(NASDAQ:AAPL). As we'll see throughout this article, while that trade would have panned out well, it's time for Berkshire Hathaway to exit its massive Apple investment.\nThe Acquisition\nOur original recommendation for the acquisition price with premium was a $1.23 trillion acquisition. Since then, Apple's market capitalization has more than doubled to $2.6 trillion. That's on the basis of substantial strength during COVID-19, where the company's FCF went from almost $65 billion to more than $90 billion.\nNew product lines for the business are growing well and it can be expected to continue growing going forward. Our pessimistic acquisition time assumption was Apple's FCF would stay constant at $65 billion while debt was paid out, however, this new FCF would have helped greatly accelerate the debt pay down for the company.\nBerkshire Hathaway's market capitalization, with the expansion in value, would be 3x as large. The company would have $865 billion in debt and have earned almost $150 billion in FCF in the most recent year. The giant would be a valuable long-term investment.\nApple Buffett Investment\nApple's Buffett investment has been arguably the best investment he's ever made.\nWarren Buffett's Apple investment has cost him roughly $40 billion. As Apple hits all-time highs, the most recent valuation of Apple's stake is almost $150 billion, implying paper profits of more than $100 billion. The peak capital gains tax rate is roughly 20%, implying ~$22 billion in taxes for the profits that the portfolio has seen so far.\nThat means that if he were to sell the investment, he'd turn $40 billion of cash into $125 billion of cash. That'd take Berkshire Hathaway's total cash position to roughly $260 billion.\nApple Valuation\nOur thesis for selling Apple is based on the company's recent massive multiple expansion.\nApple P/E Ratio - MacroTrends\nA significant part of Apple's returns over the past five years have been the company's massive multiple expansion. The company's PE ratio has gone from just over 10 to almost 30. That 3x expansion means that the company's PE yield is just over 3%. It's worth noting it's been expanding EPS and aggressively buying back shares supporting EPS.\nHowever, the takeaway here is that multiple expansion can't be expected to continue forever and the law of large numbers exists. That means that Apple's upcoming five-year returns can be expected to not match with the past five-year returns. As Apple becomes bigger and bigger, it becomes more and more a vehicle for the S&P 500 with individual company risk.\nOur Recommendation\nOur recommendation is that Berkshire Hathaway should sell Apple. For normal investors who hold Apple in their individual portfolios, we recommend the same. The reason is threefold.\n1. Apple's size means that continuing to provide market-beating returns is unlikely.\n2. The company's majority of share price performance has been multiple expansion, which can't be guaranteed to continue.\n3. Apple has enjoyed a peer-leading industry position, however, historically in tech, that's extremely difficult to maintain.\nBerkshire Hathaway will be left with a massive pile of cash and there are several ways we can see the company deploying it. For note, that $260 billion initial post tax cash will be almost half of its market capitalization. In our view, we can see several different ways that the company can utilize this cash to maximize shareholder rewards.\n1. Simply invest in the S&P 500. It has a 0.7% higher dividend yield than Apple meaning rolling the $150 billion cash into that would add more than $1 billion in additional dividend for the company. Berkshire Hathaway has discussed how beating the S&P 500 is difficult, and this is a simple solution to a complex problem.\n2. Buybacks. The remainder of Berkshire Hathaway's portfolio is incredibly strong and generates massive FCF. The company has been buying back stock to the tune of roughly $20 billion annualized. It can accelerate that, enabling the value in the rest of its portfolio to be much more magnified. Buying back a significant amount at market value is tough, but it could buy back a reasonable amount.\n3. Acquisitions. There are a few industries that Berkshire Hathaway has been willing to touch in the existing market. Energy,such as the recent almost $10 billion Dominion acquisition, has been one of them. There's plenty of larger companies in the energy markets, and Berkshire Hathaway could make a stab for a larger one towards a $100 billion valuation.\nAny of these paths, or some combination, in our opinion, could help Berkshire Hathaway drive more substantial shareholder rewards.\nWhy Discuss\nA classic question for all Seeking Alpha articles, but why are we discussing Berkshire Hathaway portfolio recommendations with you? What's the actionable advice?\nThe first is that we believe, for the same reasons, Apple investors should sell their current investments in Apple. The company is a great company, no doubt about it, however, that doesn't make it a great investment, especially at the current valuation. The law of large numbers limits upside, but as an individual company, there's still substantial downside.\nThe second is that Berkshire Hathaway investors should pay close attention to how the company treats its Apple stake as well. The investment now makes up almost 25% of the company's portfolio. That means leaving it invested in Apple, which we expect will underperform, can present a drag on the rest of the company's portfolio and hurt its value as an investment.\nAll of this, and what happens with the remainder of the company's cash position, is something we recommend investors pay close attention to.\nThesis Risk\nThe risk to our thesis is that Apple is focused on consistent growth and the company has performed well recently. That's especially true given new projects Apple is focused on,like recent news about the Apple Car. There's a chance, with a limit of the law of large numbers, Apple can for at least some period of time continue outperforming the market.\nIt's also worth noting that Berkshire Hathaway will need to, because of the 20% tax rate, find a way to reinvest at slightly higher returns.\nConclusion\nBerkshire Hathaway's massive Apple investment is now almost 25% of its valuation as a company. Even by historical norms with other companies, that's incredibly high in a single business. That single business has seen those returns primarily through multiple expansion (at the P/E of 10, the $40 billion investment would be $50 billion versus $150 billion).\nOur view is that Berkshire Hathaway should eat the tax expense and grab the cash. In our view, there are numerous things the company can do over the coming years to achieve higher returns than its Apple investment would. Whether the company does those things is important because underperformance of Apple could drag the rest of its portfolio.","news_type":1},"isVote":1,"tweetType":1,"viewCount":246,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":600201151,"gmtCreate":1638152464271,"gmtModify":1638152464398,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/600201151","repostId":"1124072014","repostType":4,"repost":{"id":"1124072014","pubTimestamp":1638140765,"share":"https://www.laohu8.com/m/news/1124072014?lang=&edition=full","pubTime":"2021-11-29 07:06","market":"us","language":"en","title":"November jobs report: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=1124072014","media":"yahoo","summary":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor","content":"<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.</p>\n<p>The Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.</p>\n<p>\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.</p>\n<p>\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply could<i>worsen</i>over the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"</p>\n<p>On a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.</p>\n<p>Growing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.</p>\n<p>Other recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.</p>\n<p>Even given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.</p>\n<p>Returning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.</p>\n<p>\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"</p>\n<p>Economic calendar</p>\n<ul>\n <li><p><b>Monday:</b>Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)</p></li>\n <li><p><b>Tuesday:</b>FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&amp;P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)</p></li>\n <li><p><b>Wednesday:</b>MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book</p></li>\n <li><p><b>Thursday:</b>Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)</p></li>\n <li><p><b>Friday:</b>Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)</p></li>\n</ul>\n<p>Earnings calendar</p>\n<ul>\n <li><p><b>Monday:</b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday:</b>Salesforce.com (CRM) after market close</p></li>\n <li><p><b>Wednesday:</b>PVH Corp. (PVH) after market close</p></li>\n <li><p><b>Thursday:</b>Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close</p></li>\n <li><p><b>Friday:</b><i>No notable reports scheduled for release</i></p></li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>November jobs report: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovember jobs report: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-29 07:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html><strong>yahoo</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an ...</p>\n\n<a href=\"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CRM":"赛富时"},"source_url":"https://finance.yahoo.com/news/november-jobs-report-what-to-know-this-week-144428419.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124072014","content_text":"As investors return from the Thanksgiving-shortened trading week, focus will shift to the U.S. labor market.\nThe Labor Department's monthly jobs report due for release on Friday is set to provide an updated snapshot of the strength in hiring and labor force participation in the U.S. economy. Consensus economists are looking for a half-million jobs to have returned in November, with the pace of hiring slowing only slightly from October's 531,000 gain. The unemployment rate is also expected to improve further to 4.5% from October's 4.6%, reaching the lowest level since March 2020.\n\"We expect non-farm payrolls to have risen by 500,000 in November, but the growing risk of a winter COVID wave and a dwindling supply of available workers will weigh on jobs growth soon,\" wrote Paul Ashworth, chief North America economist for Capital Economics, in a note last week.\n\"Employment growth can’t continue at this pace for much longer unless the labor force stages a more notable recovery. If anything, labor supply couldworsenover the coming months as the federal vaccine mandate covering 100 [million] workers begins on January 4,\" Ashworth added. \"That suggests wage growth will remain strong, and we expect a 0.4% [month-over-month] rise in average hourly earnings in October.\"\nOn a year-over-year basis, average hourly earnings are expected to rise by 5.0%, accelerating even further after October's already marked 4.9% rise and representing the fastest wage growth rate since February.\nGrowing average wages and a tight labor market — while a positive for consumers and their ability to spend — has also stoked concerns over persistent inflation. Last week's Personal Consumption Expenditures (PCE) deflator from the Bureau of Economic Analysis for October showed an annual jump of 5.0% in the index, or the biggest rise since 1990. And the core PCE, or the Fed's preferred inflation gauge stripping out volatile food and energy prices, rose by 4.1% year-over-year — the most in three decades.\nOther recent data have homed in on the tight labor market and presaged a potentially strong November jobs report. Last week'sinitial jobless claims fell to a 52-year low of 199,000, taking out both the prior pandemic-era low and pre-pandemic average for new first-time filings. This served as yet another point underscoring the steep competition for labor among U.S. employers, with companies attempting to hire and retain their existing workforces amid widespread labor shortages.\nEven given these lingering scarcities, the labor force participation rate has yet to return to pre-pandemic levels. The civilian labor force was still down by nearly 3 million participants compared to February 2020, with lingering concerns over the virus and adesire by many working-age individuals to seek out new roles with better flexibility and benefitsstill keeping many individuals on the sidelines of the workforce. Consensus economists expect the labor force participation rate to tick up only slightly in November to reach 61.7%, growing from October's 61.6% but coming in well below the 63.3% rate from February 2020.\nReturning the economy back to pre-pandemic labor force participation levels and ensuring job gains are seen equitably across different groups has become a key focus for the Federal Reserve. And the distance still left to make up on these fronts has also been the biggest factor keeping the Fed ultra-accommodative with its monetary policy support, even after a parade of hotter-than-expected inflation reports that would appear to warrant a more hawkish policy tilt and a quicker-than-expected hike to interest rates.Fed Chair Jerome Powell's renomination to remain as head of the central bankfurther suggests the Fed's focus on the labor market as a critical informing factor for monetary policy will remain.\n\"Market views for future Fed rate increases have been pulled forward aggressively in response to evidence that elevated inflation pressures are likely to persist for longer,\" wrote Deutsche Bank economist Justin Weidner in a note last week. \"However, as Chair Powell's November press conference made evident, prospects for the labor market to return to maximum employment remain a critical consideration for when the Fed will eventually begin to actively tighten monetary policy.\"\nEconomic calendar\n\nMonday:Pending home sales, month-over-month, October (0.7% expected, -2.3% in September); Dallas Federal Reserve Manufacturing Activity Index, November (17.0 expected, 14.6 in October)\nTuesday:FHFA House Price Index, month-over-month, September (1.2% expected, 1.0% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, month-over-month, September (1.30% expected, 1.17% in August); S&P CoreLogic Case-Shiller 20-City Composite Index, September (19.66% during prior month); MNI Chicago PMI, November (67.0 expected, 68.4 in October); Conference Board Consumer Confidence Index, November (110.0 expected, 113.8 in October)\nWednesday:MBA Mortgage Applications, November 26 (1.8% during prior week); ADP Employment Change, November (515,000 expected, 571,000 in October); Markit U.S. Manufacturing PMI, November final (59.1 during prior month); Construction Spending, month-over-month, October (0.5% expected, -0.5% in September); ISM Manufacturing, November (61.0 expected, 60.8 in October); Federal Reserve releases Beige Book\nThursday:Challenger job cuts, November (-71.7% in October); Initial jobless claims, week ended Nov. 27 (199,000 during prior week); Continuing claims, Nov. 20 (2.049 during prior week)\nFriday:Change in non-farm payrolls, November (500,000 expected, 531,000 in October); Unemployment rate, November (4.5% expected, 4.6% in October); Average Hourly Earnings, month-over-month, November (0.4% expected, 0.4% in October); Average Hourly Earnings, year-over-year, November (5.0% expected, 4.9% in October); Markit U.S. Services PMI, November final (57.0 in prior print); Markit U.S. Composite PMI, November final (56.5 in prior print); ISM Services Index, November (65.0 expected, 66.7 in October); Factory Orders, October (0.5% expected, 0.2% in September); Durable Goods Orders, October final (-0.5% in prior print)\n\nEarnings calendar\n\nMonday:No notable reports scheduled for release\nTuesday:Salesforce.com (CRM) after market close\nWednesday:PVH Corp. (PVH) after market close\nThursday:Dollar General (DG), Kroger (KR) before market open; Ulta Beauty (ULTA) after market close\nFriday:No notable reports scheduled for release","news_type":1},"isVote":1,"tweetType":1,"viewCount":324,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":801596503,"gmtCreate":1627521821102,"gmtModify":1633764179013,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like mine pls thanks","listText":"Like mine pls thanks","text":"Like mine pls thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/801596503","repostId":"1127264445","repostType":4,"repost":{"id":"1127264445","pubTimestamp":1627514621,"share":"https://www.laohu8.com/m/news/1127264445?lang=&edition=full","pubTime":"2021-07-29 07:23","market":"us","language":"en","title":"S&P 500 ends off day's lows; Powell says Fed still a ways away from rate hikes","url":"https://stock-news.laohu8.com/highlight/detail?id=1127264445","media":"Reuters","summary":"NEW YORK (Reuters) - The S&P 500 ended little changed on Wednesday but off its session lows after th","content":"<p>NEW YORK (Reuters) - The S&amp;P 500 ended little changed on Wednesday but off its session lows after the Federal Reserve said the U.S. economic recovery remains on track and Chair Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> said the central bank was still a ways away from considering raising interest rates.</p>\n<p>Keeping the market in check, shares of tech giant <a href=\"https://laohu8.com/S/AAPL\">Apple</a> Inc fell 1.2% after it forecast slowing revenue growth.</p>\n<p>In a news conference following the release of a new policy statement from the Fed, Powell also said the U.S. job market still had “some ground to cover” before it would be time to pull back from the economic support the U.S. central bank put in place in the spring of 2020 to battle the coronavirus pandemic’s economic shocks.</p>\n<p>“It looks like probably the most positive thing for the market was that they are nowhere near increasing interest rates,” said Alan Lancz, president, Alan B. Lancz &amp; Associates Inc, an investment advisory firm based in Toledo, Ohio.</p>\n<p>Right after the Fed statement, the S&amp;P 500 index reversed slight declines though it still ended a hair lower on the day.</p>\n<p><a href=\"https://laohu8.com/S/ISBC\">Investors</a> have been worried about how rising inflation and a spike in COVID-19 cases might impact the central bank’s plan to potentially start withdrawing its stimulus.</p>\n<p>The central bank also said that higher inflation remained the result of “transitory factors.” The Fed kept its overnight benchmark interest rate near zero and left unchanged its bond-buying program.</p>\n<p>The <a href=\"https://laohu8.com/S/NDAQ\">Nasdaq</a> ended higher and shares of Google parent <a href=\"https://laohu8.com/S/GOOG\">Alphabet</a> Inc hit an all-time high as a surge in advertising spending helped it post record quarterly results. The stock ended up 3.2%.</p>\n<p>The Dow Jones Industrial Average fell 127.59 points, or 0.36%, to 34,930.93, the S&amp;P 500 lost 0.82 point, or 0.02%, to 4,400.64 and the Nasdaq Composite added 102.01 points, or 0.7%, to 14,762.58.</p>\n<p>The Fed’s statement came at the conclusion of its latest two-day policy meeting.</p>\n<p>“They had a chance to signal they were going to become more hawkish and they chose not to take it. The most important thing is they are predictable and they are remaining predictable,” said Ellen Hazen, portfolio manager at F.L. Putnam Investment Management in <a href=\"https://laohu8.com/S/WEBK\">Wellesley</a>, Massachusetts.</p>\n<p>In other earnings news, <a href=\"https://laohu8.com/S/MSFT\">Microsoft</a> Corp ended down 0.1% even as a boom in cloud services helped it beat Wall Street expectations for revenue and earnings.</p>\n<p>Volume on U.S. exchanges was 9.86 billion shares, compared with a similar average for the full session over the last 20 trading days.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 2.61-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 42 new 52-week highs and no new lows; the Nasdaq Composite recorded 44 new highs and 67 new lows.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>S&P 500 ends off day's lows; Powell says Fed still a ways away from rate hikes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nS&P 500 ends off day's lows; Powell says Fed still a ways away from rate hikes\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-29 07:23 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-ends-off-days-lows-powell-says-fed-still-a-ways-away-from-rate-hikes-idUSL1N2P435H><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>NEW YORK (Reuters) - The S&P 500 ended little changed on Wednesday but off its session lows after the Federal Reserve said the U.S. economic recovery remains on track and Chair Jerome Powell said the ...</p>\n\n<a href=\"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-ends-off-days-lows-powell-says-fed-still-a-ways-away-from-rate-hikes-idUSL1N2P435H\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"161125":"标普500","OEF":"标普100指数ETF-iShares","UPRO":"三倍做多标普500ETF","SPY":"标普500ETF",".DJI":"道琼斯","SPXU":"三倍做空标普500ETF","SDS":"两倍做空标普500ETF","OEX":"标普100",".IXIC":"NASDAQ Composite","IVV":"标普500指数ETF",".SPX":"S&P 500 Index","SSO":"两倍做多标普500ETF","SH":"标普500反向ETF"},"source_url":"https://www.reuters.com/article/usa-stocks/us-stocks-sp-500-ends-off-days-lows-powell-says-fed-still-a-ways-away-from-rate-hikes-idUSL1N2P435H","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1127264445","content_text":"NEW YORK (Reuters) - The S&P 500 ended little changed on Wednesday but off its session lows after the Federal Reserve said the U.S. economic recovery remains on track and Chair Jerome Powell said the central bank was still a ways away from considering raising interest rates.\nKeeping the market in check, shares of tech giant Apple Inc fell 1.2% after it forecast slowing revenue growth.\nIn a news conference following the release of a new policy statement from the Fed, Powell also said the U.S. job market still had “some ground to cover” before it would be time to pull back from the economic support the U.S. central bank put in place in the spring of 2020 to battle the coronavirus pandemic’s economic shocks.\n“It looks like probably the most positive thing for the market was that they are nowhere near increasing interest rates,” said Alan Lancz, president, Alan B. Lancz & Associates Inc, an investment advisory firm based in Toledo, Ohio.\nRight after the Fed statement, the S&P 500 index reversed slight declines though it still ended a hair lower on the day.\nInvestors have been worried about how rising inflation and a spike in COVID-19 cases might impact the central bank’s plan to potentially start withdrawing its stimulus.\nThe central bank also said that higher inflation remained the result of “transitory factors.” The Fed kept its overnight benchmark interest rate near zero and left unchanged its bond-buying program.\nThe Nasdaq ended higher and shares of Google parent Alphabet Inc hit an all-time high as a surge in advertising spending helped it post record quarterly results. The stock ended up 3.2%.\nThe Dow Jones Industrial Average fell 127.59 points, or 0.36%, to 34,930.93, the S&P 500 lost 0.82 point, or 0.02%, to 4,400.64 and the Nasdaq Composite added 102.01 points, or 0.7%, to 14,762.58.\nThe Fed’s statement came at the conclusion of its latest two-day policy meeting.\n“They had a chance to signal they were going to become more hawkish and they chose not to take it. The most important thing is they are predictable and they are remaining predictable,” said Ellen Hazen, portfolio manager at F.L. Putnam Investment Management in Wellesley, Massachusetts.\nIn other earnings news, Microsoft Corp ended down 0.1% even as a boom in cloud services helped it beat Wall Street expectations for revenue and earnings.\nVolume on U.S. exchanges was 9.86 billion shares, compared with a similar average for the full session over the last 20 trading days.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.85-to-1 ratio; on Nasdaq, a 2.61-to-1 ratio favored advancers.\nThe S&P 500 posted 42 new 52-week highs and no new lows; the Nasdaq Composite recorded 44 new highs and 67 new lows.","news_type":1},"isVote":1,"tweetType":1,"viewCount":62,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":844255917,"gmtCreate":1636433705459,"gmtModify":1636433705891,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/844255917","repostId":"1121670869","repostType":4,"repost":{"id":"1121670869","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636431530,"share":"https://www.laohu8.com/m/news/1121670869?lang=&edition=full","pubTime":"2021-11-09 12:18","market":"us","language":"en","title":"Overnight US stock market review : Congress passed $1 trillion bipartisan infrastructure bill; Amd shares rose 10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1121670869","media":"Tiger Newspress","summary":"Market Overview\nThe S&P 500 closed at a record high Monday after Congress approved an infrastructure","content":"<p><b>Market Overview</b></p>\n<p>The S&amp;P 500 closed at a record high Monday after Congress approved an infrastructure spending package.</p>\n<p>The broad index gained 0.09% to close above 4,700 for the first time at 4,701.70. The Dow Jones Industrial Average added 104.27 points, or 0.3%, to close at 36,432.22. The Nasdaq Composite ticked up 0.07% at 15,982.36. All three stock averages posted record closes.</p>\n<p>Other important events included that the U.S. House of Representatives passed&nbsp;$1 trillion bipartisan infrastructure bill,Musk&nbsp;would&nbsp;sell 10% of Tesla stock based on Twitter poll, several&nbsp;Fed officials spoke on Monday&nbsp;and so on.</p>\n<p><b>Tesla shares closed Monday down nearly 5% as</b>&nbsp;<b>Musk&nbsp;will&nbsp;sell 10% of Tesla stock</b></p>\n<p>Tesla shares closed Monday down 4.8% after CEO Elon Musk said he would sell 10% of his holdings in the electric car maker — more than $20 billion worth by most calculations — based on the results of a&nbsp;poll he conducted on Twitter over the weekend.</p>\n<p>According to analyst Daniel Ives of Wedbush Securities, Musk owns about 23% of Tesla’s stock and has about $10 billion in taxes coming due on stock options that vest next summer.</p>\n<p>Much of Musk’s wealth is held in shares of Tesla, which does not pay him a cash salary.</p>\n<p>“I only have stock, thus the only way for me to pay taxes personally is to sell stock,” Musk tweeted.</p>\n<p>The sometimes abrasive and unpredictable Musk, whose net worth is around $300 billion, said he proposed selling the stock as some Democrats have been pushing for billionaires to pay taxes when the price of the stocks they hold goes up, even if they don’t sell any shares. However, the wording on unrealized gains, also called a “billionaires tax,” was removed from President Joe Biden’s budget, which is still being negotiated.</p>\n<p>“Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” he tweeted Saturday afternoon. “Do you support this?”</p>\n<p>Musk said he would abide by the results of the poll, which ended with 58% of more than 3.5 million votes calling for him to sell the stock. He did not say when he would sell the stock.</p>\n<p><b>AMD shares closed&nbsp;up 10% after company won&nbsp;Meta partnership</b></p>\n<p>Advanced Micro Devices on Monday announced new specialized processors for different data-center workloads. It also added Facebook as a customer for its server chips. AMD stock surged higher on the news.</p>\n<p>AMD announced that Meta Platforms, the parent company of social network Facebook, is the latest hyperscale cloud company to adopt AMD's Epyc central processing units, or CPUs.</p>\n<p>On Monday, AMD launched its AMD Instinct MI200 series accelerators, which are optimized for high-performance computing and artificial-intelligence workloads. The company described them as \"the first exascale-class GPU accelerators.\" AMD competes with Nvidia in GPUs.</p>\n<p>AMD also previewed the use of 3D chiplet packaging technology in server CPUs. Third-generation AMD Epyc processors with AMD 3D V-Cache will offer a 50% average performance uplift across targeted technical computing workloads. The new chips will launch in the first quarter of 2022.</p>\n<p><b>The U.S. House of Representatives passed&nbsp;$1 trillion bipartisan infrastructure bil</b>l</p>\n<p>The U.S. House of Representatives late Friday&nbsp;passed a more than $1 trillion infrastructure bill, sending the legislation to President&nbsp;Joe Biden&nbsp;for his signature.&nbsp;</p>\n<p>The Senate&nbsp;approved the revamp of transportation, utilities and broadband&nbsp;in August. The legislation’s passage is perhaps the unified Democratic government’s most concrete achievement since it approved a $1.9 trillion coronavirus relief package in the spring.</p>\n<p>The measure passed in a 228-206 vote. Thirteen Republicans supported it, while six Democrats voted against it. Biden could sign the bill within days.</p>\n<p>The bipartisan Infrastructure Investment and Jobs Act would put $550 billion in new money into transportation projects, the utility grid and broadband. The package includes $110 billion for roads, bridges and other major projects, along with $66 billion for passenger and freight rail and $39 billion for public transit.</p>\n<p>It would put $65 billion into broadband, a priority for many lawmakers after the coronavirus pandemic highlighted inequities in internet access for households and students across the country. The legislation would also invest $55 billion into water systems, including efforts to replace lead pipes.</p>\n<p>Industrials and materials stocks rallied Monday with those names set to benefit from the spending package. The&nbsp;Global X U.S. Infrastructure Development&nbsp;exchange-traded fund rose nearly 1.3% and&nbsp;hit a new all-time high&nbsp;Monday morning.</p>\n<p>Mining company&nbsp;Freeport-McMoRan, construction materials stock&nbsp;Vulcan&nbsp;and steel corporation&nbsp;Nucor&nbsp;were among the notable gainers on the S&amp;P 500. Construction equipment manufacturer&nbsp;Caterpillar&nbsp;led the Dow’s rally with a 4% gain. Heavy equipment producer&nbsp;Deere&nbsp;saw its shares rise about 1.6%. United Rentals, Martin Marietta and Jacobs Engineering were among other infrastructure-related gainers.</p>\n<p><b>Fed Said&nbsp;U.S. Public Health Among Biggest Near-Term Risks to Financial System</b></p>\n<p>The potential for U.S. public health to worsen as the Covid-19 pandemic continues is one of the greatest near-term risks to the financial system, the Federal Reserve said, while noting that asset prices are susceptible to large declines should investor sentiment shift.</p>\n<p>Any deterioration in the public-health situation could slow the recent economic recovery, particularly if widespread business closures returned and supply chains were further disrupted, the Fed said. The number of new Covid-19 cases has fallen in recent months, but a resurgence this summer, tied to the Delta variant, coincided with a slowdown in hiring and economic growth.</p>\n<p>Still, other parts of the financial system appear resilient. Banks remain well capitalized, the central bank said, and key measures of vulnerability from business and household debt have largely returned to pre-pandemic levels.</p>\n<p>The Fed also warned that structural vulnerabilities persist in some types of money-market mutual funds and other cash-management vehicles, as well as in bond and bank loan mutual funds. The vulnerabilities could amplify shocks to the financial system in times of stress, as they have in prior crises, the central bank said.</p>\n<p>Moreover,Fed officials have indicated that they continue to have serious concerns about risks in asset markets. Staff at a July Fed meeting characterized vulnerabilities to the financial system as notable, pointing in part to rapidly increasing house prices that had left valuation measures stretched.</p>\n<p><b>Fed’s Clarida Sees Interest-Rate Liftoff Test Met by End of 2022</b></p>\n<p>Federal Reserve Vice Chair Richard Clarida said the “necessary conditions” to raise the U.S. central bank’s benchmark lending rate from near zero will probably be in place at the end of next year.</p>\n<p>“We are clearly a ways away from considering raising interest rates,” Clarida told a virtual event Monday hosted by the Brookings Institution in Washington. “I believe that these three necessary conditions for raising the target range for the federal funds rate will have been met by year-end 2022,” he said, referring to the labor market and inflation tests laid out by the Fed for liftoff.</p>\n<p>Clarida said he expected inflation pressures to ease “as the labor market and global supply chains eventually adjust and, importantly, do so without putting persistent upward pressure on price inflation and wage gains adjusted for productivity.” U.S. central bankers in August 2020 adopted a new approach to the central bank’s goals for employment and price stability. The inflation target was redefined as 2% on average, to overcome years of undershooting.</p>\n<p>He also pointed out&nbsp;that the risks to inflation are to the upside, and said he would not want to see another year of inflation overshoot along the lines of 2021. Inflation by the Fed’s preferred measure rose 4.4% for the 12 months ending September, and minus food and energy it rose 3.6%.</p>\n<p>“Inflation so far this year represents, to me, much more than a ‘moderate’ overshoot of our 2% longer-run inflation objective, and I would not consider a repeat performance next year a policy success,” he said.</p>\n<p>Several other Fed officials also spoke on Monday. Highlights from those remarks include:</p>\n<p>St. Louis Fed President James Bullard, who said he had penciled in two rate increases next year and argued the central bank should be prepared to speed up its pace of tapering asset purchases. “We have done a lot to move the policy in a more hawkish direction. We can do more, but that will be data-dependent. We will have to see how that comes in,” he told Fox Business in an interview.</p>\n<p>Philadelphia Fed President Patrick Harker, in a speech to the Economic Club of New York, said “I don’t expect that the federal funds rate will rise before the tapering is complete, but we are monitoring inflation very closely and are prepared to take action, should circumstances warrant it.”</p>\n<p>Chicago Fed President Charles Evans expects elevated inflation to eventually fade, but he says “there are some indications that inflationary pressures may be building more broadly.”</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Overnight US stock market review : Congress passed $1 trillion bipartisan infrastructure bill; Amd shares rose 10%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nOvernight US stock market review : Congress passed $1 trillion bipartisan infrastructure bill; Amd shares rose 10%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-09 12:18</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><b>Market Overview</b></p>\n<p>The S&amp;P 500 closed at a record high Monday after Congress approved an infrastructure spending package.</p>\n<p>The broad index gained 0.09% to close above 4,700 for the first time at 4,701.70. The Dow Jones Industrial Average added 104.27 points, or 0.3%, to close at 36,432.22. The Nasdaq Composite ticked up 0.07% at 15,982.36. All three stock averages posted record closes.</p>\n<p>Other important events included that the U.S. House of Representatives passed&nbsp;$1 trillion bipartisan infrastructure bill,Musk&nbsp;would&nbsp;sell 10% of Tesla stock based on Twitter poll, several&nbsp;Fed officials spoke on Monday&nbsp;and so on.</p>\n<p><b>Tesla shares closed Monday down nearly 5% as</b>&nbsp;<b>Musk&nbsp;will&nbsp;sell 10% of Tesla stock</b></p>\n<p>Tesla shares closed Monday down 4.8% after CEO Elon Musk said he would sell 10% of his holdings in the electric car maker — more than $20 billion worth by most calculations — based on the results of a&nbsp;poll he conducted on Twitter over the weekend.</p>\n<p>According to analyst Daniel Ives of Wedbush Securities, Musk owns about 23% of Tesla’s stock and has about $10 billion in taxes coming due on stock options that vest next summer.</p>\n<p>Much of Musk’s wealth is held in shares of Tesla, which does not pay him a cash salary.</p>\n<p>“I only have stock, thus the only way for me to pay taxes personally is to sell stock,” Musk tweeted.</p>\n<p>The sometimes abrasive and unpredictable Musk, whose net worth is around $300 billion, said he proposed selling the stock as some Democrats have been pushing for billionaires to pay taxes when the price of the stocks they hold goes up, even if they don’t sell any shares. However, the wording on unrealized gains, also called a “billionaires tax,” was removed from President Joe Biden’s budget, which is still being negotiated.</p>\n<p>“Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” he tweeted Saturday afternoon. “Do you support this?”</p>\n<p>Musk said he would abide by the results of the poll, which ended with 58% of more than 3.5 million votes calling for him to sell the stock. He did not say when he would sell the stock.</p>\n<p><b>AMD shares closed&nbsp;up 10% after company won&nbsp;Meta partnership</b></p>\n<p>Advanced Micro Devices on Monday announced new specialized processors for different data-center workloads. It also added Facebook as a customer for its server chips. AMD stock surged higher on the news.</p>\n<p>AMD announced that Meta Platforms, the parent company of social network Facebook, is the latest hyperscale cloud company to adopt AMD's Epyc central processing units, or CPUs.</p>\n<p>On Monday, AMD launched its AMD Instinct MI200 series accelerators, which are optimized for high-performance computing and artificial-intelligence workloads. The company described them as \"the first exascale-class GPU accelerators.\" AMD competes with Nvidia in GPUs.</p>\n<p>AMD also previewed the use of 3D chiplet packaging technology in server CPUs. Third-generation AMD Epyc processors with AMD 3D V-Cache will offer a 50% average performance uplift across targeted technical computing workloads. The new chips will launch in the first quarter of 2022.</p>\n<p><b>The U.S. House of Representatives passed&nbsp;$1 trillion bipartisan infrastructure bil</b>l</p>\n<p>The U.S. House of Representatives late Friday&nbsp;passed a more than $1 trillion infrastructure bill, sending the legislation to President&nbsp;Joe Biden&nbsp;for his signature.&nbsp;</p>\n<p>The Senate&nbsp;approved the revamp of transportation, utilities and broadband&nbsp;in August. The legislation’s passage is perhaps the unified Democratic government’s most concrete achievement since it approved a $1.9 trillion coronavirus relief package in the spring.</p>\n<p>The measure passed in a 228-206 vote. Thirteen Republicans supported it, while six Democrats voted against it. Biden could sign the bill within days.</p>\n<p>The bipartisan Infrastructure Investment and Jobs Act would put $550 billion in new money into transportation projects, the utility grid and broadband. The package includes $110 billion for roads, bridges and other major projects, along with $66 billion for passenger and freight rail and $39 billion for public transit.</p>\n<p>It would put $65 billion into broadband, a priority for many lawmakers after the coronavirus pandemic highlighted inequities in internet access for households and students across the country. The legislation would also invest $55 billion into water systems, including efforts to replace lead pipes.</p>\n<p>Industrials and materials stocks rallied Monday with those names set to benefit from the spending package. The&nbsp;Global X U.S. Infrastructure Development&nbsp;exchange-traded fund rose nearly 1.3% and&nbsp;hit a new all-time high&nbsp;Monday morning.</p>\n<p>Mining company&nbsp;Freeport-McMoRan, construction materials stock&nbsp;Vulcan&nbsp;and steel corporation&nbsp;Nucor&nbsp;were among the notable gainers on the S&amp;P 500. Construction equipment manufacturer&nbsp;Caterpillar&nbsp;led the Dow’s rally with a 4% gain. Heavy equipment producer&nbsp;Deere&nbsp;saw its shares rise about 1.6%. United Rentals, Martin Marietta and Jacobs Engineering were among other infrastructure-related gainers.</p>\n<p><b>Fed Said&nbsp;U.S. Public Health Among Biggest Near-Term Risks to Financial System</b></p>\n<p>The potential for U.S. public health to worsen as the Covid-19 pandemic continues is one of the greatest near-term risks to the financial system, the Federal Reserve said, while noting that asset prices are susceptible to large declines should investor sentiment shift.</p>\n<p>Any deterioration in the public-health situation could slow the recent economic recovery, particularly if widespread business closures returned and supply chains were further disrupted, the Fed said. The number of new Covid-19 cases has fallen in recent months, but a resurgence this summer, tied to the Delta variant, coincided with a slowdown in hiring and economic growth.</p>\n<p>Still, other parts of the financial system appear resilient. Banks remain well capitalized, the central bank said, and key measures of vulnerability from business and household debt have largely returned to pre-pandemic levels.</p>\n<p>The Fed also warned that structural vulnerabilities persist in some types of money-market mutual funds and other cash-management vehicles, as well as in bond and bank loan mutual funds. The vulnerabilities could amplify shocks to the financial system in times of stress, as they have in prior crises, the central bank said.</p>\n<p>Moreover,Fed officials have indicated that they continue to have serious concerns about risks in asset markets. Staff at a July Fed meeting characterized vulnerabilities to the financial system as notable, pointing in part to rapidly increasing house prices that had left valuation measures stretched.</p>\n<p><b>Fed’s Clarida Sees Interest-Rate Liftoff Test Met by End of 2022</b></p>\n<p>Federal Reserve Vice Chair Richard Clarida said the “necessary conditions” to raise the U.S. central bank’s benchmark lending rate from near zero will probably be in place at the end of next year.</p>\n<p>“We are clearly a ways away from considering raising interest rates,” Clarida told a virtual event Monday hosted by the Brookings Institution in Washington. “I believe that these three necessary conditions for raising the target range for the federal funds rate will have been met by year-end 2022,” he said, referring to the labor market and inflation tests laid out by the Fed for liftoff.</p>\n<p>Clarida said he expected inflation pressures to ease “as the labor market and global supply chains eventually adjust and, importantly, do so without putting persistent upward pressure on price inflation and wage gains adjusted for productivity.” U.S. central bankers in August 2020 adopted a new approach to the central bank’s goals for employment and price stability. The inflation target was redefined as 2% on average, to overcome years of undershooting.</p>\n<p>He also pointed out&nbsp;that the risks to inflation are to the upside, and said he would not want to see another year of inflation overshoot along the lines of 2021. Inflation by the Fed’s preferred measure rose 4.4% for the 12 months ending September, and minus food and energy it rose 3.6%.</p>\n<p>“Inflation so far this year represents, to me, much more than a ‘moderate’ overshoot of our 2% longer-run inflation objective, and I would not consider a repeat performance next year a policy success,” he said.</p>\n<p>Several other Fed officials also spoke on Monday. Highlights from those remarks include:</p>\n<p>St. Louis Fed President James Bullard, who said he had penciled in two rate increases next year and argued the central bank should be prepared to speed up its pace of tapering asset purchases. “We have done a lot to move the policy in a more hawkish direction. We can do more, but that will be data-dependent. We will have to see how that comes in,” he told Fox Business in an interview.</p>\n<p>Philadelphia Fed President Patrick Harker, in a speech to the Economic Club of New York, said “I don’t expect that the federal funds rate will rise before the tapering is complete, but we are monitoring inflation very closely and are prepared to take action, should circumstances warrant it.”</p>\n<p>Chicago Fed President Charles Evans expects elevated inflation to eventually fade, but he says “there are some indications that inflationary pressures may be building more broadly.”</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMD":"美国超微公司","TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1121670869","content_text":"Market Overview\nThe S&P 500 closed at a record high Monday after Congress approved an infrastructure spending package.\nThe broad index gained 0.09% to close above 4,700 for the first time at 4,701.70. The Dow Jones Industrial Average added 104.27 points, or 0.3%, to close at 36,432.22. The Nasdaq Composite ticked up 0.07% at 15,982.36. All three stock averages posted record closes.\nOther important events included that the U.S. House of Representatives passed $1 trillion bipartisan infrastructure bill,Musk would sell 10% of Tesla stock based on Twitter poll, several Fed officials spoke on Monday and so on.\nTesla shares closed Monday down nearly 5% as Musk will sell 10% of Tesla stock\nTesla shares closed Monday down 4.8% after CEO Elon Musk said he would sell 10% of his holdings in the electric car maker — more than $20 billion worth by most calculations — based on the results of a poll he conducted on Twitter over the weekend.\nAccording to analyst Daniel Ives of Wedbush Securities, Musk owns about 23% of Tesla’s stock and has about $10 billion in taxes coming due on stock options that vest next summer.\nMuch of Musk’s wealth is held in shares of Tesla, which does not pay him a cash salary.\n“I only have stock, thus the only way for me to pay taxes personally is to sell stock,” Musk tweeted.\nThe sometimes abrasive and unpredictable Musk, whose net worth is around $300 billion, said he proposed selling the stock as some Democrats have been pushing for billionaires to pay taxes when the price of the stocks they hold goes up, even if they don’t sell any shares. However, the wording on unrealized gains, also called a “billionaires tax,” was removed from President Joe Biden’s budget, which is still being negotiated.\n“Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my Tesla stock,” he tweeted Saturday afternoon. “Do you support this?”\nMusk said he would abide by the results of the poll, which ended with 58% of more than 3.5 million votes calling for him to sell the stock. He did not say when he would sell the stock.\nAMD shares closed up 10% after company won Meta partnership\nAdvanced Micro Devices on Monday announced new specialized processors for different data-center workloads. It also added Facebook as a customer for its server chips. AMD stock surged higher on the news.\nAMD announced that Meta Platforms, the parent company of social network Facebook, is the latest hyperscale cloud company to adopt AMD's Epyc central processing units, or CPUs.\nOn Monday, AMD launched its AMD Instinct MI200 series accelerators, which are optimized for high-performance computing and artificial-intelligence workloads. The company described them as \"the first exascale-class GPU accelerators.\" AMD competes with Nvidia in GPUs.\nAMD also previewed the use of 3D chiplet packaging technology in server CPUs. Third-generation AMD Epyc processors with AMD 3D V-Cache will offer a 50% average performance uplift across targeted technical computing workloads. The new chips will launch in the first quarter of 2022.\nThe U.S. House of Representatives passed $1 trillion bipartisan infrastructure bill\nThe U.S. House of Representatives late Friday passed a more than $1 trillion infrastructure bill, sending the legislation to President Joe Biden for his signature. \nThe Senate approved the revamp of transportation, utilities and broadband in August. The legislation’s passage is perhaps the unified Democratic government’s most concrete achievement since it approved a $1.9 trillion coronavirus relief package in the spring.\nThe measure passed in a 228-206 vote. Thirteen Republicans supported it, while six Democrats voted against it. Biden could sign the bill within days.\nThe bipartisan Infrastructure Investment and Jobs Act would put $550 billion in new money into transportation projects, the utility grid and broadband. The package includes $110 billion for roads, bridges and other major projects, along with $66 billion for passenger and freight rail and $39 billion for public transit.\nIt would put $65 billion into broadband, a priority for many lawmakers after the coronavirus pandemic highlighted inequities in internet access for households and students across the country. The legislation would also invest $55 billion into water systems, including efforts to replace lead pipes.\nIndustrials and materials stocks rallied Monday with those names set to benefit from the spending package. The Global X U.S. Infrastructure Development exchange-traded fund rose nearly 1.3% and hit a new all-time high Monday morning.\nMining company Freeport-McMoRan, construction materials stock Vulcan and steel corporation Nucor were among the notable gainers on the S&P 500. Construction equipment manufacturer Caterpillar led the Dow’s rally with a 4% gain. Heavy equipment producer Deere saw its shares rise about 1.6%. United Rentals, Martin Marietta and Jacobs Engineering were among other infrastructure-related gainers.\nFed Said U.S. Public Health Among Biggest Near-Term Risks to Financial System\nThe potential for U.S. public health to worsen as the Covid-19 pandemic continues is one of the greatest near-term risks to the financial system, the Federal Reserve said, while noting that asset prices are susceptible to large declines should investor sentiment shift.\nAny deterioration in the public-health situation could slow the recent economic recovery, particularly if widespread business closures returned and supply chains were further disrupted, the Fed said. The number of new Covid-19 cases has fallen in recent months, but a resurgence this summer, tied to the Delta variant, coincided with a slowdown in hiring and economic growth.\nStill, other parts of the financial system appear resilient. Banks remain well capitalized, the central bank said, and key measures of vulnerability from business and household debt have largely returned to pre-pandemic levels.\nThe Fed also warned that structural vulnerabilities persist in some types of money-market mutual funds and other cash-management vehicles, as well as in bond and bank loan mutual funds. The vulnerabilities could amplify shocks to the financial system in times of stress, as they have in prior crises, the central bank said.\nMoreover,Fed officials have indicated that they continue to have serious concerns about risks in asset markets. Staff at a July Fed meeting characterized vulnerabilities to the financial system as notable, pointing in part to rapidly increasing house prices that had left valuation measures stretched.\nFed’s Clarida Sees Interest-Rate Liftoff Test Met by End of 2022\nFederal Reserve Vice Chair Richard Clarida said the “necessary conditions” to raise the U.S. central bank’s benchmark lending rate from near zero will probably be in place at the end of next year.\n“We are clearly a ways away from considering raising interest rates,” Clarida told a virtual event Monday hosted by the Brookings Institution in Washington. “I believe that these three necessary conditions for raising the target range for the federal funds rate will have been met by year-end 2022,” he said, referring to the labor market and inflation tests laid out by the Fed for liftoff.\nClarida said he expected inflation pressures to ease “as the labor market and global supply chains eventually adjust and, importantly, do so without putting persistent upward pressure on price inflation and wage gains adjusted for productivity.” U.S. central bankers in August 2020 adopted a new approach to the central bank’s goals for employment and price stability. The inflation target was redefined as 2% on average, to overcome years of undershooting.\nHe also pointed out that the risks to inflation are to the upside, and said he would not want to see another year of inflation overshoot along the lines of 2021. Inflation by the Fed’s preferred measure rose 4.4% for the 12 months ending September, and minus food and energy it rose 3.6%.\n“Inflation so far this year represents, to me, much more than a ‘moderate’ overshoot of our 2% longer-run inflation objective, and I would not consider a repeat performance next year a policy success,” he said.\nSeveral other Fed officials also spoke on Monday. Highlights from those remarks include:\nSt. Louis Fed President James Bullard, who said he had penciled in two rate increases next year and argued the central bank should be prepared to speed up its pace of tapering asset purchases. “We have done a lot to move the policy in a more hawkish direction. We can do more, but that will be data-dependent. We will have to see how that comes in,” he told Fox Business in an interview.\nPhiladelphia Fed President Patrick Harker, in a speech to the Economic Club of New York, said “I don’t expect that the federal funds rate will rise before the tapering is complete, but we are monitoring inflation very closely and are prepared to take action, should circumstances warrant it.”\nChicago Fed President Charles Evans expects elevated inflation to eventually fade, but he says “there are some indications that inflationary pressures may be building more broadly.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":180495040,"gmtCreate":1623217552580,"gmtModify":1634035680319,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Please like and comment. Thx.","listText":"Please like and comment. Thx.","text":"Please like and comment. Thx.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":5,"repostSize":0,"link":"https://laohu8.com/post/180495040","repostId":"1183830906","repostType":4,"repost":{"id":"1183830906","pubTimestamp":1623216866,"share":"https://www.laohu8.com/m/news/1183830906?lang=&edition=full","pubTime":"2021-06-09 13:34","market":"us","language":"en","title":"Cathie Wood Sells Snapchat, DocuSign For Second Straight Day, Buys Spotify","url":"https://stock-news.laohu8.com/highlight/detail?id=1183830906","media":"benzinga","summary":"Cathie Wood-led Ark Investment Management on Monday booked profit in DocuSign Inc for a second strai","content":"<p>Cathie Wood-led Ark Investment Management on Monday booked profit in&nbsp;<b>DocuSign Inc</b>&nbsp;for a second straight day,&nbsp;after boosting confidence in&nbsp;the e-signature company's ability to draw more customers.</p><p>Ark Invest sold 46,938 shares, estimated to be worth about $11.37 million, in DocuSign as shares of the San Francisco, California-based company closed 0.56% higher at $242.32 on Tuesday. Shares of DocuSign have risen about 4% since Friday.</p><p>Wood's firm&nbsp;said on Friday, after market hours, DocuSignappears to be gaining tractionin international markets and the growth in its Agreement Cloud amid COVID-19 is not a temporary shift.</p><p>Wood’s firm sold the shares in DocuSign via the&nbsp;<b>Ark Innovation ETF</b>&nbsp;. Ark also holds a stake in the company via the&nbsp;<b>Ark Next Generation Internet ETF</b>.</p><p>The popular investment firm’s holding in DocuSign, whose worth is estimated to be about $592.9 million based on Tuesday’s closing price,&nbsp; is now down to 2.46 million shares.</p><p>The investment firm also sold 77,407 shares, estimated to be worth about $4.65 million, in Snapchat parent&nbsp;<b>Snap Inc</b>&nbsp;.</p><p>Shares of the social media company closed 1.99% lower at $60.15 on Tuesday.</p><p>Wood’s firm sold the shares in Snap via ARKW and also holds a stake in the company via the&nbsp;<b>Ark Fintech Innovation ETF</b>&nbsp;. Ark’s stake in Snap is now down to 2.75 million shares, lowering its estimated value to about $168.55 million, as of Tuesday.</p><p>The New York-based investment firm also bought 60,383 shares, estimated to be worth $14.64 million, in&nbsp;<b>Spotify Technology</b>&nbsp;, its second straight buy in the digital music streaming company.</p><p>Shares of Spotify closed marginally down at $242.51 on Tuesday.</p><p>ARKK made the purchase. It&nbsp;held about 3.12 million shares, worth about $758.4 million, in the company ahead of Tuesday's trade. ARKW too has a stake in Spotify.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cathie Wood Sells Snapchat, DocuSign For Second Straight Day, Buys Spotify</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCathie Wood Sells Snapchat, DocuSign For Second Straight Day, Buys Spotify\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-09 13:34 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/etfs/sector-etfs/21/06/21485239/cathie-wood-sells-snapchat-docusign-for-second-straight-day-buys-spotify><strong>benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood-led Ark Investment Management on Monday booked profit in DocuSign Inc for a second straight day, after boosting confidence in the e-signature company's ability to draw more customers.Ark ...</p>\n\n<a href=\"https://www.benzinga.com/etfs/sector-etfs/21/06/21485239/cathie-wood-sells-snapchat-docusign-for-second-straight-day-buys-spotify\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPOT":"Spotify Technology S.A.","SNAP":"Snap Inc"},"source_url":"https://www.benzinga.com/etfs/sector-etfs/21/06/21485239/cathie-wood-sells-snapchat-docusign-for-second-straight-day-buys-spotify","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1183830906","content_text":"Cathie Wood-led Ark Investment Management on Monday booked profit in DocuSign Inc for a second straight day, after boosting confidence in the e-signature company's ability to draw more customers.Ark Invest sold 46,938 shares, estimated to be worth about $11.37 million, in DocuSign as shares of the San Francisco, California-based company closed 0.56% higher at $242.32 on Tuesday. Shares of DocuSign have risen about 4% since Friday.Wood's firm said on Friday, after market hours, DocuSignappears to be gaining tractionin international markets and the growth in its Agreement Cloud amid COVID-19 is not a temporary shift.Wood’s firm sold the shares in DocuSign via the Ark Innovation ETF . Ark also holds a stake in the company via the Ark Next Generation Internet ETF.The popular investment firm’s holding in DocuSign, whose worth is estimated to be about $592.9 million based on Tuesday’s closing price,  is now down to 2.46 million shares.The investment firm also sold 77,407 shares, estimated to be worth about $4.65 million, in Snapchat parent Snap Inc .Shares of the social media company closed 1.99% lower at $60.15 on Tuesday.Wood’s firm sold the shares in Snap via ARKW and also holds a stake in the company via the Ark Fintech Innovation ETF . Ark’s stake in Snap is now down to 2.75 million shares, lowering its estimated value to about $168.55 million, as of Tuesday.The New York-based investment firm also bought 60,383 shares, estimated to be worth $14.64 million, in Spotify Technology , its second straight buy in the digital music streaming company.Shares of Spotify closed marginally down at $242.51 on Tuesday.ARKK made the purchase. It held about 3.12 million shares, worth about $758.4 million, in the company ahead of Tuesday's trade. ARKW too has a stake in Spotify.","news_type":1},"isVote":1,"tweetType":1,"viewCount":136,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157000646,"gmtCreate":1625549912885,"gmtModify":1633939731144,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Please like&nbsp;","listText":"Please like&nbsp;","text":"Please like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/157000646","repostId":"2149353488","repostType":4,"isVote":1,"tweetType":1,"viewCount":130,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":162477558,"gmtCreate":1624073852874,"gmtModify":1634011037605,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Pls help to like and comment. Thx.","listText":"Pls help to like and comment. Thx.","text":"Pls help to like and comment. Thx.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/162477558","repostId":"1166679093","repostType":4,"repost":{"id":"1166679093","pubTimestamp":1624065234,"share":"https://www.laohu8.com/m/news/1166679093?lang=&edition=full","pubTime":"2021-06-19 09:13","market":"us","language":"en","title":"3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%","url":"https://stock-news.laohu8.com/highlight/detail?id=1166679093","media":"fool","summary":"Meme stocks have been all the rage so far this year. That's understandable, with several of them del","content":"<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.</p>\n<p>However, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.</p>\n<p>AMC Entertainment</p>\n<p><b>AMC Entertainment</b>(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.</p>\n<p>The consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.</p>\n<p>But isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.</p>\n<p>However, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.</p>\n<p>Clover Health Investments</p>\n<p>Only a few days ago, it looked like&nbsp;<b>Clover Health Investments</b>(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.</p>\n<p>Since the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.</p>\n<p>Clover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.</p>\n<p>Still, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.</p>\n<p>Sundial Growers</p>\n<p>At one point earlier this year,&nbsp;<b>Sundial Growers</b>(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.</p>\n<p>Analysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.</p>\n<p>There certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.</p>\n<p>Sundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.</p>\n<p>However, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the&nbsp;<b>Nasdaq</b>&nbsp;stock exchange.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Meme Stocks Wall Street Predicts Will Plunge More Than 20%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-19 09:13 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/><strong>fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CLOV":"Clover Health Corp","SNDL":"SNDL Inc.","AMC":"AMC院线"},"source_url":"https://www.fool.com/investing/2021/06/18/3-meme-stocks-wall-street-predicts-will-plunge-mor/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1166679093","content_text":"Meme stocks have been all the rage so far this year. That's understandable, with several of them delivering triple-digit and even four-digit percentage gains.\nHowever, what goes up can come down. Analysts don't expect the online frenzy fueling the ginormous jumps for some of the most popular stocks will be sustainable. Here are three meme stocks that Wall Street thinks will plunge by more than 20% within the next 12 months.\nAMC Entertainment\nAMC Entertainment(NYSE:AMC)ranks as the best-performing meme stock of all. Shares of the movie theater operator have skyrocketed close to 2,500% year to date.\nThe consensus among analysts, though, is that the stock could lose 90% of its current value. Even the most optimistic analyst surveyed by Refinitiv has a price target for AMC that's more than 70% below the current share price.\nBut isn't AMC's business picking up? Yep. The easing of restrictions has enabled the company to reopen 99% of its U.S. theaters. AMC could benefit as seating capacity limitations imposed by state and local governments are raised. Thereleases of multiple movies this summerand later this year that are likely to be hits should also help.\nHowever, Wall Street clearly believes that AMC's share price has gotten way ahead of its business prospects. The stock is trading at nearly eight times higher than it was before the COVID-19 pandemic.\nClover Health Investments\nOnly a few days ago, it looked like Clover Health Investments(NASDAQ:CLOV)might push AMC to the side as the hottest meme stock. Retail investors viewed Clover as a primeshort squeezecandidate.\nSince the beginning of June, shares of Clover Health have jumped more than 65%. Analysts, however, don't expect those gains to last. The average price target for the stock is 25% below the current share price.\nClover Health's valuation does seem to have gotten out of hand. The healthcare stock currently trades at more than 170 times trailing-12-month sales. That's a nosebleed level, especially considering that the company is the subject of investigations by the U.S. Department of Justice and the Securities and Exchange Commission.\nStill, Clover Health could deliver improving financial results this year. The company hopes to significantly increase its membership by targeting the original Medicare program. This represents a major new market opportunity in addition to its current Medicare Advantage business.\nSundial Growers\nAt one point earlier this year, Sundial Growers(NASDAQ:SNDL)appeared to be a legitimate contender to become the biggest winner among meme stocks. The Canadian marijuana stock vaulted more than 520% higher year to date before giving up much of its gains. However, Sundial's share price has still more than doubled in 2021.\nAnalysts anticipate that the pot stock could fall even further. The consensus price target for Sundial reflects a 23% discount to its current share price. One analyst even thinks the stock could sink 55%.\nThere certainly are reasons to be pessimistic about Sundial's core cannabis business. The company's net cannabis revenue fell year over year in the first quarter of 2021. Although Sundial is taking steps that it hopes will turn things around, it remains to be seen if those efforts will succeed.\nSundial's business deals could give investors reasons for optimism. After all, the company posted positive adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA) in Q1 due to its investments.\nHowever, the cash that Sundial is using to make these investments has come at the cost of increased dilution of its stock. The company can't afford any additional dilution without having to resort to desperate measures to keep its listing on the Nasdaq stock exchange.","news_type":1},"isVote":1,"tweetType":1,"viewCount":60,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":138259739,"gmtCreate":1621945559321,"gmtModify":1634185288164,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like and comment thanks&nbsp;","listText":"Like and comment thanks&nbsp;","text":"Like and comment thanks","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/138259739","repostId":"2138167318","repostType":4,"isVote":1,"tweetType":1,"viewCount":174,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":871718109,"gmtCreate":1637111933771,"gmtModify":1637111934126,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/871718109","repostId":"1126829465","repostType":4,"repost":{"id":"1126829465","pubTimestamp":1637108959,"share":"https://www.laohu8.com/m/news/1126829465?lang=&edition=full","pubTime":"2021-11-17 08:29","market":"sg","language":"en","title":"Rebound Predicted For Singapore Stock Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1126829465","media":"Nasdaq","summary":"(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through","content":"<p>(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had stumbled more than 30 points or 1 percent. The Straits Times Index now sits just beneath the 3,240-point plateau although it's likely to tick higher again on Wednesday.</p>\n<p>The global forecast for the Asian markets is upbeat on solid economic data and support from the technology stocks. The European markets were mixed and the U.S. bourses were up and the Asian markets figure to split the difference.</p>\n<p>The STI finished barely lower on Tuesday following mixed performances from the financial shares and industrial issues.</p>\n<p>For the day, the index dipped 1.78 points or 0.05 percent to finish at 3,238.80 after trading between 3,230.96 and 3,246.25. Volume was 1.58 billion shares worth 1.17 billion Singapore dollars. There were 261 gainers and 200 decliners.</p>\n<p>Among the actives, Ascendas REIT sank 0.65 percent, while City Developments gained 0.28 percent, Comfort DelGro advanced 0.67 percent, Dairy Farm International skidded 0.89 percent, DBS Group shed 0.47 percent, Genting Singapore jumped 1.21 percent, Mapletree Logistics Trust climbed 1.02 percent, Oversea-Chinese Banking Corporation collected 0.08 percent, SATS and SembCorp Industries both added 0.49 percent, Singapore Airlines was up 0.19 percent, Singapore Exchange dropped 0.53 percent, Singapore Press Holdings spiked 1.72 percent, Singapore Technologies Engineering rose 0.26 percent, SingTel and Yangzijiang Shipbuilding both tumbled 1.55 percent, Thai Beverage soared 1.38 percent, United Overseas Bank eased 0.14 percent, Wilmar International lost 0.23 percent and Keppel Corp, Mapletree Commercial Trust, CapitaLand Integrated Commercial Trust and UOL Group were unchanged.</p>\n<p>The lead from Wall Street is positive as the major averages opened higher on Tuesday and remained in the green throughout the session.</p>\n<p>The Dow added 54.77 points or 0.15 percent to finish at 36,142.22, while the NASDAQ jumped 120.01 points or 0.76 percent to close at 15,973.86 and the S&amp;P 500 rose 18.10 points or 0.39 percent to end at 4,700.90.</p>\n<p>The strength on Wall Street reflected a positive reaction to some upbeat U.S. economic data, including a Commerce Department report showing retail sales spiked more than expected in October.</p>\n<p>The Federal Reserve also released a report showing industrial production rebounded by much more than expected in October.</p>\n<p>Crude oil futures settled lower on Tuesday, weighed down by a forecast by the International Energy Agency that global crude output will rise and help ease tight supplies. West Texas Intermediate Crude oil futures for December ended lower by $0.12 or 0.2 percent at $80.76 a barrel.</p>\n<p>Closer to home, Singapore will release October figures for non-oil domestic exports later this morning, with forecasts suggesting an increase of 0.4 percent on month and 15.0 percent on year following the 1.2 percent monthly increase and the 12.3 percent annual gain.</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Rebound Predicted For Singapore Stock Market</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRebound Predicted For Singapore Stock Market\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-17 08:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/rebound-predicted-for-singapore-stock-market><strong>Nasdaq</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had stumbled more than 30...</p>\n\n<a href=\"https://www.nasdaq.com/articles/rebound-predicted-for-singapore-stock-market\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"STI.SI":"富时新加坡海峡指数"},"source_url":"https://www.nasdaq.com/articles/rebound-predicted-for-singapore-stock-market","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1126829465","content_text":"(RTTNews) - The Singapore stock market has alternated between positive and negative finishes through the last four trading days since the end of the two-day slide in which it had stumbled more than 30 points or 1 percent. The Straits Times Index now sits just beneath the 3,240-point plateau although it's likely to tick higher again on Wednesday.\nThe global forecast for the Asian markets is upbeat on solid economic data and support from the technology stocks. The European markets were mixed and the U.S. bourses were up and the Asian markets figure to split the difference.\nThe STI finished barely lower on Tuesday following mixed performances from the financial shares and industrial issues.\nFor the day, the index dipped 1.78 points or 0.05 percent to finish at 3,238.80 after trading between 3,230.96 and 3,246.25. Volume was 1.58 billion shares worth 1.17 billion Singapore dollars. There were 261 gainers and 200 decliners.\nAmong the actives, Ascendas REIT sank 0.65 percent, while City Developments gained 0.28 percent, Comfort DelGro advanced 0.67 percent, Dairy Farm International skidded 0.89 percent, DBS Group shed 0.47 percent, Genting Singapore jumped 1.21 percent, Mapletree Logistics Trust climbed 1.02 percent, Oversea-Chinese Banking Corporation collected 0.08 percent, SATS and SembCorp Industries both added 0.49 percent, Singapore Airlines was up 0.19 percent, Singapore Exchange dropped 0.53 percent, Singapore Press Holdings spiked 1.72 percent, Singapore Technologies Engineering rose 0.26 percent, SingTel and Yangzijiang Shipbuilding both tumbled 1.55 percent, Thai Beverage soared 1.38 percent, United Overseas Bank eased 0.14 percent, Wilmar International lost 0.23 percent and Keppel Corp, Mapletree Commercial Trust, CapitaLand Integrated Commercial Trust and UOL Group were unchanged.\nThe lead from Wall Street is positive as the major averages opened higher on Tuesday and remained in the green throughout the session.\nThe Dow added 54.77 points or 0.15 percent to finish at 36,142.22, while the NASDAQ jumped 120.01 points or 0.76 percent to close at 15,973.86 and the S&P 500 rose 18.10 points or 0.39 percent to end at 4,700.90.\nThe strength on Wall Street reflected a positive reaction to some upbeat U.S. economic data, including a Commerce Department report showing retail sales spiked more than expected in October.\nThe Federal Reserve also released a report showing industrial production rebounded by much more than expected in October.\nCrude oil futures settled lower on Tuesday, weighed down by a forecast by the International Energy Agency that global crude output will rise and help ease tight supplies. West Texas Intermediate Crude oil futures for December ended lower by $0.12 or 0.2 percent at $80.76 a barrel.\nCloser to home, Singapore will release October figures for non-oil domestic exports later this morning, with forecasts suggesting an increase of 0.4 percent on month and 15.0 percent on year following the 1.2 percent monthly increase and the 12.3 percent annual gain.","news_type":1},"isVote":1,"tweetType":1,"viewCount":119,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":851693504,"gmtCreate":1634899767762,"gmtModify":1634899768087,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/851693504","repostId":"1169239209","repostType":4,"repost":{"id":"1169239209","pubTimestamp":1634896805,"share":"https://www.laohu8.com/m/news/1169239209?lang=&edition=full","pubTime":"2021-10-22 18:00","market":"us","language":"en","title":"Investors Bet Inflation Pressures Will Linger","url":"https://stock-news.laohu8.com/highlight/detail?id=1169239209","media":"The Wall Street Journal","summary":"The 10-year break-even rate suggests that the consumer-price index will rise by an annual average of","content":"<blockquote>\n <b>The 10-year break-even rate suggests that the consumer-price index will rise by an annual average of 2.57% over the next decade, worrying some investors.</b>\n</blockquote>\n<p>A key measure of investors’ inflation expectations has climbed in recent weeks, adding fuel to concerns about rising consumer prices.</p>\n<p>As of Wednesday, the gauge known as the 10-year break-even rate suggested that the consumer-price index will rise by an annual average of 2.57% over the next decade, according to Federal Reserve Economic Data, or FRED. That is up from a recent low of 2.28% in late September and the highest level since 2013.</p>\n<p>The break-even rate is found by looking at the difference in yields between nominal Treasury bonds and Treasury inflation-protected securities, or TIPS. The rate is so called because TIPS holders can earn the same return as holders of nominal Treasurys if average annual CPI inflation matches that gap over the life of the bonds.</p>\n<p>Rising break-even rates worry some investors because the move suggests current inflation pressures could last longer than previously expected. The Labor Department said on Oct. 13 that last month’s consumer-price indexrose by 5.4% from a year earlier, in unadjusted terms. While that index tends to run slightly higher than the Federal Reserve’s preferred inflation gauge, the data still confirmed that inflation is much higher than the central bank’s 2% annual target.</p>\n<p>Investors and analysts generally expect inflation to cool in the coming months as businesses ramp up the supply of goods to meet consumer demand and consumers further ease supply-chain pressures by returning to more normal spending patterns—purchasing fewer goods and more services. Many, though, have revised their forecasts upward in light of surging energy prices, rising rents andincreasing evidence of a tightening employment market.</p>\n<p>Some analysts caution that break-even rates still don’t suggest serious concern about longer-term inflation, though they may be heading in that direction. Yield differentials between nominal and inflation-protected securities, for example, suggest CPI inflation&nbsp;will moderate to 2.6%&nbsp;in five yearsthen&nbsp;drop down to just below 2% about a decade from now. And even those numbers could overstate baseline expectations because break-evens can also rise based on increasing uncertainty about the inflation outlook.</p>\n<p>“Break-evens are flashing maybe a yellow light here, but certainly not a red light,” said Michael Pond, head of global inflation-linked research atBarclays PLC.</p>\n<p>Several factors have lifted break-even rates this year, including a vaccine-fueled economic recovery, massive amounts of government stimulus and consistent messaging from central bankers that the Fed will be patient in its approach to tightening monetary policy.</p>\n<p>Last year, Fed officials announceda new policy framework, stating they would welcome inflation being modestly above their 2% target for a time to make up for the extended period it has spent below that level.</p>\n<p>Investors’ concerns over inflation have ebbed and flowed this year, but have clearly increased lately, driving a flood of cash toward inflation-protected bonds. About $2.1 billion on net was funneled into mutual and exchange-traded funds that focus on TIPS during the two weeks ending Oct. 13, according to Refinitiv Lipper data, the largest two-week inflow in more than two months. That compared with a net outflow of $1.7 billion from all taxable bond funds during the same period.</p>\n<p>Fed officials themselves have recentlyexpressed concernsthat disrupted supply chains were raising the risks of more persistent inflation. At the same time, Chairman Jerome Powell has said the central bank doesn’t expect the current spike in consumer prices to lead to a new regime in which inflation remains high year after year.</p>\n<p>Break-even rates, notably, have climbed even as investors have pulled forward their forecasts for when the Fed will start to raise interest rates. Federal-funds futures, which investors use to wager on interest rate policy, recently showed a 51% chance of a rate increase by July 2022 and 75% by September 2022. That is up from around 15% and 27% a month ago, respectively.</p>\n<p>“The question right now is at what point does the pull forward [in rate increases] and possible tightening make investors believe that central banks can slow the growth of inflation,” said Jim Vogel, interest-rates strategist at FHN Financial.</p>\n<p>Raising interest rates typically slows economic growth by increasing borrowing costs and pushing consumers to spend less, thereby cooling inflation as well.</p>\n<p>Shorter-dated inflation expectations can continue to rise with commodity price concerns, but it has been surprising that the market’s pulling forward of interest-rate hikes hasn’t done more to arrest the rise in investors’ inflation expectations, some analysts say.</p>\n<p>Still, rising interest-rate expectations and inflation forecasts aren’t incompatible, Barclays’ Mr. Pond said. Even if the Fed starts raising interest rates next year, it could still be years before rates reach the so-called neutral level that officials believe would neither stimulate nor slow the economy.</p>\n<p>“The Fed is saying we’re going to continue to run a stimulative policy even as we see inflation above our target over the next three years,” he said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Investors Bet Inflation Pressures Will Linger</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInvestors Bet Inflation Pressures Will Linger\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-22 18:00 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/investors-bet-inflation-pressures-will-linger-11634849018?mod=markets_lead_pos5><strong>The Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The 10-year break-even rate suggests that the consumer-price index will rise by an annual average of 2.57% over the next decade, worrying some investors.\n\nA key measure of investors’ inflation ...</p>\n\n<a href=\"https://www.wsj.com/articles/investors-bet-inflation-pressures-will-linger-11634849018?mod=markets_lead_pos5\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯"},"source_url":"https://www.wsj.com/articles/investors-bet-inflation-pressures-will-linger-11634849018?mod=markets_lead_pos5","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1169239209","content_text":"The 10-year break-even rate suggests that the consumer-price index will rise by an annual average of 2.57% over the next decade, worrying some investors.\n\nA key measure of investors’ inflation expectations has climbed in recent weeks, adding fuel to concerns about rising consumer prices.\nAs of Wednesday, the gauge known as the 10-year break-even rate suggested that the consumer-price index will rise by an annual average of 2.57% over the next decade, according to Federal Reserve Economic Data, or FRED. That is up from a recent low of 2.28% in late September and the highest level since 2013.\nThe break-even rate is found by looking at the difference in yields between nominal Treasury bonds and Treasury inflation-protected securities, or TIPS. The rate is so called because TIPS holders can earn the same return as holders of nominal Treasurys if average annual CPI inflation matches that gap over the life of the bonds.\nRising break-even rates worry some investors because the move suggests current inflation pressures could last longer than previously expected. The Labor Department said on Oct. 13 that last month’s consumer-price indexrose by 5.4% from a year earlier, in unadjusted terms. While that index tends to run slightly higher than the Federal Reserve’s preferred inflation gauge, the data still confirmed that inflation is much higher than the central bank’s 2% annual target.\nInvestors and analysts generally expect inflation to cool in the coming months as businesses ramp up the supply of goods to meet consumer demand and consumers further ease supply-chain pressures by returning to more normal spending patterns—purchasing fewer goods and more services. Many, though, have revised their forecasts upward in light of surging energy prices, rising rents andincreasing evidence of a tightening employment market.\nSome analysts caution that break-even rates still don’t suggest serious concern about longer-term inflation, though they may be heading in that direction. Yield differentials between nominal and inflation-protected securities, for example, suggest CPI inflation will moderate to 2.6% in five yearsthen drop down to just below 2% about a decade from now. And even those numbers could overstate baseline expectations because break-evens can also rise based on increasing uncertainty about the inflation outlook.\n“Break-evens are flashing maybe a yellow light here, but certainly not a red light,” said Michael Pond, head of global inflation-linked research atBarclays PLC.\nSeveral factors have lifted break-even rates this year, including a vaccine-fueled economic recovery, massive amounts of government stimulus and consistent messaging from central bankers that the Fed will be patient in its approach to tightening monetary policy.\nLast year, Fed officials announceda new policy framework, stating they would welcome inflation being modestly above their 2% target for a time to make up for the extended period it has spent below that level.\nInvestors’ concerns over inflation have ebbed and flowed this year, but have clearly increased lately, driving a flood of cash toward inflation-protected bonds. About $2.1 billion on net was funneled into mutual and exchange-traded funds that focus on TIPS during the two weeks ending Oct. 13, according to Refinitiv Lipper data, the largest two-week inflow in more than two months. That compared with a net outflow of $1.7 billion from all taxable bond funds during the same period.\nFed officials themselves have recentlyexpressed concernsthat disrupted supply chains were raising the risks of more persistent inflation. At the same time, Chairman Jerome Powell has said the central bank doesn’t expect the current spike in consumer prices to lead to a new regime in which inflation remains high year after year.\nBreak-even rates, notably, have climbed even as investors have pulled forward their forecasts for when the Fed will start to raise interest rates. Federal-funds futures, which investors use to wager on interest rate policy, recently showed a 51% chance of a rate increase by July 2022 and 75% by September 2022. That is up from around 15% and 27% a month ago, respectively.\n“The question right now is at what point does the pull forward [in rate increases] and possible tightening make investors believe that central banks can slow the growth of inflation,” said Jim Vogel, interest-rates strategist at FHN Financial.\nRaising interest rates typically slows economic growth by increasing borrowing costs and pushing consumers to spend less, thereby cooling inflation as well.\nShorter-dated inflation expectations can continue to rise with commodity price concerns, but it has been surprising that the market’s pulling forward of interest-rate hikes hasn’t done more to arrest the rise in investors’ inflation expectations, some analysts say.\nStill, rising interest-rate expectations and inflation forecasts aren’t incompatible, Barclays’ Mr. Pond said. Even if the Fed starts raising interest rates next year, it could still be years before rates reach the so-called neutral level that officials believe would neither stimulate nor slow the economy.\n“The Fed is saying we’re going to continue to run a stimulative policy even as we see inflation above our target over the next three years,” he said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":164,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":828526526,"gmtCreate":1633926659437,"gmtModify":1633926659567,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Buy!","listText":"Buy!","text":"Buy!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/828526526","repostId":"2174971913","repostType":4,"repost":{"id":"2174971913","pubTimestamp":1633907096,"share":"https://www.laohu8.com/m/news/2174971913?lang=&edition=full","pubTime":"2021-10-11 07:04","market":"us","language":"en","title":"Big banks kick off Q3 earnings season, CPI inflation data: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2174971913","media":"Yahoo Finance","summary":"Third-quarter earnings season ramps up in earnest this week with a packed schedule of major financia","content":"<p>Third-quarter earnings season ramps up in earnest this week with a packed schedule of major financial companies poised to report results. Key economic data will include the U.S. consumer price index for September, in the latest print on the state of inflation in the U.S. economy.</p>\n<p>Investors have been anxiously awaiting the start of the latest earnings season and bracing for a deceleration in corporate profit growth after a strong second quarter.</p>\n<p>S&amp;P 500 earnings are expected to grow by 27.6% in aggregate for the third quarter, slowing sharply from the second quarter's nearly 90% growth rate, according to data from FactSet. Still, last quarter's results had been aided by easy comparisons to the pandemic-depressed profit levels of mid-2020. And at nearly 30%, the expected earnings growth rate for the third quarter would still be the third-fastest pace for the index since 2010.</p>\n<p>Traders are especially looking to see that supply-side challenges and rising input and labor costs weighed heavily on corporate profits for the latest quarter. Nearly two dozen S&amp;P 500 companies — including major names like FedEx (FDX) and Nike (NKE) — have already reported third-quarter results, giving hints about the magnitude of the margin pressure being exerted by supply-side challenges.</p>\n<p>\"Supply chain disruptions and costs have been cited by the highest number companies in the index to date as a factor that either had a negative impact on earnings or revenues in Q3, or is expected to have a negative impact on earnings or revenues in future quarters,\" FactSet's John Butters wrote in a note on Friday. Of the 21 S&amp;P 500 component companies that have reported results so far, 15 of them have discussed negative impacts from these factors, Butters added.</p>\n<p>\"After supply chain disruptions, labor shortages and costs (14), COVID costs and impacts (11), and transportation and freight costs (11) have been discussed by the highest number of S&amp;P 500 companies,\" he added.</p>\n<p>For many companies, the specter of eventual interest rate hikes from the Federal Reserve and the present inflationary environment has presented a slew of concerns over higher input and borrowing costs. But for the Big Banks, a higher interest-rate environment generally translates into stronger profits in their key lending businesses, allowing them to command higher rates on loans.</p>\n<p>The major U.S. banks including JPMorgan Chase (JPM), Bank of America (BAC), Goldman Sachs (GS) and <a href=\"https://laohu8.com/S/MSTLW\">Morgan Stanley</a> (MS) are each set to report quarterly results this week. Heading into these results, many analysts have said they expect to see net interest margins expand alongside the creep higher in benchmark interest rates this year. And as the economic recovery chugs along, banks may further release loan loss reserves they set aside to protect against potential defaults and nonpayments over the course of the pandemic.</p>\n<p>\"We expect 3Q21 EPS [earnings per share] results to be stronger on a year-over-year basis as loan loss reserves continue to be released albeit at a lower level than 1Q/2Q21 and the group posts positive revenue growth,\" RBC Capital Markets analyst Gerard Cassidy wrote in a note last week.</p>\n<p>\"Key themes that we expect to see in the results include: (1) more signs of net interest margin (NIM) stabilization; (2) growth in the consumer loan, residential mortgage and commercial real estate mortgage portfolios; and (3) positive outlook guidance on credit, loan growth (especially commercial &amp; industrial loans,) and NIM,\" he added. \"Lastly, commentary on core operating expenses should be listened to carefully to see if the banks are starting to feel non-incentive compensation wage pressure.\"</p>\n<p>According to Matt O'Connor, Deutsche Bank managing director of U.S. banks equity research, banks still have considerable room for loan growth with the economic recovery under way. Total industry loans are still 1% below pre-pandemic levels from the fourth quarter of 2019, he said, and are down by an even more significant mid-single-digits percentage when excluding loans made via the COVID-era Paycheck Protection Program.</p>\n<p>“We remain positive on bank stocks given a likely multi-year positive backdrop for credit, interest rates and loan growth,” O'Connor wrote in a note. “It’s hard to be too negative on the banks given a generally favorable macroeconomic outlook among most (despite some slower activity more recently) and the prospect for higher rates and faster loan growth, though was we’ve noted before the timing/magnitude of this remains unclear.”</p>\n<p>For the year-to-date, the financials sector remains the second-best performer in the S&amp;P 500 after the energy sector, climbing more than 30% so far in 2021.</p>\n<h2>Consumer price index</h2>\n<p>One of the most closely watched economic reports this week will be the Bureau of Labor Statistics' Consumer Price Index, due for release on Wednesday.</p>\n<p>The report is expected to show consumer prices rose at roughly the same month-on-month and annual rate in September as in August, reinforcing the persistent inflationary pressures present even as the economic recovery rolls on.</p>\n<p>Consensus economists are looking for the consumer price index to jump by 0.3% in September over the previous month and by 5.3% over the prior year.</p>\n<p>At least some of that increase will likely come as a result of jumping energy prices, with crude oil and natural gas prices spiking amid elevated demand and tight supply over the past month. However, even excluding more volatile food and energy prices, the CPI likely still rose at a 4.0% annual pace.</p>\n<p>The so-called core measure of CPI has moderated from June's 4.5% annual clip, or the fastest rate since 1991, but has still held markedly higher compared to pre-pandemic standards. Some of the categories mostly closely associated with the economic reopening have seen prices pull back after initial surges in the spring and early summer — but not by enough to bring down the overall level of CPI.</p>\n<p>“The key takeaway from the upcoming consumer price index will be how broadly across categories we are seeing price increases,\" Greg McBride, chief financial analyst for Bankrate, said in an email on Friday. \"While used car prices, airfares, and lodging have all pulled back a bit, underscoring the idea that higher inflation might indeed be transitory, increases in others like shelter costs might just be heating up.”</p>\n<p>Other areas of the economy have also begun to show persistently heightened levels of inflation, with U.S. crude oil futures skyrocketing to their highest level since 2014 last week and commodity prices across the board moving higher. And last week's September jobs report also reflected a number of inflationary pressures in the labor market, with average hourly wages accelerating to the fastest year-over-year pace since February, and rise in the workweek taking place alongside a drop in labor force participation.</p>\n<p>\"We expect reopening effects to continue to fade, but the risk from supply constraints is likely to be longer-lasting than previously expected,\" High Frequency Economics' Rubeela Farooqi wrote in a note. \"That should provide ongoing support to goods prices, even as services inflation continues to revert to more typical trends on a normalization of activity.\"</p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday:</b> <i>No notable reports scheduled for release </i></p></li>\n <li><p><b>Tuesday: </b>NFIB Small Business Optimism, September (99.5 expected, 100.1 during prior month); JOLTS Job Openings, August (10.938 million expected, 10.934 million during prior month)</p></li>\n <li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended Oct. 8 (-6.9% during prior week); Consumer price index, month-over-month, September (0.3% expected, 0.3% during prior month); CPI excluding food and energy, month-over-month, September (0.2% expected, 0.1% during prior month); CPI year-over-year, September (5.3% expected, 5.3% during prior month); CPI excluding food and energy, year-over-year, September (4.0% expected, 4.0% during prior month); Real Average Hourly earnings, year-over-year, September (-1.1% during prior month); Real Average Weekly earnings, year-over-year, September (-1.4% during prior month); FOMC meeting minutes</p></li>\n <li><p><b>Thursday: </b>Initial jobless claims, week ended Oct. 9 (325,000 expected, 326,000 during prior week); Continuing claims, week ended Oct. 2 (2.696 million expected, 2.714 million during prior week); Producer price index, month-over-month, September (0.6% expected, 0.7% during prior month); PPI excluding food and energy, month-over-month, September (0.5% expected, 0.6% during prior month); PPI, year-over-year, September (8.7% expected, 8.3% during prior month); PPI excluding food and energy, year-over-year. September (7.1% expected, 6.7% during prior month)</p></li>\n <li><p><b>Friday: </b>Empire Manufacturing, October (25.0 expected, 34.3 during prior month); Retail sales, month-over-month, September (-0.2% expected, 0.7% during prior month); Retail sales excluding autos and gas, month-over-month, September (0.6% expected, 1.8% during prior month); Import price index, month-over-month, September (0.6% expected, -0.3% during prior month); University of Michigan sentiment, October preliminary (73.5 expected, 72.8 during prior month)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>JPMorgan Chase (JPM), BlackRock (BLK), First Republic Bank (FRC), Delta Air Lines (DAL) before market open</p></li>\n <li><p><b>Thursday: </b>Bank of America (BAC), Domino's Pizza (DPZ), <a href=\"https://laohu8.com/S/WBA\">Walgreens Boots Alliance</a> (WBA), The Progressive Corp. (PGR), UnitedHealth Group (UNH), US Bancorp (USB), Wells Fargo (WFC), Morgan Stanley (MS), Citigroup (C) before market open; Alcoa (AA) after market close</p></li>\n <li><p><b>Friday: </b>PNC Financial Services (PNC), <a href=\"https://laohu8.com/S/TFC\">Truist Financial Corp</a>. (TFC), Coinbase Global (COIN), The Charles Schwab Corp. (SCHW), Goldman Sachs (GS) before market open</p></li>\n</ul>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Big banks kick off Q3 earnings season, CPI inflation data: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBig banks kick off Q3 earnings season, CPI inflation data: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-11 07:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/big-banks-kick-off-q-3-earnings-season-cpi-inflation-data-what-to-know-this-week-170456712.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Third-quarter earnings season ramps up in earnest this week with a packed schedule of major financial companies poised to report results. Key economic data will include the U.S. consumer price index ...</p>\n\n<a href=\"https://finance.yahoo.com/news/big-banks-kick-off-q-3-earnings-season-cpi-inflation-data-what-to-know-this-week-170456712.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SPY.AU":"SPDR® S&P 500® ETF Trust","BAC":"美国银行","GS":"高盛","MS":"摩根士丹利","C":"花旗","JPM":"摩根大通","WFC":"富国银行"},"source_url":"https://finance.yahoo.com/news/big-banks-kick-off-q-3-earnings-season-cpi-inflation-data-what-to-know-this-week-170456712.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2174971913","content_text":"Third-quarter earnings season ramps up in earnest this week with a packed schedule of major financial companies poised to report results. Key economic data will include the U.S. consumer price index for September, in the latest print on the state of inflation in the U.S. economy.\nInvestors have been anxiously awaiting the start of the latest earnings season and bracing for a deceleration in corporate profit growth after a strong second quarter.\nS&P 500 earnings are expected to grow by 27.6% in aggregate for the third quarter, slowing sharply from the second quarter's nearly 90% growth rate, according to data from FactSet. Still, last quarter's results had been aided by easy comparisons to the pandemic-depressed profit levels of mid-2020. And at nearly 30%, the expected earnings growth rate for the third quarter would still be the third-fastest pace for the index since 2010.\nTraders are especially looking to see that supply-side challenges and rising input and labor costs weighed heavily on corporate profits for the latest quarter. Nearly two dozen S&P 500 companies — including major names like FedEx (FDX) and Nike (NKE) — have already reported third-quarter results, giving hints about the magnitude of the margin pressure being exerted by supply-side challenges.\n\"Supply chain disruptions and costs have been cited by the highest number companies in the index to date as a factor that either had a negative impact on earnings or revenues in Q3, or is expected to have a negative impact on earnings or revenues in future quarters,\" FactSet's John Butters wrote in a note on Friday. Of the 21 S&P 500 component companies that have reported results so far, 15 of them have discussed negative impacts from these factors, Butters added.\n\"After supply chain disruptions, labor shortages and costs (14), COVID costs and impacts (11), and transportation and freight costs (11) have been discussed by the highest number of S&P 500 companies,\" he added.\nFor many companies, the specter of eventual interest rate hikes from the Federal Reserve and the present inflationary environment has presented a slew of concerns over higher input and borrowing costs. But for the Big Banks, a higher interest-rate environment generally translates into stronger profits in their key lending businesses, allowing them to command higher rates on loans.\nThe major U.S. banks including JPMorgan Chase (JPM), Bank of America (BAC), Goldman Sachs (GS) and Morgan Stanley (MS) are each set to report quarterly results this week. Heading into these results, many analysts have said they expect to see net interest margins expand alongside the creep higher in benchmark interest rates this year. And as the economic recovery chugs along, banks may further release loan loss reserves they set aside to protect against potential defaults and nonpayments over the course of the pandemic.\n\"We expect 3Q21 EPS [earnings per share] results to be stronger on a year-over-year basis as loan loss reserves continue to be released albeit at a lower level than 1Q/2Q21 and the group posts positive revenue growth,\" RBC Capital Markets analyst Gerard Cassidy wrote in a note last week.\n\"Key themes that we expect to see in the results include: (1) more signs of net interest margin (NIM) stabilization; (2) growth in the consumer loan, residential mortgage and commercial real estate mortgage portfolios; and (3) positive outlook guidance on credit, loan growth (especially commercial & industrial loans,) and NIM,\" he added. \"Lastly, commentary on core operating expenses should be listened to carefully to see if the banks are starting to feel non-incentive compensation wage pressure.\"\nAccording to Matt O'Connor, Deutsche Bank managing director of U.S. banks equity research, banks still have considerable room for loan growth with the economic recovery under way. Total industry loans are still 1% below pre-pandemic levels from the fourth quarter of 2019, he said, and are down by an even more significant mid-single-digits percentage when excluding loans made via the COVID-era Paycheck Protection Program.\n“We remain positive on bank stocks given a likely multi-year positive backdrop for credit, interest rates and loan growth,” O'Connor wrote in a note. “It’s hard to be too negative on the banks given a generally favorable macroeconomic outlook among most (despite some slower activity more recently) and the prospect for higher rates and faster loan growth, though was we’ve noted before the timing/magnitude of this remains unclear.”\nFor the year-to-date, the financials sector remains the second-best performer in the S&P 500 after the energy sector, climbing more than 30% so far in 2021.\nConsumer price index\nOne of the most closely watched economic reports this week will be the Bureau of Labor Statistics' Consumer Price Index, due for release on Wednesday.\nThe report is expected to show consumer prices rose at roughly the same month-on-month and annual rate in September as in August, reinforcing the persistent inflationary pressures present even as the economic recovery rolls on.\nConsensus economists are looking for the consumer price index to jump by 0.3% in September over the previous month and by 5.3% over the prior year.\nAt least some of that increase will likely come as a result of jumping energy prices, with crude oil and natural gas prices spiking amid elevated demand and tight supply over the past month. However, even excluding more volatile food and energy prices, the CPI likely still rose at a 4.0% annual pace.\nThe so-called core measure of CPI has moderated from June's 4.5% annual clip, or the fastest rate since 1991, but has still held markedly higher compared to pre-pandemic standards. Some of the categories mostly closely associated with the economic reopening have seen prices pull back after initial surges in the spring and early summer — but not by enough to bring down the overall level of CPI.\n“The key takeaway from the upcoming consumer price index will be how broadly across categories we are seeing price increases,\" Greg McBride, chief financial analyst for Bankrate, said in an email on Friday. \"While used car prices, airfares, and lodging have all pulled back a bit, underscoring the idea that higher inflation might indeed be transitory, increases in others like shelter costs might just be heating up.”\nOther areas of the economy have also begun to show persistently heightened levels of inflation, with U.S. crude oil futures skyrocketing to their highest level since 2014 last week and commodity prices across the board moving higher. And last week's September jobs report also reflected a number of inflationary pressures in the labor market, with average hourly wages accelerating to the fastest year-over-year pace since February, and rise in the workweek taking place alongside a drop in labor force participation.\n\"We expect reopening effects to continue to fade, but the risk from supply constraints is likely to be longer-lasting than previously expected,\" High Frequency Economics' Rubeela Farooqi wrote in a note. \"That should provide ongoing support to goods prices, even as services inflation continues to revert to more typical trends on a normalization of activity.\"\nEconomic calendar\n\nMonday: No notable reports scheduled for release \nTuesday: NFIB Small Business Optimism, September (99.5 expected, 100.1 during prior month); JOLTS Job Openings, August (10.938 million expected, 10.934 million during prior month)\nWednesday: MBA Mortgage Applications, week ended Oct. 8 (-6.9% during prior week); Consumer price index, month-over-month, September (0.3% expected, 0.3% during prior month); CPI excluding food and energy, month-over-month, September (0.2% expected, 0.1% during prior month); CPI year-over-year, September (5.3% expected, 5.3% during prior month); CPI excluding food and energy, year-over-year, September (4.0% expected, 4.0% during prior month); Real Average Hourly earnings, year-over-year, September (-1.1% during prior month); Real Average Weekly earnings, year-over-year, September (-1.4% during prior month); FOMC meeting minutes\nThursday: Initial jobless claims, week ended Oct. 9 (325,000 expected, 326,000 during prior week); Continuing claims, week ended Oct. 2 (2.696 million expected, 2.714 million during prior week); Producer price index, month-over-month, September (0.6% expected, 0.7% during prior month); PPI excluding food and energy, month-over-month, September (0.5% expected, 0.6% during prior month); PPI, year-over-year, September (8.7% expected, 8.3% during prior month); PPI excluding food and energy, year-over-year. September (7.1% expected, 6.7% during prior month)\nFriday: Empire Manufacturing, October (25.0 expected, 34.3 during prior month); Retail sales, month-over-month, September (-0.2% expected, 0.7% during prior month); Retail sales excluding autos and gas, month-over-month, September (0.6% expected, 1.8% during prior month); Import price index, month-over-month, September (0.6% expected, -0.3% during prior month); University of Michigan sentiment, October preliminary (73.5 expected, 72.8 during prior month)\n\nEarnings calendar\n\nMonday: No notable reports scheduled for release\nTuesday: No notable reports scheduled for release\nWednesday: JPMorgan Chase (JPM), BlackRock (BLK), First Republic Bank (FRC), Delta Air Lines (DAL) before market open\nThursday: Bank of America (BAC), Domino's Pizza (DPZ), Walgreens Boots Alliance (WBA), The Progressive Corp. (PGR), UnitedHealth Group (UNH), US Bancorp (USB), Wells Fargo (WFC), Morgan Stanley (MS), Citigroup (C) before market open; Alcoa (AA) after market close\nFriday: PNC Financial Services (PNC), Truist Financial Corp. (TFC), Coinbase Global (COIN), The Charles Schwab Corp. (SCHW), Goldman Sachs (GS) before market open","news_type":1},"isVote":1,"tweetType":1,"viewCount":93,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":897296614,"gmtCreate":1628919857938,"gmtModify":1631893532781,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/897296614","repostId":"2159521376","repostType":4,"repost":{"id":"2159521376","pubTimestamp":1628906786,"share":"https://www.laohu8.com/m/news/2159521376?lang=&edition=full","pubTime":"2021-08-14 10:06","market":"us","language":"en","title":"Chasing Tesla: Here are the current electric vehicle plans of every major car maker","url":"https://stock-news.laohu8.com/highlight/detail?id=2159521376","media":"MarketWatch","summary":"At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles ","content":"<p>At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes that EVs can shift from niche to normal.</p>\n<p>EVs accounted for 2.4% of U.S. cars sold in 2020, up from 0.7% five years ago, according to BloombergNEF. The research provider expects that share to increase to 11% in 2025; by 2030, it expects that slightly over a third of vehicles sold in the U.S. will be electric.</p>\n<p>Several auto makers had already announced bigger EV ambitions even before the White House call.</p>\n<p>Here are each major car maker's stated plans for EVs, including, when available, investment amounts and the range of models they hope to bring to market.</p>\n<p>This information was collated from company sites, previous reports, and BloombergNEF projections, and will be updated regularly.</p>\n<p><b>Audi</b></p>\n<p>Audi, a brand known for its luxury cars and owned by Germany's Volkswagen AG , has promised to have battery-electric vehicles comprise 35% of its sales by 2025. By that time, Audi buyers will choose from about 20 EV models.</p>\n<p><b>BMW</b></p>\n<p>BMW AG , a luxury-car maker from Germany, was among the first EV innovators. It launched its i3 compact EV eight years ago, then as $one of the few serious competitors to Tesla Inc.'s vehicles.</p>\n<p>BMW's EV pipeline has slowed, but the auto maker has promised that 25% of its European sales will be all-electric and hybrid vehicles this year, and that all sales of its Mini brand will be battery electric by 2030. It expects to launch more than 10 battery EVs models in the next couple of years.</p>\n<p><b>Daimler/Mercedes-Benz</b></p>\n<p>Mercedes-Benz, owned by Daimler AG , expects that between 15% and 25% of its sales will be comprised of EV sales by 2025; by 2030, that percentage is expected to grow to 50%. Mercedes-Benz is slated to end 2021 offering three new electric passenger car models and more to come in 2022.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ec4b2abd59e5b19c9eec0034342af25e\" tg-width=\"700\" tg-height=\"413\" width=\"100%\" height=\"auto\"><span>SOURCE: MERCEDES</span></p>\n<p><b>Ford</b></p>\n<p>Ford Motor Co. <a href=\"https://laohu8.com/S/F\">$(F)$</a> has said that 40% of its global sales by 2030 will be sales of EVs . Ford is aiming to have dozens of electrified models by 2022, the year that will also mark the debut of its much-awaited all-electric F-150 Lightning pickup truck.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/3a44fec36dac046911679a2ba769cb2b\" tg-width=\"700\" tg-height=\"450\" width=\"100%\" height=\"auto\"><span>The Ford F-150 Lightning o JEFF KOWALSKY/AGENCE FRANCE-PRESSE/GETTY IMAGES</span></p>\n<p>Ford has called the Lightning the \"pillar\" of its more than $22 billion bet on EVs, which includes EV models for other best-selling vehicles such as the Mustang and its Transit van.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/87df52ddef1af1d1342d685897e83652\" tg-width=\"700\" tg-height=\"392\" width=\"100%\" height=\"auto\"><span>SOURCE: FORD</span></p>\n<p><b>GM</b></p>\n<p>General Motors Co. <a href=\"https://laohu8.com/S/GM\">$(GM)$</a> surprised Wall Street in January by saying it aims to phase out all of its internal combustion engine vehicles by 2035 and only sell zero-emission vehicles by then. The auto maker also promises to be carbon-neutral by 2040.</p>\n<p>GM has said that it will offer 30 all-electric models globally by mid-decade, and that 40% percent of the company's U.S. models will be battery electric vehicles by the end of 2025. Its Hummer electric is expected for next year, with production starting this fall.</p>\n<p><b>Honda</b></p>\n<p>The Japanese maker (7267.TO), which owns the namesake Honda brand and also the luxury-car brand Acura, is projected to derive 40% of its sales from EVs and fuel-cell electric cars by 2030. In April 2020, Honda and GM announced a partnership to develop Honda electric cars using GM's Ultium batteries.</p>\n<p><b>Hyundai</b></p>\n<p>The Korean car maker , which also owns Kia, is aiming to have 40% of its Kia and Hyundai brands sales to be of EVs and fuel-cell electric vehicles by 2025. Its Hyundai brand plans on more than 30 electric passenger vehicles by then.</p>\n<p><b>Mazda</b></p>\n<p>Mazda plans to offer 5% of its vehicles as battery electric by 2030, but EV sales targets as a percentage of total sales are unknown at the moment. Mazda does not offer EVs in the U.S., but sells a few EV and hybrid models elsewhere.</p>\n<p><b>Nissan</b></p>\n<p>Nissan Motor Co. Ltd. was among the first auto makers to offer an all-electric vehicle, and its the Nissan Leaf for years was one of the few options available for those without the deep pockets needed for a Tesla Inc. <a href=\"https://laohu8.com/S/TSLA\">$(TSLA)$</a> Model S.</p>\n<p>Nissan plans to offer 20 EV models in China by next year, and for the U.S. the company recently said it plans that more than 40% of its U.S. vehicle sales by 2030 will be fully electric.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5cbdfabce43725b3d966cf5db5b820f6\" tg-width=\"700\" tg-height=\"466\" width=\"100%\" height=\"auto\"><span>The Nissan Leaf NISSAN</span></p>\n<p><b>Porsche</b></p>\n<p>The car maker and almost synonym of sports cars is aiming to have half of its sales be of EV vehicles by 2025.</p>\n<p><b>Stellantis</b></p>\n<p><a href=\"https://laohu8.com/S/STLA\">Stellantis NV</a> (STLA.MI), the global auto maker formed earlier this year through the merger of Fiat Chrysler Automobiles NV and France's PSA Group, said in July it was investing $35 billion in EVs and adjacent technologies through 2025.</p>\n<p>By that year, Stellantis is expected to derive 31% of its U.S. sales and 38% of its European sales from EVs, percentages that are seen growing to 35% of U.S. sales and 70% of European sales by 2030.</p>\n<p><b>Subaru</b></p>\n<p>The Japanese maker is expected to derive 40% of its sales from EVs and hybrid electric vehicles by 2030.</p>\n<p><b>Toyota</b></p>\n<p>Some 70% of sales for the world's No. 1 car maker (7203.TO) are expected to come from EVs and fuel-cell electric vehicles by 2030. Toyota plans to offer 15 battery EV models by 2025. The car maker, of course, broke ground with its hybrid Toyota Prius two decades ago.</p>\n<p><b>Volkswagen</b></p>\n<p>The car maker is expected to derive 70% of its European sales from EVs and 50% of its U.S. sales from EVs by 2030. Volkswagen has pledged to spend about $40 billion through 2025 on EVs.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chasing Tesla: Here are the current electric vehicle plans of every major car maker</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChasing Tesla: Here are the current electric vehicle plans of every major car maker\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-14 10:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes ...</p>\n\n<a href=\"https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HYEVF":"Hyundai Elevator Co Ltd.","TSLA":"特斯拉","HMC":"本田汽车","STLA":"Stellantis NV","F":"福特汽车","DDAIF":"戴姆勒汽车","VLKAF":"Volkswagen AG","FUJHF":"Subaru Corporation ","GM":"通用汽车","TM":"丰田汽车","NSANY":"日产汽车"},"source_url":"https://www.marketwatch.com/story/chasing-tesla-here-are-the-current-electric-vehicle-plans-of-every-major-car-maker-11628876816?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2159521376","content_text":"At President Joe Biden's urging, the auto industry pledged to boost production of electric vehicles to the point that they account for about half of total U.S. sales by 2030, a plan that raises hopes that EVs can shift from niche to normal.\nEVs accounted for 2.4% of U.S. cars sold in 2020, up from 0.7% five years ago, according to BloombergNEF. The research provider expects that share to increase to 11% in 2025; by 2030, it expects that slightly over a third of vehicles sold in the U.S. will be electric.\nSeveral auto makers had already announced bigger EV ambitions even before the White House call.\nHere are each major car maker's stated plans for EVs, including, when available, investment amounts and the range of models they hope to bring to market.\nThis information was collated from company sites, previous reports, and BloombergNEF projections, and will be updated regularly.\nAudi\nAudi, a brand known for its luxury cars and owned by Germany's Volkswagen AG , has promised to have battery-electric vehicles comprise 35% of its sales by 2025. By that time, Audi buyers will choose from about 20 EV models.\nBMW\nBMW AG , a luxury-car maker from Germany, was among the first EV innovators. It launched its i3 compact EV eight years ago, then as $one of the few serious competitors to Tesla Inc.'s vehicles.\nBMW's EV pipeline has slowed, but the auto maker has promised that 25% of its European sales will be all-electric and hybrid vehicles this year, and that all sales of its Mini brand will be battery electric by 2030. It expects to launch more than 10 battery EVs models in the next couple of years.\nDaimler/Mercedes-Benz\nMercedes-Benz, owned by Daimler AG , expects that between 15% and 25% of its sales will be comprised of EV sales by 2025; by 2030, that percentage is expected to grow to 50%. Mercedes-Benz is slated to end 2021 offering three new electric passenger car models and more to come in 2022.\nSOURCE: MERCEDES\nFord\nFord Motor Co. $(F)$ has said that 40% of its global sales by 2030 will be sales of EVs . Ford is aiming to have dozens of electrified models by 2022, the year that will also mark the debut of its much-awaited all-electric F-150 Lightning pickup truck.\nThe Ford F-150 Lightning o JEFF KOWALSKY/AGENCE FRANCE-PRESSE/GETTY IMAGES\nFord has called the Lightning the \"pillar\" of its more than $22 billion bet on EVs, which includes EV models for other best-selling vehicles such as the Mustang and its Transit van.\nSOURCE: FORD\nGM\nGeneral Motors Co. $(GM)$ surprised Wall Street in January by saying it aims to phase out all of its internal combustion engine vehicles by 2035 and only sell zero-emission vehicles by then. The auto maker also promises to be carbon-neutral by 2040.\nGM has said that it will offer 30 all-electric models globally by mid-decade, and that 40% percent of the company's U.S. models will be battery electric vehicles by the end of 2025. Its Hummer electric is expected for next year, with production starting this fall.\nHonda\nThe Japanese maker (7267.TO), which owns the namesake Honda brand and also the luxury-car brand Acura, is projected to derive 40% of its sales from EVs and fuel-cell electric cars by 2030. In April 2020, Honda and GM announced a partnership to develop Honda electric cars using GM's Ultium batteries.\nHyundai\nThe Korean car maker , which also owns Kia, is aiming to have 40% of its Kia and Hyundai brands sales to be of EVs and fuel-cell electric vehicles by 2025. Its Hyundai brand plans on more than 30 electric passenger vehicles by then.\nMazda\nMazda plans to offer 5% of its vehicles as battery electric by 2030, but EV sales targets as a percentage of total sales are unknown at the moment. Mazda does not offer EVs in the U.S., but sells a few EV and hybrid models elsewhere.\nNissan\nNissan Motor Co. Ltd. was among the first auto makers to offer an all-electric vehicle, and its the Nissan Leaf for years was one of the few options available for those without the deep pockets needed for a Tesla Inc. $(TSLA)$ Model S.\nNissan plans to offer 20 EV models in China by next year, and for the U.S. the company recently said it plans that more than 40% of its U.S. vehicle sales by 2030 will be fully electric.\nThe Nissan Leaf NISSAN\nPorsche\nThe car maker and almost synonym of sports cars is aiming to have half of its sales be of EV vehicles by 2025.\nStellantis\nStellantis NV (STLA.MI), the global auto maker formed earlier this year through the merger of Fiat Chrysler Automobiles NV and France's PSA Group, said in July it was investing $35 billion in EVs and adjacent technologies through 2025.\nBy that year, Stellantis is expected to derive 31% of its U.S. sales and 38% of its European sales from EVs, percentages that are seen growing to 35% of U.S. sales and 70% of European sales by 2030.\nSubaru\nThe Japanese maker is expected to derive 40% of its sales from EVs and hybrid electric vehicles by 2030.\nToyota\nSome 70% of sales for the world's No. 1 car maker (7203.TO) are expected to come from EVs and fuel-cell electric vehicles by 2030. Toyota plans to offer 15 battery EV models by 2025. The car maker, of course, broke ground with its hybrid Toyota Prius two decades ago.\nVolkswagen\nThe car maker is expected to derive 70% of its European sales from EVs and 50% of its U.S. sales from EVs by 2030. Volkswagen has pledged to spend about $40 billion through 2025 on EVs.","news_type":1},"isVote":1,"tweetType":1,"viewCount":78,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":802519126,"gmtCreate":1627787341865,"gmtModify":1631893532885,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Aiya, avoid these companies","listText":"Aiya, avoid these companies","text":"Aiya, avoid these companies","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/802519126","repostId":"1153879814","repostType":4,"repost":{"id":"1153879814","pubTimestamp":1627784753,"share":"https://www.laohu8.com/m/news/1153879814?lang=&edition=full","pubTime":"2021-08-01 10:25","market":"sg","language":"en","title":"SIA, SIAE, Singtel potential candidates for company restructuring: Maybank","url":"https://stock-news.laohu8.com/highlight/detail?id=1153879814","media":"Singapore Business","summary":"Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play f","content":"<blockquote>\n <b><i>Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?</i></b>\n</blockquote>\n<p>Drivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of Singapore Press Holdings (SPH) and a possible merger between Keppel Offshore &amp; Marine and Sembcorp Marine Ltd, according to a report by Maybank Kim Eng.</p>\n<p>According to the report, the drivers catalyzing these restructurings remain in play and are unlikely to retreat in the near-term.</p>\n<p>Some Singapore companies named by Maybank that are potential candidates for a corporate restructuring are Singtel, Singapore Airlines Group and the Singapore Institute of Aerospace Engineers.</p>\n<p>Maybank said Singtel is currently exploring options to review its stakes in associates and infrastructure assets to unlock latent value.</p>\n<p>Continued weakness and expected long lead time to recovery of international air travel may force certain rationalization for SIA and SIAE. Meanwhile, big developers like CityDev and UOL also have sizable development businesses similar to CAPL.</p>","source":"lsy1618986048053","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>SIA, SIAE, Singtel potential candidates for company restructuring: Maybank</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSIA, SIAE, Singtel potential candidates for company restructuring: Maybank\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-01 10:25 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank><strong>Singapore Business</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of ...</p>\n\n<a href=\"https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"C6L.SI":"新加坡航空公司"},"source_url":"https://sbr.com.sg/economy/news/sia-siae-singtel-potential-candidates-company-restructuring-maybank","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153879814","content_text":"Who will follow in SPH, Keppel and Sembcorp steps in corporate restructuring?\n\nDrivers are in play for more corporate restructuring from Singapore firms following the major restructuring plans of Singapore Press Holdings (SPH) and a possible merger between Keppel Offshore & Marine and Sembcorp Marine Ltd, according to a report by Maybank Kim Eng.\nAccording to the report, the drivers catalyzing these restructurings remain in play and are unlikely to retreat in the near-term.\nSome Singapore companies named by Maybank that are potential candidates for a corporate restructuring are Singtel, Singapore Airlines Group and the Singapore Institute of Aerospace Engineers.\nMaybank said Singtel is currently exploring options to review its stakes in associates and infrastructure assets to unlock latent value.\nContinued weakness and expected long lead time to recovery of international air travel may force certain rationalization for SIA and SIAE. Meanwhile, big developers like CityDev and UOL also have sizable development businesses similar to CAPL.","news_type":1},"isVote":1,"tweetType":1,"viewCount":162,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":113872601,"gmtCreate":1622607002303,"gmtModify":1634099978663,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Not buying","listText":"Not buying","text":"Not buying","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":4,"repostSize":0,"link":"https://laohu8.com/post/113872601","repostId":"1156329812","repostType":4,"repost":{"id":"1156329812","pubTimestamp":1622605755,"share":"https://www.laohu8.com/m/news/1156329812?lang=&edition=full","pubTime":"2021-06-02 11:49","market":"hk","language":"en","title":"3 Stocks to Buy to Escape the Dogecoin Doldrums","url":"https://stock-news.laohu8.com/highlight/detail?id=1156329812","media":"Nasdaq","summary":"Cryptocurrencies have crashed in recent weeks. None of them, though, has experienced a more spectacu","content":"<p>Cryptocurrencies have crashed in recent weeks. None of them, though, has experienced a more spectacular dive than<b>Dogecoin</b>(CRYPTO: DOGE). Elon Musk's favorite cryptocurrency is down nearly 50% below its highs set in early May.</p>\n<p>Some investors might be waiting for a fantastic comeback. Others, however, could be looking for alternatives to park their money in the hopes of better returns. If you're in the latter group, here are three stocks to buy to escape the Dogecoin doldrums.</p>\n<p>Etsy</p>\n<p>If you're afraid you'll miss the lovable Dogecoin mascot, check out<b>Etsy</b>(NASDAQ: ETSY). You'll be able to find all kinds of Shiba Inu products on the e-commerce platform, including aprons, caps, mugs, and shirts. Scooping up some Etsy shares could make you feel even better over the long term.</p>\n<p>But isn't Etsy more than 30% off its peak this year? Yep. However, the stock still looks likean unstoppable winner despite this big sell-off.</p>\n<p>Sponsored LinksIf You Need to Kill Time on Your Computer, this City-Building Game is a Must-Have. No Install.Forge of Empires - Free Online Game<a href=\"https://trc.taboola.com/nasdaq-nasdaq/log/3/click?pi=%2Finvesting%2F2021%2F06%2F01%2F3-stocks-to-buy-to-escape-the-dogecoin-doldrums&amp;ri=d3d9864eae1d5f37311bed7023df82ad&amp;sd=v2_9d0fd2fbd1306eb114a30664b3a2671b_739155c7-32f9-4cfc-bd2a-7c945c8cc6a6-tuct6dec6e5_1622604486_1622605735_CIi3jgYQpexOGNnN2tacLyACKAMwXjiHxgpQ____________AVgAYLcGaMnN7e355PrqbQ&amp;ui=739155c7-32f9-4cfc-bd2a-7c945c8cc6a6-tuct6dec6e5&amp;it=text&amp;ii=~~V1~~7963819353821056689~~i73ZcBKj5avlKD9AMzHGRn8SwDy8THpsXPV7z5v_UUXTxvAnL2wqac4MyzR7uD46gj3kUkbS3FhelBtnsiJV6MhkDZRZzzIqDobN6rWmCPA3hYz5D3PLat6nhIftiT1lwdxwdlxkeV_Mfb3eos_TQZ2aCsfRTCrpH3w_BXgfRXl8g_Y9s0PUb1DSS6IYbNmOcPDrZ6cmbg2V6AesWbmKs3w4fVOyfw9IZbtjpMeFtL7aOS5DgJaEvlkZkO6m1rasWzV-pEzQxc5A-MICQRwgu46zhr_uog6GC70OqLAd6RE&amp;pt=text&amp;li=rbox-t2m&amp;sig=7df137af269bcf2a027be84d71231cd868846ed53e0e&amp;redir=https%3A%2F%2Fom.forgeofempires.com%2Ffoe%2F%3Fref%3Dtab_row_en_mktdet2%26%26external_param%3D2970284978%26pid%3Dnasdaq-nasdaq%26bid%3Dhttp%253A%252F%252Fcdn.taboola.com%252Flibtrc%252Fstatic%252Fthumbnails%252F7e016667a06c3953bbd551436b1db2b6.jpeg%26tblci%3DGiAMA8PNIiTHpXwfI80QgUGi9otCulqnNQ0QQHd4vgNlqSDJqD8oxoL5-LqC1Lz_AQ%23tblciGiAMA8PNIiTHpXwfI80QgUGi9otCulqnNQ0QQHd4vgNlqSDJqD8oxoL5-LqC1Lz_AQ&amp;vi=1622605735641&amp;p=innogamesforgeofempiressc&amp;r=73&amp;lti=deflated&amp;ppb=CJcG&amp;cpb=EhIyMDIxMDUzMS04LVJFTEVBU0UYASAAKhlzZy50YWJvb2xhc3luZGljYXRpb24uY29tMgl3YXRlcjMxMDc4gPqp8gVAh8YKWP___________wFjCO___________wEQ7___________ARgRZGMI3P__________ARDc__________8BGCRkYwjcChCgEBgWZGMI0gMQ4AYYCGRjCJYUEJwcGBhkYwj3__________8BEPf__________wEYCWRjCMgcEMUnGBlkYwj0FBCeHRgfZA&amp;cta=true\" target=\"_blank\">Play Now</a></p>\n<p>Some investors were worried after Etsy's executives said that the growth rate for gross merchandise sales (GMS) would slow down in the second quarter. It's important to remember, though, that year-over-year comparisons against the second and third quarters of 2020, when Etsy's sales skyrocketed due to the pandemic, were destined to disappoint.</p>\n<p>Etsy's long-term prospects remain as strong as ever. The company's platform enjoys a competitive moat that's proved unassailable so far. It continues to invest in technological innovations that boost traffic and sales, and it's expanding further into major international markets.</p>\n<p>Dogecoin may or may not claw its way back to previous highs. I predict that Etsy will easily do so.</p>\n<p>Intuitive Surgical</p>\n<p>What's more fun than a cryptocurrency that was started as a joke? Robots! I'm not talking about the kind of robots that take over the world. No, I have in mind robots that help people -- like the robotic surgical systems pioneered by<b>Intuitive Surgical</b>(NASDAQ: ISRG).</p>\n<p>Like Dogecoin, Intuitive Surgical has been a huge winner since its creation. Thehealthcare stockis up close 13,750% over the last couple of decades or so. There's still plenty of room to run, though.</p>\n<p>More than 1.2 million procedures were performed with Intuitive's robotic surgical systems last year. The company estimates that roughly 6 million procedures are done each year for the types of surgery for which its systems already have regulatory clearances. Add to that total another 14 million soft-tissue procedures that Intuitive could target with technological innovations.</p>\n<p>Interestingly, Intuitive Surgical's greatest strength isDogecoin's biggest weakness. The company has an exceptionally strong moat with its huge head start in the market for robotic surgical systems. Dogecoin doesn't have much of a moat at all. Over the next decade and beyond, I think this difference will make Intuitive Surgical the bigger winner by far.</p>\n<p>Mastercard</p>\n<p>Fans of Dogecoin might envision a future where the cryptocurrency is used for billions of digital transactions every week. For<b>Mastercard</b>(NYSE: MA), that future is now. In the first quarter of 2021, the company processed 23.8 billion transactions with a gross dollar volume of more than $1.7 billion.</p>\n<p>Over the near term, Mastercard should benefit as economies reopen. CEO Michael Miebachnoted in the company's first-quarter conference call, \"We're encouraged by the return of domestic spending levels to pre-pandemic trends.\" International spending levels haven't fully rebounded, but there are reasons to hope that the increased availability of vaccines will make a big impact.</p>\n<p>I like Mastercard's long-term prospects even more. The company should be a clear beneficiary as consumers continue to shift away from cash. Its contactless payment options will likely drive growth for years to come.</p>\n<p>If you're still drawn to cryptocurrencies, though, Mastercard has something to offer on that front as well. The company plans to support select cryptocurrencies on its payment network this year. Whether or not Dogecoin is in the group remains to be seen. Even if not, investing in Mastercard should pay off nicely over the long run.</p>","source":"lsy1603171495471","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks to Buy to Escape the Dogecoin Doldrums</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks to Buy to Escape the Dogecoin Doldrums\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-02 11:49 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.nasdaq.com/articles/3-stocks-to-buy-to-escape-the-dogecoin-doldrums-2021-06-01><strong>Nasdaq</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cryptocurrencies have crashed in recent weeks. None of them, though, has experienced a more spectacular dive thanDogecoin(CRYPTO: DOGE). Elon Musk's favorite cryptocurrency is down nearly 50% below ...</p>\n\n<a href=\"https://www.nasdaq.com/articles/3-stocks-to-buy-to-escape-the-dogecoin-doldrums-2021-06-01\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"source_url":"https://www.nasdaq.com/articles/3-stocks-to-buy-to-escape-the-dogecoin-doldrums-2021-06-01","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156329812","content_text":"Cryptocurrencies have crashed in recent weeks. None of them, though, has experienced a more spectacular dive thanDogecoin(CRYPTO: DOGE). Elon Musk's favorite cryptocurrency is down nearly 50% below its highs set in early May.\nSome investors might be waiting for a fantastic comeback. Others, however, could be looking for alternatives to park their money in the hopes of better returns. If you're in the latter group, here are three stocks to buy to escape the Dogecoin doldrums.\nEtsy\nIf you're afraid you'll miss the lovable Dogecoin mascot, check outEtsy(NASDAQ: ETSY). You'll be able to find all kinds of Shiba Inu products on the e-commerce platform, including aprons, caps, mugs, and shirts. Scooping up some Etsy shares could make you feel even better over the long term.\nBut isn't Etsy more than 30% off its peak this year? Yep. However, the stock still looks likean unstoppable winner despite this big sell-off.\nSponsored LinksIf You Need to Kill Time on Your Computer, this City-Building Game is a Must-Have. No Install.Forge of Empires - Free Online GamePlay Now\nSome investors were worried after Etsy's executives said that the growth rate for gross merchandise sales (GMS) would slow down in the second quarter. It's important to remember, though, that year-over-year comparisons against the second and third quarters of 2020, when Etsy's sales skyrocketed due to the pandemic, were destined to disappoint.\nEtsy's long-term prospects remain as strong as ever. The company's platform enjoys a competitive moat that's proved unassailable so far. It continues to invest in technological innovations that boost traffic and sales, and it's expanding further into major international markets.\nDogecoin may or may not claw its way back to previous highs. I predict that Etsy will easily do so.\nIntuitive Surgical\nWhat's more fun than a cryptocurrency that was started as a joke? Robots! I'm not talking about the kind of robots that take over the world. No, I have in mind robots that help people -- like the robotic surgical systems pioneered byIntuitive Surgical(NASDAQ: ISRG).\nLike Dogecoin, Intuitive Surgical has been a huge winner since its creation. Thehealthcare stockis up close 13,750% over the last couple of decades or so. There's still plenty of room to run, though.\nMore than 1.2 million procedures were performed with Intuitive's robotic surgical systems last year. The company estimates that roughly 6 million procedures are done each year for the types of surgery for which its systems already have regulatory clearances. Add to that total another 14 million soft-tissue procedures that Intuitive could target with technological innovations.\nInterestingly, Intuitive Surgical's greatest strength isDogecoin's biggest weakness. The company has an exceptionally strong moat with its huge head start in the market for robotic surgical systems. Dogecoin doesn't have much of a moat at all. Over the next decade and beyond, I think this difference will make Intuitive Surgical the bigger winner by far.\nMastercard\nFans of Dogecoin might envision a future where the cryptocurrency is used for billions of digital transactions every week. ForMastercard(NYSE: MA), that future is now. In the first quarter of 2021, the company processed 23.8 billion transactions with a gross dollar volume of more than $1.7 billion.\nOver the near term, Mastercard should benefit as economies reopen. CEO Michael Miebachnoted in the company's first-quarter conference call, \"We're encouraged by the return of domestic spending levels to pre-pandemic trends.\" International spending levels haven't fully rebounded, but there are reasons to hope that the increased availability of vaccines will make a big impact.\nI like Mastercard's long-term prospects even more. The company should be a clear beneficiary as consumers continue to shift away from cash. Its contactless payment options will likely drive growth for years to come.\nIf you're still drawn to cryptocurrencies, though, Mastercard has something to offer on that front as well. The company plans to support select cryptocurrencies on its payment network this year. Whether or not Dogecoin is in the group remains to be seen. Even if not, investing in Mastercard should pay off nicely over the long run.","news_type":1},"isVote":1,"tweetType":1,"viewCount":86,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":133200295,"gmtCreate":1621747818717,"gmtModify":1634186792697,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Comments pls","listText":"Comments pls","text":"Comments pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/133200295","repostId":"1153943475","repostType":4,"repost":{"id":"1153943475","pubTimestamp":1621610182,"share":"https://www.laohu8.com/m/news/1153943475?lang=&edition=full","pubTime":"2021-05-21 23:16","market":"us","language":"en","title":"U.S., South Korea Announce Vaccine, Semiconductor Partnership","url":"https://stock-news.laohu8.com/highlight/detail?id=1153943475","media":"Bloomberg","summary":"Commerce Secretary Raimondo met with South Korea’s Moon Friday\nSouth Korea needs Covid vaccines, U.S","content":"<ul>\n <li>Commerce Secretary Raimondo met with South Korea’s Moon Friday</li>\n <li>South Korea needs Covid vaccines, U.S. faces chip shortage</li>\n</ul>\n<p>U.S. Commerce Secretary Gina Raimondo and South Korean President Moon Jae-in announced an agreement to deepen cooperation in a range of industries including pharmaceutical companies making Covid-19 vaccines, electric-vehicle batteries and semiconductor producers.</p>\n<p>“The importance of this bilateral relationship for both nations cannot be overstated,” Raimondo said. “As we recover from the pandemic, our countries will benefit from deepening that collaboration, particularly in sectors that are critical to the future of our economies.”</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/4def3d2ef68db771f0c78737eb004855\" tg-width=\"1000\" tg-height=\"736\"><span>Gina RaimondoPhotographer: Leigh Vogel/UPI/Bloomberg</span></p>\n<p>South Korea is eager to secure supplies of Covid-19 vaccines that the U.S. has recently allowed to be exported. At the same time, the U.S. has sought help from allies including South Korea to alleviate a semiconductorshortagethat’s led to idling of auto plants across North America.</p>\n<p>Raimondo on Friday morning held a roundtable on supply chain issues with South Korean Minister of Trade, Industry and Energy Moon Sung-wook. The meeting was attended by more than a dozen executives from companies including&nbsp;Samsung Electronics Co.,LG Corp.,Qualcomm Inc.a&nbsp;nd&nbsp;Hyundai Motor Group.</p>\n<p>Moon is set to participate in a bilateral meeting with President Joe Biden on Friday afternoon and later hold a joint press conference.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S., South Korea Announce Vaccine, Semiconductor Partnership</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S., South Korea Announce Vaccine, Semiconductor Partnership\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 23:16 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-05-21/u-s-south-korea-announce-vaccine-semiconductor-partnership?srnd=premium-asia><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Commerce Secretary Raimondo met with South Korea’s Moon Friday\nSouth Korea needs Covid vaccines, U.S. faces chip shortage\n\nU.S. Commerce Secretary Gina Raimondo and South Korean President Moon Jae-in ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-05-21/u-s-south-korea-announce-vaccine-semiconductor-partnership?srnd=premium-asia\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"HYMLF":"Hyundai Motor Co., Ltd.","QCOM":"高通",".DJI":"道琼斯",".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","SSNLF":"三星电子","LGCOF":"Legal & Gen Ucits ETF Plc "},"source_url":"https://www.bloomberg.com/news/articles/2021-05-21/u-s-south-korea-announce-vaccine-semiconductor-partnership?srnd=premium-asia","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153943475","content_text":"Commerce Secretary Raimondo met with South Korea’s Moon Friday\nSouth Korea needs Covid vaccines, U.S. faces chip shortage\n\nU.S. Commerce Secretary Gina Raimondo and South Korean President Moon Jae-in announced an agreement to deepen cooperation in a range of industries including pharmaceutical companies making Covid-19 vaccines, electric-vehicle batteries and semiconductor producers.\n“The importance of this bilateral relationship for both nations cannot be overstated,” Raimondo said. “As we recover from the pandemic, our countries will benefit from deepening that collaboration, particularly in sectors that are critical to the future of our economies.”\nGina RaimondoPhotographer: Leigh Vogel/UPI/Bloomberg\nSouth Korea is eager to secure supplies of Covid-19 vaccines that the U.S. has recently allowed to be exported. At the same time, the U.S. has sought help from allies including South Korea to alleviate a semiconductorshortagethat’s led to idling of auto plants across North America.\nRaimondo on Friday morning held a roundtable on supply chain issues with South Korean Minister of Trade, Industry and Energy Moon Sung-wook. The meeting was attended by more than a dozen executives from companies including Samsung Electronics Co.,LG Corp.,Qualcomm Inc.a nd Hyundai Motor Group.\nMoon is set to participate in a bilateral meeting with President Joe Biden on Friday afternoon and later hold a joint press conference.","news_type":1},"isVote":1,"tweetType":1,"viewCount":81,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":139324515,"gmtCreate":1621594863637,"gmtModify":1634187804478,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Okay buy","listText":"Okay buy","text":"Okay buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/139324515","repostId":"1146351743","repostType":4,"repost":{"id":"1146351743","pubTimestamp":1621594735,"share":"https://www.laohu8.com/m/news/1146351743?lang=&edition=full","pubTime":"2021-05-21 18:58","market":"us","language":"en","title":"Merck's Valuation Continues To Say 'BUY'","url":"https://stock-news.laohu8.com/highlight/detail?id=1146351743","media":"seekingalpha","summary":"Summary\n\nMerck is one of the largest positions in the pharmaceutical segment in my core portfolio. T","content":"<p><b>Summary</b></p>\n<ul>\n <li>Merck is one of the largest positions in the pharmaceutical segment in my core portfolio. The company is currently at roughly no P/L in terms of ROIC.</li>\n <li>I expect Merck to appreciate significantly over the coming years thanks to EPS growth as well as dividend growth.</li>\n <li>The company at current valuation is an excellent \"BUY\" with significant upside, even if there are some risks to the company at this point.</li>\n</ul>\n<p>Merck(NYSE:MRK)is one of my largest pharma/healthcare holdings in the entire portfolio, and for a very good reason. The company's valuation seen in relation to its historical multiples as well as realistic upsides and recent results show us a very positive sort of scenario with plenty of potential upsides.</p>\n<p>In this article, we'll go through a few of the reasons why I still invest in the company, and why I consider it one of the (though not the) best investments you can make into the space today.</p>\n<p><b>Merck - How has the company been doing?</b></p>\n<p>Merck is a massive company, with a huge pipeline, a humongous portfolio, and impressive sales. Unfortunately, those impressive sales took a slight downward turn the last quarter, with the company reporting YoY declining sales and EPS, even if it's in fairly low numbers of -1% in sales, and -9% in non-GAAP EPS performance during the quarter.</p>\n<p>The company continued to invest significant capital, $2.4B during 1Q20, in new development and paid out $1.6B in company dividends. The company also received some important approvals in Keytruda and oncology, as well as some positive results in HIV medication. The FDA approvedKeytrudafor use in certain types of cancer and heart failures, and there were positives news out of China and Japan as well.</p>\n<p>Segment-wise, Oncology is showing continued growth...</p>\n<p><img src=\"https://static.tigerbbs.com/270d5db8383687242cf8f902b8f9741a\" tg-width=\"490\" tg-height=\"471\">(Source: Merck)</p>\n<p>...withKeytrudabeing the star of the show in terms of absolute volume, but Lynparza outdoing it in terms of growth. In terms of vaccines, Merck hasn't participated in the COVID-19 vaccine trends or production, which has impacted performance significantly here. The company is experiencing double-digit declines in both Gardasil and Pneumovax, the latter down 36% YoY in terms of sales.</p>\n<p>These negatives trends, which are likely to persist somewhat, are weighed up by performance in hospitals, with Bridion sales up 11% or $340M YoY. The company also has its animal health segment, which is showing 15% YoY growth across the board, with companion sales increasing by 24% and livestock by 9%. This was a mix of animal intelligence products, parasiticides, and animal vaccines.</p>\n<p>A geographical YoY overview shows the company's weakness as a non-COVID 19 participant, with the exception of LATAM which went well...</p>\n<p><img src=\"https://static.tigerbbs.com/304ecba6662ea9bf45564c00329f25d8\" tg-width=\"640\" tg-height=\"318\">(Source: Merck)</p>\n<p>...but the overall message here is that any growth managed by the company has been more or less offset by the effects of COVID-19 and more. Overall sales are absolutely flat YoY.</p>\n<p>However, Merck expects things to improve in lock-step with lightning of restrictions and return of normalcy.</p>\n<p>The company has given us 2021E guidance, and that guidance brings to mind the analyst expectations upon which, in part, my positive Merck thesis rests. The company has updated its 2021E guidance as of 1Q21, and this guidance closer matches where overall analyst expectations have been going for the past quarter.</p>\n<p>Revenue guidance is unchanged, with a slightly negative effect on margins due to COVID-19, as well as a slight drop in overall GAAP EPS, with an assumed &lt;3% positive impact on non-GAAP EPS. Overall, the updated guidance very closely matches the previous one, further crystallizing the positive long-term thesis for the company.</p>\n<p>Merck also continues towards its planning of spinning off its Organon operations, containing its women's health &amp; Biosimilars, which will trade on the NYSE under the OGN ticker as of June 3rd, in less than a month. Besides this spin-off, Merck's portfolio remains attractive and well-filled with appealing brands and products that the company has added over the past few years, as well as having ongoing cooperations with many smaller and larger companies.</p>\n<p><img src=\"https://static.tigerbbs.com/7362a4b8cafbad663516c6b3e444a6bf\" tg-width=\"640\" tg-height=\"276\">(Source: Merck)</p>\n<p>The company's HIV development, for instance, is being facilitated through cooperation with Gilead(NASDAQ:GILD). The company has a strong 0-10+ year plan, which includes revenue growth, margins expansion and both inorganic and organic growth.</p>\n<p>The company expects to address more of its pipeline within the coming 5-10 years.</p>\n<p>I want to point out that despite the poor performance of the share for the past few months, the company's fundamentals and its dividend track record remain absolutely solid.</p>\n<p><img src=\"https://static.tigerbbs.com/c3be4580175b0af1aa18d1a18337d60f\" tg-width=\"571\" tg-height=\"268\">(Source: Merck)</p>\n<p>Two questions for Merck shareholders.</p>\n<p><b>First, what to do with any dividends, and the spin-off for shareholders of the new, traded company?</b></p>\n<p>The question is relevant since whenever a company spins off parts of its operations - in this case, 15% of Merck's revenue - the company's EPS available for dividends shrinks. Merck's dividend has a current NTM payout ratio of 38%, inclusive of the spin-off, which comes to really no worry at all given the dividend increases we've been seeing from Merck. Company EPS has been growing with impressive steps for the past 10 years.</p>\n<p><img src=\"https://static.tigerbbs.com/60e264631bf0e140618715125e10b492\" tg-width=\"452\" tg-height=\"359\">(Source: SimplySafeDividends)</p>\n<p>Part of this is thanks to extensive company buybacks, but the company has also managed to grow sales by nearly $10B in less than 7 years, all the while posting class-leading operating margins north of 30%.</p>\n<p>EPS should decrease around 10-15% from the spin-off, and the current expectation is that the spin-off will have no material impact on either the company's dividend growth or its long-term payout ratio. The fact is that the company has already confirmed this in the latest earnings call - the company is not going to cut or lower the dividend, and will in fact grow it to a 47-50% payout ratio (Source: Merck Earnings Call, 2020)</p>\n<p>However, the assets that the company is spinning off aren't exactly the crown jewels. Back in 2020, the company expected revenue growth in Organon to flat to negative in 2021 due to loss of exclusivity for several drugs. Organon hopes to achieve single-digit annual revenue growth following this, but the accuracy of these expectations is yet to be put to the test.</p>\n<p>Naturally, the company is talking up the opportunities in women's health, including fertility drugs, contraceptives, and other things in the biosimilar segments, but these will only account for 30% of Organon's revenues as of the latest calculations.</p>\n<p>Further, as of the latest financial data, Merck expects to pull an $8-$9B tax-free dividend from Organon, which will add debt to the company's balance sheet.</p>\n<p>The conclusion here that I currently see is that the company is spinning off some of the weaker assets, and the starting position for the new company, its ability to generate earnings and shareholder returns seems somewhat muddled.</p>\n<p>Because of this, I personally wouldn't go ahead and just invest in Organon. The latest news is that the dividend received from Merck will be a special dividend paid out during June 2nd, 2021, which will be significant for me given my own $38,000+ Merck position. Every Merck share will entitle the holder to 1/10th of one Organon share in the form of cash.</p>\n<p>Reasons for this? Lack of overall current visibility of earnings growth, a high potential leverage from the get-go (3-4X to EBITDA), potential margin issues to mention a few. Lack of knowledge and visibility, in the end, is enough for me to put my money elsewhere.</p>\n<p><b>Secondly, and as some other authors have alluded to, there's a potential problem for Merck here</b></p>\n<p>As any company that spins off part of its business, this transaction will weaken Merck's portfolio, which will become even more dependent on a few drugs. Three of its current blockbusters account to almost 40% of its revenues. Keytruda is growing for the treatment of lung cancers as well as other, and now almost represents a quarter of the company's sales. So for better or worse, for the foreseeable future, Merck will be very dependent on Keytruda until it loses patent protection in the year of 2028.</p>\n<p>This puts the demand on Merck to continue to build its drug portfolio to help soften the blow here. The $8-$9B from Organon will certainly serve to add some cushioning to the company's already strong liquidity profile, and also to build its R&amp;D further, even if the way to get the funding is essentially cutting off part of its own body.</p>\n<p>However - my view on Merck's existing portfolio is a positive one.</p>\n<p>There's continued cash flow, strong cash flow, expected from the company's portfolio, and the current patent protection gives us 7 years for Keytruda, 7 years for Gardasil, and 1-2 years for Januvia, which is around 7% for the company's sales.</p>\n<p>I expect that based on these trends, and the company's strong R&amp;D, the company will remain a strong business with safe trends for the next few years. It's AA-rated, with excellent leverage. Merck has announced that the dividend from Organon will be used for buybacks, not for inorganic growth or increasing the dividend.</p>\n<p>So, my conclusion is - don't buy Organon, invest the money in Merck or elsewhere at this time.</p>\n<p>Let's look at the valuation.</p>\n<p><b>Merck - What is the valuation?</b></p>\n<p>Merck's valuation continues to be one of the primary arguments for investing in the business. The current valuation trends clearly lag the company's reported and expected earnings trends.</p>\n<p><img src=\"https://static.tigerbbs.com/e39a81094c586691cb558dbc51e25c42\" tg-width=\"640\" tg-height=\"423\">(Source: F.A.S.T Graphs)</p>\n<p>History shows us that Merck can trade at depressed valuations for very extended periods of time - several years, only to normalize despite only modest earnings growth during reversal. Over the past year, the company hasn't appreciated to fair value, despite significantly growing earnings and expecting to grow them even further.</p>\n<p>The fact is, the undervaluation we see now is in the face of both the company's fundamentals, its valuation, analyst targets, expectations, and trends.</p>\n<p>The upside for this AA-rated giant is significant, coming in at around 16.5% annually to even a 15.5X P/E ratio, based on an average annual growth rate of 8.5% in terms of EPS. Eve trading essentially flat at 12.4X from today's 12.91X average P/E ratio, the upside to 2024E results is just north of 10% per year.</p>\n<p><img src=\"https://static.tigerbbs.com/7a0dd03966c5ace7335c72089554f594\" tg-width=\"640\" tg-height=\"467\">(Source: F.A.S.T Graphs)</p>\n<p>How likely are these targets? Let us just say that Merck has never failed to hit its analyst marks for the past 10 years, with a 10% Margin of error, making the company's targets if not guaranteed, at least very likely based on historical target accuracy.</p>\n<p>So what exactly is the downside here? Why is the company not reversing? A few notes. One of the reasons is likely to be the aforementioned spin-off, which has a tendency to worry certain investors as it's an uncertainty for Merck, despite the company having clarified its dividend ambitions.</p>\n<p>Another note that analysts that are more mellowed with regards to this company is the overreliance on Keytruda and other blockbuster drugs, which make up a significant portion of this company's revenues. 57% of total revenues are from six drugs alone, and these drugs are facing competition.</p>\n<p>However, historically, Merck has always been able to outperform and keep its EPS growth rate steady. There's very little reason the company should be unable to do the same in the long term here. The argument that Merck faces increased competition should, in my opinion, be seen as a fairly standard argument able to be made on the basis of any pharmaceutical company with blockbuster drugs facing competition. Not including in consideration the company's historical performance in these questions is to ignore the company's fundamental strengths.</p>\n<p>I consider the upside here to be very clear, and established both in fundamentals, history, forecasts, and analysis accuracy.</p>\n<p>Analyst targets reflect this upside as well.</p>\n<p><img src=\"https://static.tigerbbs.com/05589bb9d69a6dd3e7cd792e8f10fb9a\" tg-width=\"640\" tg-height=\"97\">(Source: S&amp;P Global, Google Sheets)</p>\n<p>Even S&amp;P Global analysts see an upside of nearly 20% of this company at current price levels.</p>\n<p>There is, simply put, very little to suggest that the company would have poor prospects to outperform over the coming few years.</p>\n<p>How to invest in Merck</p>\n<p><b>Option 1 - Long-term investment</b></p>\n<p>Merck's common share is where I consider an investment wise at this particular point in time. The common share offers upsides of over 15-20% to both forward estimates, current targets, and historical valuation levels.</p>\n<p>While puts are possible, I view the common shares as the most appealing way for a conservative dividend investor to invest in the company.</p>\n<p><b>Option 2 - Selling cash-secured puts</b></p>\n<p>Selling cash-covered put options is another good way to make money off a company while waiting for it to drop further and making money until then. Because of the company's position, and a lower price being even more appealing, this could make it perfect for a nice put.</p>\n<p>As of writing this article, I was able to find the following put.</p>\n<p><img src=\"https://static.tigerbbs.com/e94af35f617e432741927d6e29436485\" tg-width=\"507\" tg-height=\"382\">(Source: Author's Data, Google Sheets, Option data from IBKR/Yahoo Finance)</p>\n<p>This is a good put. The company hasn't traded at such levels for some time, and undervaluation at strike price is appealing. The capital outlay is relatively limited, though still well above $5000/contract, and the annualized yield of 6.22% is fairly good for Merck. The only drawback is the time - nearly 20 days until the contract expires.</p>\n<p>Given that I prefer to invest in the common share, you won't see me writing this put. I see a better overall upside in the common share. However, those of you wanting an option, this is a valid one, and not a bad one, as I see it.</p>\n<p><b>Option 3- Selling covered calls</b></p>\n<p>Covered calls are a no-go for me here. The available ones offer less than 2% annualized RoR for putting a position at risk for the chance of a very likely capital appreciation. The company just isn't in a good position for this sort of strategy.</p>\n<p><b>Thesis</b></p>\n<p>I've been tilting my investment capital heavily towards healthcare &amp; pharma for some months at this point, and I continue to do so. The appealing valuation and potential upsides in the investments speak for themselves. Merck is one of those potentials. Even if it's not the one with the highest upside - it's one with a very appealing conservative upside, and one trading well below 15X P/E, which I consider to be a fair value here.</p>\n<p>Because of this, conservative investors should take note of Merck as a potential investment for their portfolios. I don't advise anyone to aim for a larger position size than 3-4%, and my portfolio position in the company has now reached this size.</p>\n<p>For those of you not at such exposure, however, this is a potentially good opportunity. My five requirements for investment are as follows.</p>\n<ol>\n <li>This company is overall qualitative.</li>\n <li>This company is fundamentally safe/conservative &amp; well-run.</li>\n <li>This company pays a well-covered dividend.</li>\n <li>This company is currently cheap.</li>\n <li>This company has realistic upside based on earnings growth or multiple expansion/reversion.</li>\n</ol>\n<p>All of these 5 requirements, as I see it, are fulfilled with Merck. The company gives investors what they should require from an investment, starting with fundamentals and dividend history, and moving to positive estimates, upsides, and forecast accuracy.</p>\n<p>I don't consider any of the risks to be significant enough to warrant not investing here, and consider Merck a 20% undervalued \"BUY\" with a significant upside.</p>\n<p>Thank you for reading.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Merck's Valuation Continues To Say 'BUY'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMerck's Valuation Continues To Say 'BUY'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-21 18:58 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4430387-mercks-valuation-continues-to-say-buy><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nMerck is one of the largest positions in the pharmaceutical segment in my core portfolio. The company is currently at roughly no P/L in terms of ROIC.\nI expect Merck to appreciate ...</p>\n\n<a href=\"https://seekingalpha.com/article/4430387-mercks-valuation-continues-to-say-buy\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRK":"默沙东"},"source_url":"https://seekingalpha.com/article/4430387-mercks-valuation-continues-to-say-buy","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1146351743","content_text":"Summary\n\nMerck is one of the largest positions in the pharmaceutical segment in my core portfolio. The company is currently at roughly no P/L in terms of ROIC.\nI expect Merck to appreciate significantly over the coming years thanks to EPS growth as well as dividend growth.\nThe company at current valuation is an excellent \"BUY\" with significant upside, even if there are some risks to the company at this point.\n\nMerck(NYSE:MRK)is one of my largest pharma/healthcare holdings in the entire portfolio, and for a very good reason. The company's valuation seen in relation to its historical multiples as well as realistic upsides and recent results show us a very positive sort of scenario with plenty of potential upsides.\nIn this article, we'll go through a few of the reasons why I still invest in the company, and why I consider it one of the (though not the) best investments you can make into the space today.\nMerck - How has the company been doing?\nMerck is a massive company, with a huge pipeline, a humongous portfolio, and impressive sales. Unfortunately, those impressive sales took a slight downward turn the last quarter, with the company reporting YoY declining sales and EPS, even if it's in fairly low numbers of -1% in sales, and -9% in non-GAAP EPS performance during the quarter.\nThe company continued to invest significant capital, $2.4B during 1Q20, in new development and paid out $1.6B in company dividends. The company also received some important approvals in Keytruda and oncology, as well as some positive results in HIV medication. The FDA approvedKeytrudafor use in certain types of cancer and heart failures, and there were positives news out of China and Japan as well.\nSegment-wise, Oncology is showing continued growth...\n(Source: Merck)\n...withKeytrudabeing the star of the show in terms of absolute volume, but Lynparza outdoing it in terms of growth. In terms of vaccines, Merck hasn't participated in the COVID-19 vaccine trends or production, which has impacted performance significantly here. The company is experiencing double-digit declines in both Gardasil and Pneumovax, the latter down 36% YoY in terms of sales.\nThese negatives trends, which are likely to persist somewhat, are weighed up by performance in hospitals, with Bridion sales up 11% or $340M YoY. The company also has its animal health segment, which is showing 15% YoY growth across the board, with companion sales increasing by 24% and livestock by 9%. This was a mix of animal intelligence products, parasiticides, and animal vaccines.\nA geographical YoY overview shows the company's weakness as a non-COVID 19 participant, with the exception of LATAM which went well...\n(Source: Merck)\n...but the overall message here is that any growth managed by the company has been more or less offset by the effects of COVID-19 and more. Overall sales are absolutely flat YoY.\nHowever, Merck expects things to improve in lock-step with lightning of restrictions and return of normalcy.\nThe company has given us 2021E guidance, and that guidance brings to mind the analyst expectations upon which, in part, my positive Merck thesis rests. The company has updated its 2021E guidance as of 1Q21, and this guidance closer matches where overall analyst expectations have been going for the past quarter.\nRevenue guidance is unchanged, with a slightly negative effect on margins due to COVID-19, as well as a slight drop in overall GAAP EPS, with an assumed <3% positive impact on non-GAAP EPS. Overall, the updated guidance very closely matches the previous one, further crystallizing the positive long-term thesis for the company.\nMerck also continues towards its planning of spinning off its Organon operations, containing its women's health & Biosimilars, which will trade on the NYSE under the OGN ticker as of June 3rd, in less than a month. Besides this spin-off, Merck's portfolio remains attractive and well-filled with appealing brands and products that the company has added over the past few years, as well as having ongoing cooperations with many smaller and larger companies.\n(Source: Merck)\nThe company's HIV development, for instance, is being facilitated through cooperation with Gilead(NASDAQ:GILD). The company has a strong 0-10+ year plan, which includes revenue growth, margins expansion and both inorganic and organic growth.\nThe company expects to address more of its pipeline within the coming 5-10 years.\nI want to point out that despite the poor performance of the share for the past few months, the company's fundamentals and its dividend track record remain absolutely solid.\n(Source: Merck)\nTwo questions for Merck shareholders.\nFirst, what to do with any dividends, and the spin-off for shareholders of the new, traded company?\nThe question is relevant since whenever a company spins off parts of its operations - in this case, 15% of Merck's revenue - the company's EPS available for dividends shrinks. Merck's dividend has a current NTM payout ratio of 38%, inclusive of the spin-off, which comes to really no worry at all given the dividend increases we've been seeing from Merck. Company EPS has been growing with impressive steps for the past 10 years.\n(Source: SimplySafeDividends)\nPart of this is thanks to extensive company buybacks, but the company has also managed to grow sales by nearly $10B in less than 7 years, all the while posting class-leading operating margins north of 30%.\nEPS should decrease around 10-15% from the spin-off, and the current expectation is that the spin-off will have no material impact on either the company's dividend growth or its long-term payout ratio. The fact is that the company has already confirmed this in the latest earnings call - the company is not going to cut or lower the dividend, and will in fact grow it to a 47-50% payout ratio (Source: Merck Earnings Call, 2020)\nHowever, the assets that the company is spinning off aren't exactly the crown jewels. Back in 2020, the company expected revenue growth in Organon to flat to negative in 2021 due to loss of exclusivity for several drugs. Organon hopes to achieve single-digit annual revenue growth following this, but the accuracy of these expectations is yet to be put to the test.\nNaturally, the company is talking up the opportunities in women's health, including fertility drugs, contraceptives, and other things in the biosimilar segments, but these will only account for 30% of Organon's revenues as of the latest calculations.\nFurther, as of the latest financial data, Merck expects to pull an $8-$9B tax-free dividend from Organon, which will add debt to the company's balance sheet.\nThe conclusion here that I currently see is that the company is spinning off some of the weaker assets, and the starting position for the new company, its ability to generate earnings and shareholder returns seems somewhat muddled.\nBecause of this, I personally wouldn't go ahead and just invest in Organon. The latest news is that the dividend received from Merck will be a special dividend paid out during June 2nd, 2021, which will be significant for me given my own $38,000+ Merck position. Every Merck share will entitle the holder to 1/10th of one Organon share in the form of cash.\nReasons for this? Lack of overall current visibility of earnings growth, a high potential leverage from the get-go (3-4X to EBITDA), potential margin issues to mention a few. Lack of knowledge and visibility, in the end, is enough for me to put my money elsewhere.\nSecondly, and as some other authors have alluded to, there's a potential problem for Merck here\nAs any company that spins off part of its business, this transaction will weaken Merck's portfolio, which will become even more dependent on a few drugs. Three of its current blockbusters account to almost 40% of its revenues. Keytruda is growing for the treatment of lung cancers as well as other, and now almost represents a quarter of the company's sales. So for better or worse, for the foreseeable future, Merck will be very dependent on Keytruda until it loses patent protection in the year of 2028.\nThis puts the demand on Merck to continue to build its drug portfolio to help soften the blow here. The $8-$9B from Organon will certainly serve to add some cushioning to the company's already strong liquidity profile, and also to build its R&D further, even if the way to get the funding is essentially cutting off part of its own body.\nHowever - my view on Merck's existing portfolio is a positive one.\nThere's continued cash flow, strong cash flow, expected from the company's portfolio, and the current patent protection gives us 7 years for Keytruda, 7 years for Gardasil, and 1-2 years for Januvia, which is around 7% for the company's sales.\nI expect that based on these trends, and the company's strong R&D, the company will remain a strong business with safe trends for the next few years. It's AA-rated, with excellent leverage. Merck has announced that the dividend from Organon will be used for buybacks, not for inorganic growth or increasing the dividend.\nSo, my conclusion is - don't buy Organon, invest the money in Merck or elsewhere at this time.\nLet's look at the valuation.\nMerck - What is the valuation?\nMerck's valuation continues to be one of the primary arguments for investing in the business. The current valuation trends clearly lag the company's reported and expected earnings trends.\n(Source: F.A.S.T Graphs)\nHistory shows us that Merck can trade at depressed valuations for very extended periods of time - several years, only to normalize despite only modest earnings growth during reversal. Over the past year, the company hasn't appreciated to fair value, despite significantly growing earnings and expecting to grow them even further.\nThe fact is, the undervaluation we see now is in the face of both the company's fundamentals, its valuation, analyst targets, expectations, and trends.\nThe upside for this AA-rated giant is significant, coming in at around 16.5% annually to even a 15.5X P/E ratio, based on an average annual growth rate of 8.5% in terms of EPS. Eve trading essentially flat at 12.4X from today's 12.91X average P/E ratio, the upside to 2024E results is just north of 10% per year.\n(Source: F.A.S.T Graphs)\nHow likely are these targets? Let us just say that Merck has never failed to hit its analyst marks for the past 10 years, with a 10% Margin of error, making the company's targets if not guaranteed, at least very likely based on historical target accuracy.\nSo what exactly is the downside here? Why is the company not reversing? A few notes. One of the reasons is likely to be the aforementioned spin-off, which has a tendency to worry certain investors as it's an uncertainty for Merck, despite the company having clarified its dividend ambitions.\nAnother note that analysts that are more mellowed with regards to this company is the overreliance on Keytruda and other blockbuster drugs, which make up a significant portion of this company's revenues. 57% of total revenues are from six drugs alone, and these drugs are facing competition.\nHowever, historically, Merck has always been able to outperform and keep its EPS growth rate steady. There's very little reason the company should be unable to do the same in the long term here. The argument that Merck faces increased competition should, in my opinion, be seen as a fairly standard argument able to be made on the basis of any pharmaceutical company with blockbuster drugs facing competition. Not including in consideration the company's historical performance in these questions is to ignore the company's fundamental strengths.\nI consider the upside here to be very clear, and established both in fundamentals, history, forecasts, and analysis accuracy.\nAnalyst targets reflect this upside as well.\n(Source: S&P Global, Google Sheets)\nEven S&P Global analysts see an upside of nearly 20% of this company at current price levels.\nThere is, simply put, very little to suggest that the company would have poor prospects to outperform over the coming few years.\nHow to invest in Merck\nOption 1 - Long-term investment\nMerck's common share is where I consider an investment wise at this particular point in time. The common share offers upsides of over 15-20% to both forward estimates, current targets, and historical valuation levels.\nWhile puts are possible, I view the common shares as the most appealing way for a conservative dividend investor to invest in the company.\nOption 2 - Selling cash-secured puts\nSelling cash-covered put options is another good way to make money off a company while waiting for it to drop further and making money until then. Because of the company's position, and a lower price being even more appealing, this could make it perfect for a nice put.\nAs of writing this article, I was able to find the following put.\n(Source: Author's Data, Google Sheets, Option data from IBKR/Yahoo Finance)\nThis is a good put. The company hasn't traded at such levels for some time, and undervaluation at strike price is appealing. The capital outlay is relatively limited, though still well above $5000/contract, and the annualized yield of 6.22% is fairly good for Merck. The only drawback is the time - nearly 20 days until the contract expires.\nGiven that I prefer to invest in the common share, you won't see me writing this put. I see a better overall upside in the common share. However, those of you wanting an option, this is a valid one, and not a bad one, as I see it.\nOption 3- Selling covered calls\nCovered calls are a no-go for me here. The available ones offer less than 2% annualized RoR for putting a position at risk for the chance of a very likely capital appreciation. The company just isn't in a good position for this sort of strategy.\nThesis\nI've been tilting my investment capital heavily towards healthcare & pharma for some months at this point, and I continue to do so. The appealing valuation and potential upsides in the investments speak for themselves. Merck is one of those potentials. Even if it's not the one with the highest upside - it's one with a very appealing conservative upside, and one trading well below 15X P/E, which I consider to be a fair value here.\nBecause of this, conservative investors should take note of Merck as a potential investment for their portfolios. I don't advise anyone to aim for a larger position size than 3-4%, and my portfolio position in the company has now reached this size.\nFor those of you not at such exposure, however, this is a potentially good opportunity. My five requirements for investment are as follows.\n\nThis company is overall qualitative.\nThis company is fundamentally safe/conservative & well-run.\nThis company pays a well-covered dividend.\nThis company is currently cheap.\nThis company has realistic upside based on earnings growth or multiple expansion/reversion.\n\nAll of these 5 requirements, as I see it, are fulfilled with Merck. The company gives investors what they should require from an investment, starting with fundamentals and dividend history, and moving to positive estimates, upsides, and forecast accuracy.\nI don't consider any of the risks to be significant enough to warrant not investing here, and consider Merck a 20% undervalued \"BUY\" with a significant upside.\nThank you for reading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":203,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":822128477,"gmtCreate":1634103901965,"gmtModify":1634103902559,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/822128477","repostId":"2175132100","repostType":4,"repost":{"id":"2175132100","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1634079953,"share":"https://www.laohu8.com/m/news/2175132100?lang=&edition=full","pubTime":"2021-10-13 07:05","market":"us","language":"en","title":"Wall Street closes lower on jitters ahead of earnings, Fed minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2175132100","media":"Reuters","summary":"NEW YORK, Oct 12 (Reuters) - U.S. stocks finished lower on Tuesday, extending losses late as investo","content":"<p>NEW YORK, Oct 12 (Reuters) - U.S. stocks finished lower on Tuesday, extending losses late as investors grew more jittery in the run up to third-quarter earnings, while a jump in Tesla shares helped support the market.</p>\n<p>Adding to investor caution, the Federal Reserve is expected to release minutes on Wednesday from its last policy meeting, which market participants will scour for hints about when the U.S. central bank could begin tapering its massive bond-buying program.</p>\n<p>All three major U.S. stock indexes ended in the red with the Dow down the most, weighed by healthcare&nbsp;and industrials .</p>\n<p>Earnings unofficially kick off this week with results from JPMorgan Chase &amp; Co&nbsp;on Wednesday and other banks to follow. JPMorgan's shares shed 0.8% on the day, while the S&amp;P 500 banks index&nbsp;edged down 0.6%.</p>\n<p>Analysts expect to see strong U.S. profit growth for the third quarter. But a number of companies have warned of issues and investors are worried about how supply chain problems and higher prices will affect businesses emerging from the coronavirus pandemic.</p>\n<p>\"For the most part, institutional portfolio managers are of the view - let's see what earnings look like and how much of a negative impact is being seen from shortages, higher rates and supply chain bottlenecks,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p>\n<p>\"A lot of those factors are currently reflected where equity prices are now.\"</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 117.72 points, or 0.34%, to 34,378.34, the S&amp;P 500&nbsp;lost 10.54 points, or 0.24%, to 4,350.65 and the Nasdaq Composite&nbsp;dropped 20.28 points, or 0.14%, to 14,465.93.</p>\n<p>Six of the 11 major sectors of the S&amp;P 500 ended the session in the red, with communications services&nbsp;suffering the steepest percentage loss.</p>\n<p>Tesla&nbsp;advanced 1.7% after data showed the electric vehicle maker sold 56,006 China-made vehicles in September, the highest since it started production in Shanghai about two years ago. The company's shares provided the biggest boost to the S&amp;P 500 and the Nasdaq.</p>\n<p>Shares of American Airlines Group&nbsp;rose 0.8% after the company estimated a smaller-than-expected adjusted loss for the third quarter and signaled improved bookings for the rest of the year.</p>\n<p>MGM Resorts&nbsp;surged 9.6% after of Credit Suisse upgraded the stock to \"outperform\" from \"neutral.\"</p>\n<p>Nike Inc&nbsp;gained 2.0% after Goldman Sachs initiated coverage with a \"buy\" recommendation.</p>\n<p>Investors also weighed comments from Fed Vice Chair Richard Clarida, who said the central bank has all but met its employment goal for reducing its bond buying program.</p>\n<p>U.S. data showed the labor market remained tight, with a record number of Americans quitting their jobs and job vacancies numbering more than 10 million, stoking inflation fears as employers hike wages to attract and retain workers.</p>\n<p>Wednesday's consumer price index report will attract attention from investors seeking clues about inflation.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.42-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 10 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 46 new highs and 94 new lows.</p>\n<p>Volume on U.S. exchanges was 9.17 billion shares, compared with the 10.80 billion average over the last 20 trading days.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes lower on jitters ahead of earnings, Fed minutes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes lower on jitters ahead of earnings, Fed minutes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-13 07:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>NEW YORK, Oct 12 (Reuters) - U.S. stocks finished lower on Tuesday, extending losses late as investors grew more jittery in the run up to third-quarter earnings, while a jump in Tesla shares helped support the market.</p>\n<p>Adding to investor caution, the Federal Reserve is expected to release minutes on Wednesday from its last policy meeting, which market participants will scour for hints about when the U.S. central bank could begin tapering its massive bond-buying program.</p>\n<p>All three major U.S. stock indexes ended in the red with the Dow down the most, weighed by healthcare&nbsp;and industrials .</p>\n<p>Earnings unofficially kick off this week with results from JPMorgan Chase &amp; Co&nbsp;on Wednesday and other banks to follow. JPMorgan's shares shed 0.8% on the day, while the S&amp;P 500 banks index&nbsp;edged down 0.6%.</p>\n<p>Analysts expect to see strong U.S. profit growth for the third quarter. But a number of companies have warned of issues and investors are worried about how supply chain problems and higher prices will affect businesses emerging from the coronavirus pandemic.</p>\n<p>\"For the most part, institutional portfolio managers are of the view - let's see what earnings look like and how much of a negative impact is being seen from shortages, higher rates and supply chain bottlenecks,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.</p>\n<p>\"A lot of those factors are currently reflected where equity prices are now.\"</p>\n<p>The Dow Jones Industrial Average&nbsp;fell 117.72 points, or 0.34%, to 34,378.34, the S&amp;P 500&nbsp;lost 10.54 points, or 0.24%, to 4,350.65 and the Nasdaq Composite&nbsp;dropped 20.28 points, or 0.14%, to 14,465.93.</p>\n<p>Six of the 11 major sectors of the S&amp;P 500 ended the session in the red, with communications services&nbsp;suffering the steepest percentage loss.</p>\n<p>Tesla&nbsp;advanced 1.7% after data showed the electric vehicle maker sold 56,006 China-made vehicles in September, the highest since it started production in Shanghai about two years ago. The company's shares provided the biggest boost to the S&amp;P 500 and the Nasdaq.</p>\n<p>Shares of American Airlines Group&nbsp;rose 0.8% after the company estimated a smaller-than-expected adjusted loss for the third quarter and signaled improved bookings for the rest of the year.</p>\n<p>MGM Resorts&nbsp;surged 9.6% after of Credit Suisse upgraded the stock to \"outperform\" from \"neutral.\"</p>\n<p>Nike Inc&nbsp;gained 2.0% after Goldman Sachs initiated coverage with a \"buy\" recommendation.</p>\n<p>Investors also weighed comments from Fed Vice Chair Richard Clarida, who said the central bank has all but met its employment goal for reducing its bond buying program.</p>\n<p>U.S. data showed the labor market remained tight, with a record number of Americans quitting their jobs and job vacancies numbering more than 10 million, stoking inflation fears as employers hike wages to attract and retain workers.</p>\n<p>Wednesday's consumer price index report will attract attention from investors seeking clues about inflation.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.42-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 10 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 46 new highs and 94 new lows.</p>\n<p>Volume on U.S. exchanges was 9.17 billion shares, compared with the 10.80 billion average over the last 20 trading days.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAL":"美国航空",".DJI":"道琼斯",".IXIC":"NASDAQ Composite","MGM":"美高梅","TSLA":"特斯拉","NKE":"耐克"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2175132100","content_text":"NEW YORK, Oct 12 (Reuters) - U.S. stocks finished lower on Tuesday, extending losses late as investors grew more jittery in the run up to third-quarter earnings, while a jump in Tesla shares helped support the market.\nAdding to investor caution, the Federal Reserve is expected to release minutes on Wednesday from its last policy meeting, which market participants will scour for hints about when the U.S. central bank could begin tapering its massive bond-buying program.\nAll three major U.S. stock indexes ended in the red with the Dow down the most, weighed by healthcare and industrials .\nEarnings unofficially kick off this week with results from JPMorgan Chase & Co on Wednesday and other banks to follow. JPMorgan's shares shed 0.8% on the day, while the S&P 500 banks index edged down 0.6%.\nAnalysts expect to see strong U.S. profit growth for the third quarter. But a number of companies have warned of issues and investors are worried about how supply chain problems and higher prices will affect businesses emerging from the coronavirus pandemic.\n\"For the most part, institutional portfolio managers are of the view - let's see what earnings look like and how much of a negative impact is being seen from shortages, higher rates and supply chain bottlenecks,\" said Michael James, managing director of equity trading at Wedbush Securities in Los Angeles.\n\"A lot of those factors are currently reflected where equity prices are now.\"\nThe Dow Jones Industrial Average fell 117.72 points, or 0.34%, to 34,378.34, the S&P 500 lost 10.54 points, or 0.24%, to 4,350.65 and the Nasdaq Composite dropped 20.28 points, or 0.14%, to 14,465.93.\nSix of the 11 major sectors of the S&P 500 ended the session in the red, with communications services suffering the steepest percentage loss.\nTesla advanced 1.7% after data showed the electric vehicle maker sold 56,006 China-made vehicles in September, the highest since it started production in Shanghai about two years ago. The company's shares provided the biggest boost to the S&P 500 and the Nasdaq.\nShares of American Airlines Group rose 0.8% after the company estimated a smaller-than-expected adjusted loss for the third quarter and signaled improved bookings for the rest of the year.\nMGM Resorts surged 9.6% after of Credit Suisse upgraded the stock to \"outperform\" from \"neutral.\"\nNike Inc gained 2.0% after Goldman Sachs initiated coverage with a \"buy\" recommendation.\nInvestors also weighed comments from Fed Vice Chair Richard Clarida, who said the central bank has all but met its employment goal for reducing its bond buying program.\nU.S. data showed the labor market remained tight, with a record number of Americans quitting their jobs and job vacancies numbering more than 10 million, stoking inflation fears as employers hike wages to attract and retain workers.\nWednesday's consumer price index report will attract attention from investors seeking clues about inflation.\nAdvancing issues outnumbered declining ones on the NYSE by a 1.38-to-1 ratio; on Nasdaq, a 1.42-to-1 ratio favored advancers.\nThe S&P 500 posted 10 new 52-week highs and 10 new lows; the Nasdaq Composite recorded 46 new highs and 94 new lows.\nVolume on U.S. exchanges was 9.17 billion shares, compared with the 10.80 billion average over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":183,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":831768459,"gmtCreate":1629350347471,"gmtModify":1631891821305,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/831768459","repostId":"1152703663","repostType":4,"isVote":1,"tweetType":1,"viewCount":124,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":147155628,"gmtCreate":1626344370564,"gmtModify":1633927690363,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like pls&nbsp;","listText":"Like pls&nbsp;","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":10,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/147155628","repostId":"2151251345","repostType":4,"repost":{"id":"2151251345","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1626343025,"share":"https://www.laohu8.com/m/news/2151251345?lang=&edition=full","pubTime":"2021-07-15 17:57","market":"us","language":"en","title":"UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2151251345","media":"Benzinga","summary":"UnitedHealth Group (NYSE:UNH) reported quarterly earnings of $4.70 per share which beat the analyst consensus estimate of $4.43 by 6.09 percent. This is a 33.99 percent decrease over earnings of $7.12 per share from the","content":"<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUnitedHealth Group Q2 EPS $4.70 Beats $4.43 Estimate, Sales $71.30B Beat $69.45B Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-07-15 17:57</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.</p>\n<p>The industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.</p>\n<p>For the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.</p>\n<p>Nearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.</p>\n<p>Revenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.</p>\n<p>UnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.</p>\n<p>The company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","UNH":"联合健康"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151251345","content_text":"UnitedHealth Group Inc beat quarterly profit estimates and raised its full-year earnings target on Thursday, as the largest U.S. health insurer reported strong growth in its Optum unit that manages drug benefits.\nThe industry bellwether raised its full-year profit target for the second time this year, and now expects adjusted earnings of $18.30 to $18.80 per share in 2021, compared with its previous forecast of $18.10 to $18.60.\nFor the quarter ended June 30, the company reported a medical loss ratio - the percentage of collected premiums spent on medical services - of 82.8%, compared with 70.2% a year earlier, when patients put off non-urgent care due to the COVID-19 pandemic.\nNearly half of all Americans have been fully vaccinated according to latest government data and daily new COVID-19 cases ebbed in May and June, encouraging people to return to doctors' offices for routine, non-elective medical care.\nRevenue from UnitedHealth's Optum unit, which manages drug benefits and offers healthcare data analytics services, rose 17.2% to $38.3 billion from a year earlier.\nUnitedHealth reported adjusted earnings of $4.70 per share, beating estimates of $4.43 per share, according to IBES data from Refinitiv.\nThe company has beaten Wall Street's expectations for earnings per share for at least the last eight quarters.","news_type":1},"isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":142780266,"gmtCreate":1626176770855,"gmtModify":1633929397633,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Please like! Thx!","listText":"Please like! Thx!","text":"Please like! Thx!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/142780266","repostId":"2151563412","repostType":4,"repost":{"id":"2151563412","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1626175491,"share":"https://www.laohu8.com/m/news/2151563412?lang=&edition=full","pubTime":"2021-07-13 19:24","market":"us","language":"en","title":"Goldman Sachs Group Q2 EPS $15.02 Beats $10.23 Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2151563412","media":"Tiger Newspress","summary":"Goldman Sachs reported its second-quarter earnings before the bell on Tuesday.\nHere are the numbers:","content":"<p>Goldman Sachs&nbsp;reported its second-quarter earnings before the bell on Tuesday.</p>\n<p>Here are the numbers:</p>\n<p><b>Earnings:</b>&nbsp;$15.02 per share vs. $10.24 expected by analysts polled by Refinitiv. A year ago, Goldman recorded an EPS of $6.26 (53 cents per share if accounted for costs related to the 1MDB settlement.)</p>\n<p><b>Revenue:</b>&nbsp;$15.39 billion vs. $12.17 billion expected</p>\n<p>Investment banking posted its second-highest revenue quarter ever with $3.61 billion, behind the first quarter of 2021, as a booming IPO market boosted Goldman's equity underwriting.</p>\n<p>Last month, following the strong results of the Federal Reserve'sannual stress test,&nbsp;Goldman&nbsp;said it planned on boosting its dividend by 60% to $2 per share, subject to approval from the bank's board.</p>\n<p>For its first quarter of 2021, the New York-based bankblew past analysts' expectationswith record net profits and revenues on strong performance from the firm's investment banking and trading businesses, thanks to a rise in retail banking fueled by cheap consumer deposits.</p>\n<p>Of the six biggest U.S. banks, Goldman gets the largest share of its revenue from Wall Street activities including trading and investment banking.</p>\n<p>Shares of Goldman have risen 45% in 2021 on the back of the economic recovery from the Covid-19 pandemic.</p>\n<p>Goldman Sachs&nbsp;shares&nbsp;rises&nbsp;0.7%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/a40ec6831977fb2be9119f32e2df1b54\" tg-width=\"1260\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Goldman Sachs Group Q2 EPS $15.02 Beats $10.23 Estimate</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGoldman Sachs Group Q2 EPS $15.02 Beats $10.23 Estimate\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-07-13 19:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Goldman Sachs&nbsp;reported its second-quarter earnings before the bell on Tuesday.</p>\n<p>Here are the numbers:</p>\n<p><b>Earnings:</b>&nbsp;$15.02 per share vs. $10.24 expected by analysts polled by Refinitiv. A year ago, Goldman recorded an EPS of $6.26 (53 cents per share if accounted for costs related to the 1MDB settlement.)</p>\n<p><b>Revenue:</b>&nbsp;$15.39 billion vs. $12.17 billion expected</p>\n<p>Investment banking posted its second-highest revenue quarter ever with $3.61 billion, behind the first quarter of 2021, as a booming IPO market boosted Goldman's equity underwriting.</p>\n<p>Last month, following the strong results of the Federal Reserve'sannual stress test,&nbsp;Goldman&nbsp;said it planned on boosting its dividend by 60% to $2 per share, subject to approval from the bank's board.</p>\n<p>For its first quarter of 2021, the New York-based bankblew past analysts' expectationswith record net profits and revenues on strong performance from the firm's investment banking and trading businesses, thanks to a rise in retail banking fueled by cheap consumer deposits.</p>\n<p>Of the six biggest U.S. banks, Goldman gets the largest share of its revenue from Wall Street activities including trading and investment banking.</p>\n<p>Shares of Goldman have risen 45% in 2021 on the back of the economic recovery from the Covid-19 pandemic.</p>\n<p>Goldman Sachs&nbsp;shares&nbsp;rises&nbsp;0.7%&nbsp;in&nbsp;premarket&nbsp;trading.</p>\n<p><img src=\"https://static.tigerbbs.com/a40ec6831977fb2be9119f32e2df1b54\" tg-width=\"1260\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QTWO":"Q2 Holdings Inc","GS":"高盛"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151563412","content_text":"Goldman Sachs reported its second-quarter earnings before the bell on Tuesday.\nHere are the numbers:\nEarnings: $15.02 per share vs. $10.24 expected by analysts polled by Refinitiv. A year ago, Goldman recorded an EPS of $6.26 (53 cents per share if accounted for costs related to the 1MDB settlement.)\nRevenue: $15.39 billion vs. $12.17 billion expected\nInvestment banking posted its second-highest revenue quarter ever with $3.61 billion, behind the first quarter of 2021, as a booming IPO market boosted Goldman's equity underwriting.\nLast month, following the strong results of the Federal Reserve'sannual stress test, Goldman said it planned on boosting its dividend by 60% to $2 per share, subject to approval from the bank's board.\nFor its first quarter of 2021, the New York-based bankblew past analysts' expectationswith record net profits and revenues on strong performance from the firm's investment banking and trading businesses, thanks to a rise in retail banking fueled by cheap consumer deposits.\nOf the six biggest U.S. banks, Goldman gets the largest share of its revenue from Wall Street activities including trading and investment banking.\nShares of Goldman have risen 45% in 2021 on the back of the economic recovery from the Covid-19 pandemic.\nGoldman Sachs shares rises 0.7% in premarket trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":51,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":136148562,"gmtCreate":1622001852756,"gmtModify":1634184770443,"author":{"id":"3581831647982295","authorId":"3581831647982295","name":"MoonMoon","avatar":"https://static.tigerbbs.com/7abc88bf78bc4fd17d5085b308a74c4d","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3581831647982295","authorIdStr":"3581831647982295"},"themes":[],"htmlText":"Like and comment pls","listText":"Like and comment pls","text":"Like and comment pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/136148562","repostId":"1129186705","repostType":4,"repost":{"id":"1129186705","pubTimestamp":1622001447,"share":"https://www.laohu8.com/m/news/1129186705?lang=&edition=full","pubTime":"2021-05-26 11:57","market":"us","language":"en","title":"In 2008, he was CEO of the biggest bank to ever fail. He's worried about another crisis","url":"https://stock-news.laohu8.com/highlight/detail?id=1129186705","media":"cnn","summary":"New York The banking world nearly caved in 13 years ago. The former CEO of Washington Mutual is worried that another bubble is brewing.Kerry Killinger was named CEO of WaMu in 1990 and was fired in September 2008 -- just weeks before the bank failed as a growing number of mortgage loans went bad.\"Regulated banks do have more concentrated market share now so they have to be more careful,\" Killinger said. \"But the health of the industry is great, earnings are good and oversight is strong. I'm not ","content":"<p>New York (CNN Business)The banking world nearly caved in 13 years ago. The former CEO of Washington Mutual is worried that another bubble is brewing.</p>\n<p>Kerry Killinger was named CEO of WaMu in 1990 and was fired in September 2008 -- just weeks before the bank failed as a growing number of mortgage loans went bad.</p>\n<p>WaMu was one of several top financial firms to collapse during the financial crisis last decade, but the giant savings and loan with more than $300 billion in assets still ranks as the biggest-ever bank failure. WaMu was seized by regulators in September 2008 and sold to JPMorgan Chase (JPM) for a fire-sale price of $1.9 billion.</p>\n<p>Killinger spoke to CNN Business about the similarities and differences between now and 13 years ago.</p>\n<p><b>The good news</b></p>\n<p>The Global Financial Crisis led to a wave of new federal rules that were designed to strengthen the balance sheets of top banks and ensure that another catastrophe like 2008 could never happen again.</p>\n<p>The good news is that Killinger thinks JPMorgan Chase and other \"too big to fail banks\" are in much better shape now after laws like Dodd-Frank and the Volcker Rule were put into place in the wake of the financial crisis to make big banks safer.</p>\n<p>That group of institutions also includes Bank of America (BAC), Citigroup (C), Wells Fargo (WFC), Goldman Sachs (GS) and Morgan Stanley (MS), as well as others that received government bailouts in 2008.</p>\n<p>\"Regulated banks do have more concentrated market share now so they have to be more careful,\" Killinger said. \"But the health of the industry is great, earnings are good and oversight is strong. I'm not too concerned there.\"</p>\n<p>Subprime lending, the practice of giving mortgages to people with less-than-worthy credit histories, isn't nearly as prevalent as it was during the last housing boom. But Killinger is worried about bubbles in many other parts of the economy that threaten the stability of the markets.</p>\n<p><b>Too big to fail 2.0?</b></p>\n<p>Although housing prices have surged again, Killinger is more nervous about the fact that 0% interest rates and big bond purchases by the Federal Reserve have sparked a broader mania in other assets, including cryptocurrencies and non-fungible tokens (NFTs), meme stocks, blank check SPAC mergers and exotic exchange-traded funds.</p>\n<p>\"The bubbles today are broader and deeper in a variety of categories, not just housing,\" Killinger said. \"The Fed's policy of low rates and massive asset purchases worked well to get out of the downturn, but when you keep extending it you can cause unintended consequences.\"</p>\n<p>\"The economy continues to improve. It's time for the Fed to pull in the reins on stimulus and allow interest rates to rise,\" he added.</p>\n<p>Killinger and his wife Linda, a former vice chair of the Federal Home Loan Bank of Des Moines, have written a book about the 2008 meltdown called \"Nothing Is Too Big to Fail: How the Last Financial Crisis Informs Today.\"</p>\n<p>Linda Killinger told CNN Business she's concerned about the rise of of financial tech companies, hedge funds. private equity firms and other so-called shadow banks that face little to no regulation in Washington.</p>\n<p>\"The non-bank system is a big part of the problem. And there are still a lot of loans being done by non-regulated banks such as online banks and many private companies,\" she said.</p>\n<p><b>Large financial firms may be embracing too much risk again</b></p>\n<p>At least one prominent senator is worried, like the Killingers are, that some financial firms are once again getting too unwieldy.</p>\n<p>Elizabeth Warren questioned Treasury secretary Janet Yellen earlier this year about why BlackRock (BLK), the iShares ETF giant that manages more than $9 trillion in assets but is not a bank, is not considered \"too big to fail.\"</p>\n<p>Wall Street has already gotten a brief taste of how risky some of these firms are when Archegos Capital Management, a family office with big positions in media giants ViacomCBS (VIACA) and Discovery (DISCA) and Chinese techs Baidu (BIDU) and Tencent Music (TME), imploded and caused billions of dollars in losses for banks. (AT&amp;T (T) is planning to merge its WarnerMedia unit, CNN's parent company, with Discovery.)</p>\n<p>For its part, the Fed has acknowledged some of the growing risks to the markets and economy from keeping rates lower for longer and continuing to provide crisis-level stimulus.</p>\n<p>In the minutes of its latest policy meeting, the central bank acknowledged that \"if the economy continued to make rapid progress toward the Committee's goals, it might be appropriate at some point in upcoming meetings to begin discussing a plan for adjusting the pace of asset purchases.\"</p>\n<p>But Kerry Killinger thinks the Fed has to do a better job of stress-testing big banks for their exposure to some of the types of assets that have been surging in the past year to make sure that they can withstand even more volatility.</p>\n<p>\"The Fed made the mistake of underestimating subprime in the last crisis,\" he said, referring to the now infamous comments from then Fed chair Ben Bernanke in May 2007 that \"the effect of the troubles in the subprime sector on the broader housing market will likely be limited.\"</p>\n<p>\"There are growing asset bubbles,\" Kerry Killinger said. \"The Fed needs to test more how firms would perform if these asset prices decline further. If there is a major correction, the impact could be dramatic.\"</p>\n<p>The heads of big banks will also get their chance to talk about their views on the economy later this week. The Senate Banking Committee will hold a hearing on Wednesday and the House Financial Services Committee has one scheduled for Thursday.</p>\n<p>JPMorgan Chase CEO Jamie Dimon will appear at both hearings, as will new Citgroup CEO Jane Fraser, BofA's Brian Moynihan, Wells Fargo's Charles Scharf, Goldman Sachs CEO David Solomon and Morgan Stanley's James Gorman.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>In 2008, he was CEO of the biggest bank to ever fail. He's worried about another crisis</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIn 2008, he was CEO of the biggest bank to ever fail. He's worried about another crisis\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-26 11:57 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://edition.cnn.com/2021/05/25/investing/washington-mutual-kerry-killinger-banks/index.html><strong>cnn</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>New York (CNN Business)The banking world nearly caved in 13 years ago. The former CEO of Washington Mutual is worried that another bubble is brewing.\nKerry Killinger was named CEO of WaMu in 1990 and ...</p>\n\n<a href=\"https://edition.cnn.com/2021/05/25/investing/washington-mutual-kerry-killinger-banks/index.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index","SPY":"标普500ETF",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://edition.cnn.com/2021/05/25/investing/washington-mutual-kerry-killinger-banks/index.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1129186705","content_text":"New York (CNN Business)The banking world nearly caved in 13 years ago. The former CEO of Washington Mutual is worried that another bubble is brewing.\nKerry Killinger was named CEO of WaMu in 1990 and was fired in September 2008 -- just weeks before the bank failed as a growing number of mortgage loans went bad.\nWaMu was one of several top financial firms to collapse during the financial crisis last decade, but the giant savings and loan with more than $300 billion in assets still ranks as the biggest-ever bank failure. WaMu was seized by regulators in September 2008 and sold to JPMorgan Chase (JPM) for a fire-sale price of $1.9 billion.\nKillinger spoke to CNN Business about the similarities and differences between now and 13 years ago.\nThe good news\nThe Global Financial Crisis led to a wave of new federal rules that were designed to strengthen the balance sheets of top banks and ensure that another catastrophe like 2008 could never happen again.\nThe good news is that Killinger thinks JPMorgan Chase and other \"too big to fail banks\" are in much better shape now after laws like Dodd-Frank and the Volcker Rule were put into place in the wake of the financial crisis to make big banks safer.\nThat group of institutions also includes Bank of America (BAC), Citigroup (C), Wells Fargo (WFC), Goldman Sachs (GS) and Morgan Stanley (MS), as well as others that received government bailouts in 2008.\n\"Regulated banks do have more concentrated market share now so they have to be more careful,\" Killinger said. \"But the health of the industry is great, earnings are good and oversight is strong. I'm not too concerned there.\"\nSubprime lending, the practice of giving mortgages to people with less-than-worthy credit histories, isn't nearly as prevalent as it was during the last housing boom. But Killinger is worried about bubbles in many other parts of the economy that threaten the stability of the markets.\nToo big to fail 2.0?\nAlthough housing prices have surged again, Killinger is more nervous about the fact that 0% interest rates and big bond purchases by the Federal Reserve have sparked a broader mania in other assets, including cryptocurrencies and non-fungible tokens (NFTs), meme stocks, blank check SPAC mergers and exotic exchange-traded funds.\n\"The bubbles today are broader and deeper in a variety of categories, not just housing,\" Killinger said. \"The Fed's policy of low rates and massive asset purchases worked well to get out of the downturn, but when you keep extending it you can cause unintended consequences.\"\n\"The economy continues to improve. It's time for the Fed to pull in the reins on stimulus and allow interest rates to rise,\" he added.\nKillinger and his wife Linda, a former vice chair of the Federal Home Loan Bank of Des Moines, have written a book about the 2008 meltdown called \"Nothing Is Too Big to Fail: How the Last Financial Crisis Informs Today.\"\nLinda Killinger told CNN Business she's concerned about the rise of of financial tech companies, hedge funds. private equity firms and other so-called shadow banks that face little to no regulation in Washington.\n\"The non-bank system is a big part of the problem. And there are still a lot of loans being done by non-regulated banks such as online banks and many private companies,\" she said.\nLarge financial firms may be embracing too much risk again\nAt least one prominent senator is worried, like the Killingers are, that some financial firms are once again getting too unwieldy.\nElizabeth Warren questioned Treasury secretary Janet Yellen earlier this year about why BlackRock (BLK), the iShares ETF giant that manages more than $9 trillion in assets but is not a bank, is not considered \"too big to fail.\"\nWall Street has already gotten a brief taste of how risky some of these firms are when Archegos Capital Management, a family office with big positions in media giants ViacomCBS (VIACA) and Discovery (DISCA) and Chinese techs Baidu (BIDU) and Tencent Music (TME), imploded and caused billions of dollars in losses for banks. (AT&T (T) is planning to merge its WarnerMedia unit, CNN's parent company, with Discovery.)\nFor its part, the Fed has acknowledged some of the growing risks to the markets and economy from keeping rates lower for longer and continuing to provide crisis-level stimulus.\nIn the minutes of its latest policy meeting, the central bank acknowledged that \"if the economy continued to make rapid progress toward the Committee's goals, it might be appropriate at some point in upcoming meetings to begin discussing a plan for adjusting the pace of asset purchases.\"\nBut Kerry Killinger thinks the Fed has to do a better job of stress-testing big banks for their exposure to some of the types of assets that have been surging in the past year to make sure that they can withstand even more volatility.\n\"The Fed made the mistake of underestimating subprime in the last crisis,\" he said, referring to the now infamous comments from then Fed chair Ben Bernanke in May 2007 that \"the effect of the troubles in the subprime sector on the broader housing market will likely be limited.\"\n\"There are growing asset bubbles,\" Kerry Killinger said. \"The Fed needs to test more how firms would perform if these asset prices decline further. If there is a major correction, the impact could be dramatic.\"\nThe heads of big banks will also get their chance to talk about their views on the economy later this week. The Senate Banking Committee will hold a hearing on Wednesday and the House Financial Services Committee has one scheduled for Thursday.\nJPMorgan Chase CEO Jamie Dimon will appear at both hearings, as will new Citgroup CEO Jane Fraser, BofA's Brian Moynihan, Wells Fargo's Charles Scharf, Goldman Sachs CEO David Solomon and Morgan Stanley's James Gorman.","news_type":1},"isVote":1,"tweetType":1,"viewCount":241,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}